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ABSTRACT 
Nivalenol is a mycotoxin produced by various Fusarium species. The European Commission (EC) asked the 
European Food Safety Authority (EFSA) for a scientific opinion on the risk to human and animal health related 
to the presence of nivalenol in food and feed. A total of 13 164 results for nivalenol in food, feed and 
unprocessed grains, collected in 2001-2011 from 18 European countries, were available for the evaluation. The 
highest mean concentrations for nivalenol were observed in oats, maize, barley and wheat and products thereof. 
Grains and grain-based foods, in particular bread and rolls, grain milling products, pasta, fine bakery wares and 
breakfast cereals, made the largest contribution to nivalenol exposure for humans. Animal exposure to nivalenol 
is primarily from consuming cereal grains and cereal by-products. The available information on the 
toxicokinetics of nivalenol is incomplete. Evidence exists for metabolic de-epoxidation in some species. Based 
on the data available, the Panel on Contaminants in the Food Chain (CONTAM Panel) concluded that the overall 
weight of evidence is that nivalenol is unlikely to be genotoxic. Toxic effects of nivalenol include 
immunotoxicity and haematotoxicity. A reduction in white blood cell (WBC) counts in a 90-day rat study was 
identified as the critical effect for human risk assessment. Using these data and a benchmark dose analysis the 
CONTAM Panel established a tolerable daily intake (TDI) of 1.2 µg/kg b.w. per day. All chronic human dietary 
exposures to nivalenol estimated, based on the available occurrence data in food, are below the TDI, and are 
therefore not a health concern. No toxicity data were identified for ruminants, rabbits, fish and companion 
animals but lowest-observed-adverse-effect levels were identified in pigs and poultry. Based on estimates of 
exposure the risk of adverse health effects of feed containing nivalenol is low for both these species. 
© European Food Safety Authority, 2013 
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SUMMARY 
Nivalenol belongs to the group of trichothecene mycotoxins, which are produced by fungi of the 
Fusarium genus. These fungi are abundant in various cereal crops (wheat, maize, barley, oats and rye) 
and grain based food products (bread, malt and beer). The Fusarium species invade and grow on 
crops, and may produce nivalenol under moist and cool conditions. 
Trichothecenes have a common tetracyclic, sesquiterpenoid 12,13-epoxytrichothec-9-ene ring system 
and are divided into four groups (A-D). The epoxide group between C12 and C13 seems to account for 
many of the typical toxic effects of trichothecenes. Type A and type B tricothecenes are predominant 
in food. Type B toxins include nivalenol, fusarenon-X, deoxynivalenol, 3-acetyl-deoxynivalenol and 
15-acetyl-deoxynivalenol. 
 In 2000, the Scientific Committee on Food (SCF) issued an opinion on nivalenol. The SCF concluded 
that the general toxicity, haematotoxicity and immunotoxicity of nivalenol are the critical effects and 
established a temporary tolerable daily intake (t-TDI) of 0-0.7 µg/kg body weight (b.w.) per day. This 
t-TDI was confirmed by SCF in their opinion on group evaluation of T-2 toxin, HT-2 toxin, nivalenol 
and deoxynivalenol in 2002. The Food Safety Commission in Japan (FSCJ) established in 2010 a TDI 
for nivalenol of 0.4 μg/kg b.w. per day based on decreased white blood cell (WBC) counts observed in 
a 90-day rat study.   
The European Commission (EC) asked the European Food Safety Authority (EFSA) for a scientific 
opinion on the risks to human and animal health related to the presence of nivalenol in food and feed. 
This Scientific Opinion should consider any new results of toxicological studies in order to assess if 
the t-TDI of 0.7 µg/kg b.w. per day for nivalenol derived by SCF is still appropriate. Additionally, the 
opinion should include an updated dietary exposure assessment of nivalenol taking into account recent 
analytical results on the occurrence in food and the consumption patterns of specific (vulnerable) 
groups of the population. It should also include a determination of the daily exposure levels of 
nivalenol for different farm animal species above which signs of toxicity can be observed, and the 
exposure above which the level of nivalenol transfer/carry over from feed to products of animal origin 
for human consumption results in unacceptable levels. The EC also asked for identification of the feed 
materials which could be considered as sources of contamination by nivalenol and characterisation of 
the distribution of levels of contamination for the different feed materials. Finally, EFSA was asked to 
assess the co-occurrence of nivalenol with deoxynivalenol in feed and food and assess whether an 
approach of protecting animals and/or humans against deoxynivalenol exposure is regarded as 
sufficient for protection against exposure to nivalenol or if on the basis of exposure scenarios a 
separate approach for the protection of animals and/or humans against exposure to nivalenol is 
appropriate. 
Methods for the determination of nivalenol are well established and can be applied for the analysis of 
cereals, food and feed as well as samples of human and animal origin. Quantification of nivalenol is 
mostly carried out by liquid chromatography coupled with (multi-stage) mass spectrometry often 
within a multianalyte approach. Rapid immunochemical test kits, able to selectively detect nivalenol, 
have not been developed for routine analysis. None of the chromatographic or immunochemical 
methods has been formally validated in interlaboratory validation studies, and there are no certified 
reference matrix materials available for nivalenol. The Panel on Contaminants in the Food Chain 
(CONTAM Panel) noted that the information on masked forms of nivalenol is very scarce. 
Following a call for data by EFSA, a total of 15 774 results were reported for nivalenol occurrence 
from 2001 to 2011. Data were obtained on samples collected in 18 European countries. The present 
assessment includes data submitted by November 2011. Some analytical results with high limits of 
detection (LOD) and quantification (LOQ) were excluded, as use of these data would bias the outcome 
of the assessment. Overall, 13 164 data on food (n = 3 846), feed (n = 1 707) and unprocessed grains 
(n = 7 611) fulfilled the quality criteria applied and were available for the evaluation. A high 
proportion of results were below the LOD or LOQ in food (90 %) and feed (94 %). For food the vast Nivalenol in food and feed
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majority of data were on grains and grain-based foods and for feed in the groups ‘Compound 
feedingstuffs’ and ‘Cereal grains, their products and by-products’. 
The highest mean concentrations for nivalenol in food, feed and unprocessed grains were observed in 
oats, maize, barley and wheat and products thereof. Higher concentrations were observed in 
unprocessed grains compared to grains for human consumption.  
Six percent of the available samples provided data on both nivalenol and deoxynivalenol. The 
concentrations of nivalenol were generally lower than deoxynivalenol although in some cases the 
concentrations of nivalenol were higher. This finding on co-occurrence is in line with the data reported 
in the literature.  
Reduction of levels of nivalenol is evident in the cleaning and sorting step of processing. Milling does 
not reduce levels of nivalenol per se, but rather results in a redistribution of nivalenol into different 
fractions. Normal cooking conditions appear to have little influence on the reduction of nivalenol 
concentrations in contaminated raw materials. Nivalenol is stable throughout most commercial 
processing that contaminated cereals will undergo. It is unstable under high temperatures (> 150 °C) 
and alkaline conditions, and the rate of degradation increases with increased time and/or temperature 
conditions.  
The CONTAM Panel estimated total chronic dietary exposures to nivalenol across 17 European 
countries, using lower-bound (LB) and upper-bound (UB) mean concentrations, and consumption data 
for different age groups. Exposures in the adult population (minimum LB to maximum UB) ranged 
from 0.4 to 75 ng/kg b.w. per day for average consumers, and 1.1 to 224 ng/kg b.w. per day for high 
(95
th percentile) consumers. In elderly and very elderly populations, the chronic dietary exposure to 
nivalenol was slightly lower compared to other adults. The highest chronic exposure was estimated for 
toddlers (age > 12 months to < 36 months) ranging from 4.3 to 202 ng/kg b.w. per day for average 
consumers, and 12 to 484 ng/kg b.w. per day for high consumers. Grains and grain-based foods made 
the largest contribution to the nivalenol exposure. Important contributors were bread and rolls, grain 
milling products, pasta, fine bakery wares, and breakfast cereals. The limited data on vegetarians do 
not indicate a marked difference in the dietary exposure to nivalenol between vegetarians and the 
general population but are insufficient for a firm conclusion.    
The available information on the toxicokinetics of nivalenol is incomplete. Information on the degree 
of absorption is limited, but it is rapid with a maximum plasma concentration in mice in one hour after 
oral dosing. Nivalenol is rapidly distributed to and eliminated from all examined tissues in mice with 
no apparent accumulation in any organ. In ruminants, it is likely that, as for other trichothecenes, 
extensive de-epoxidation of nivalenol may occur in the rumen prior to absorption. There is evidence of 
major species-dependent differences in the extent of de-epoxidation of nivalenol in non-ruminants, 
which may occur in the lower parts of the gastrointestinal tract in some species. The de-epoxy 
metabolite has been detected in faeces of rats, pigs and laying hens, but not in mice or broiler chicken 
and, based on in vitro studies, it is unlikely to be formed in significant proportions in humans. No 
phase II metabolites of nivalenol have been reported. The available information on the carryover of 
nivalenol from feed to food products of animal origin is very limited. The CONTAM Panel concluded 
that residues of nivalenol in products of animal origin could only marginally contribute to human 
exposure.  
In the assessment of nivalenol by the SCF, the reported LOAELs for developmental toxicity in mice 
were based on intrauterine growth retardation. No new data are available on the developmental and 
reproductive toxicity of nivalenol since the SCF assessment. The CONTAM Panel concluded based on 
the limited available data that developmental and reproductive toxicity is unlikely to be a critical effect 
for nivalenol. Based on the data available, the CONTAM Panel concluded that the overall weight of 
evidence is that nivalenol is unlikely to be genotoxic. The available studies do not allow conclusions 
to be drawn on carcinogenicity of nivalenol in experimental animals. Nivalenol in food and feed
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There is no evidence since the SCF evaluation that other toxic effects occur at doses lower than those 
inducing immunotoxicity and haematotoxicity. Studies in mice, fed diets containing nivalenol for 
24 days, 6 months, 12 months and 24 months, and a recent 90-day study in rats (performed according 
to test guideline No 408 of the Organisation for Economic Co-operation and Development) have 
reported haematological disturbances such as neutropenia, leukopenia, erythropenia and 
thrombocytopenia as critical effects of nivalenol. These effects are known to be adverse effects of 
trichothecenes and have been associated with bone marrow depression. From these studies it was 
concluded that the data for the decrease of white blood cell (WBC) count in rats fed diets containing 
nivalenol for 90 days were most appropriate for benchmark dose (BMD) modelling. The 95 % lower 
confidence limit for the benchmark dose response of 5 % extra risk (BMDL05) was calculated on the 
basis of the combined data for males and females, and was used as a reference point for the risk 
characterisation. This BMDL05 is 0.35 mg nivalenol/kg b.w. per day.  
Since nivalenol is unlikely to be genotoxic the CONTAM Panel considered it appropriate to establish 
a tolerable daily intake (TDI). To establish a TDI an uncertainty factor of 3 was applied for gaps in the 
database in addition to the default uncertainty factor of 100 for inter- and intra-species differences to 
the BMDL05 resulting in a TDI of 1.2 µg/kg b.w. per day.  
All chronic dietary exposures to nivalenol estimated, based on the available occurrence data in food, 
are below the TDI of 1.2 µg/kg b.w. per day, and are therefore not of health concern.  
Animal exposure to nivalenol is primarily from consuming cereal grains and cereal by-products. 
Levels in oilseed meals, and fresh and conserved grass and legume forages are generally low, although 
forage maize and maize silage may be an exception. The animals considered in this Scientific Opinion 
were dairy cows, beef cattle, sheep and goats, pigs and piglets, hens, broiler chickens, turkeys, ducks, 
rabbits, horses, fish, dogs and cats. For lactating dairy cows and beef cattle, the estimated LB and UB 
exposures to nivalenol were between 0.077 and 0.69 µg/kg b.w. per day. Exceptions to this were dairy 
cows and beef cattle fed on diets consisting predominantly of maize silage. The estimated LB and UB 
exposures to nivalenol for these were between 1.9 and 4.6 µg/kg b.w. per day. For small ruminants, 
the estimated LB and UB exposures to nivalenol were between 0.14 and 0.95 µg/kg b.w. per day.  
The estimated LB and UB exposures for pigs were between 0.24 and 1.6 µg/kg b.w. per day, for 
poultry 0.24 and 1.9 µg/kg b.w. per day, for rabbits 0.20 and 0.77 µg/kg b.w. per day, and for horses 
0.090 and 0.35 µg/kg b.w. per day, respectively. LB and UB exposure estimates of 0.054 and 
0.21 µg/kg b.w. per day were calculated for farmed fish. 
For companion animals, estimated LB and UB exposure for dogs (0.10 and 0.40 µg/kg b.w. per day, 
respectively) were marginally higher than for cats (0.091 and 0.35 µg/kg b.w. per day, respectively).  
Information on no-observed-adverse-effect levels (NOAELs) and lowest-observed-adverse- effect 
levels (LOAELs) for farm and companion animals is very limited. There is evidence that rumen 
microorganisms have the capacity to detoxify nivalenol and no adverse effects of nivalenol in 
ruminants have been reported. A time-dependent increase of the plasma concentration of 
immunoglobulin A and pathological changes in the gastrointestinal tract, the kidneys and spleen, and a 
dose-dependent decrease in the enteric oxoglutarate dehydrogenase were observed in young pigs. 
Based on the available data a LOAEL of 100 µg/kg b.w. per day could be identified for young pigs. 
For poultry, the available studies showed some adverse effects, such as gizzard reduced weights and 
erosions in chickens, and pale and fragile livers and pale kidneys in laying hens. Based on these data, 
LOAELs of 360 µg nivalenol/kg b.w. per day for broiler chickens and 53 µg nivalenol/kg b.w. per day 
for laying hens could be identified. No studies were identified which examined adverse effects in 
ruminants, rabbits, fish, horses, cats or dogs. 
For pigs and poultry, the risk of adverse health effects of feed containing nivalenol is low. However, 
the identified LOAELs for pigs and poultry were based on toxicological data reported only in two 
papers on pigs and two papers on poultry. For all other farm livestock and companion animal Nivalenol in food and feed
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categories considered in this Scientific Opinion, the lack of data precludes the estimation of health risk 
from the exposure to nivalenol in feed. However, the susceptibility of ruminants to nivalenol is likely 
to be low, as there is evidence that nivalenol is detoxified by de-epoxidation by rumen 
microorganisms. 
The database describing possible effects of combined exposure to nivalenol and other mycotoxins is 
very weak and not sufficient for establishing the nature of combined effects. 
The available information does not preclude that the approach used for protecting humans against 
deoxynivalenol exposure may be regarded as sufficient for protection against exposure to nivalenol. 
The usefulness of this combined approach can only be fully validated when more extensive dietary 
exposure assessments of deoxynivalenol and nivalenol become available. The CONTAM Panel was 
not able to conclude the same for animals due to the lack of data. 
The CONTAM Panel recommends that methods which have proved suitable for the determination of 
nivalenol in the low µg/kg range should be validated in interlaboratory validation studies, and 
performance criteria should be developed. Certified reference materials should be developed to 
support the determination of nivalenol in food and feed. More information on occurrence of nivalenol, 
including masked nivalenol, and co-occurrence with deoxynivalenol and structurally related 
mycotoxins in food and feed is needed. To further reduce the uncertainties in the risk assessment more 
data on genotoxicity and developmental toxicity are required. 
 Nivalenol in food and feed
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Nivalenol is a mycotoxin produced by fungi of the Fusarium genus, i.e. Fusarium cerealis ( F. 
crookwellence) and Fusarium poae and to a lesser extent also Fusarium culmorum and Fusarium 
graminearum (nivalenol was first isolated from F. nivale Fn2B, an atypical strain of F. 
sporotrichioides). These fungi are abundant in various cereal crops (wheat, maize, barley, oats, and 
rye) and processed grains (malt, beer and bread). The fungi producing trichothecenes are soil fungi 
and are important plant pathogens that grow on the crop in the field. Chemically nivalenol belongs to 
trichothecenes, type B. 
The opinion from the Scientific Committee on Food (SCF) 
The Scientific Committee on Food (SCF) issued on 19 October 2000 an opinion on Fusarium toxins 
Part 4: Nivalenol
4. The SCF concluded that the general toxicity, haematotoxicity and immunotoxicity 
of nivalenol are the critical effects. The SCF decided to use the Lowest Observed Adverse Effect 
Level (LOAEL) of 0.7 mg/kg b.w. from the long-term dietary studies with mice (Ohtsubo et al., 
1989)
5. A large uncertainty factor of 1000 was applied because of the use of a LOAEL and a limited 
database. A temporary tolerable daily intake (t-TDI) of 0-0.7 µg/kg b.w. per day was derived. 
This t-TDI was confirmed by SCF in their opinion on Fusarium toxins - Part 6: Group evaluation of 
T-2 toxin, HT-2 toxin, nivalenol and deoxynivalenol adopted on 26 February 2002
6. 
Available information on nivalenol in feed 
In accordance with Article 36 of Regulation (EC) No 178/2002, a report “Scientific information on 
mycotoxins and natural plant toxicants” has been produced following a grant agreement between the 
European Food Safety Authority (EFSA) and the author(s) of the report 
(CFP/EFSA/CONTAM/2008/01). The report presents information, inter alia, regarding nivalenol in 
feed and is available on the EFSA website (http://www.efsa.europa.eu/en/scdocs/doc/24e.pdf). 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Art. 29 (1) (a) of Regulation (EC) No 178/2002 the Commission asks EFSA for a 
scientific opinion on the risks to human and animal health related to the presence of nivalenol in food 
and feed. 
In particular the opinion should  
a) consider any new results of toxicological studies published since the latest assessment by the 
Scientific Committee on Food of 19 October 2000 on nivalenol in food in order to assess if the 
temporary tolerable intake of 0.7 µg/kg/kg b.w. for nivalenol is still appropriate.  
b) contain an updated dietary exposure assessment of nivalenol taking into account recent analytical 
results on the occurrence of nivalenol in food and the consumption patterns of specific (vulnerable) 
groups of the population (e.g. high consumers, children, people following a specific diet, etc).  
c) determine the daily exposure levels of nivalenol for the different farm animal species (difference in 
sensitivity between animal species) above which 
                                                      
4  Opinion of the Scientific Committee on Food on Fusarium toxins – Part 4: Nivalenol, adopted on 19 October 2000. 
(SCF/CS/CNTM/MYC/26 Final) http://ec.europa.eu/food/fs/sc/scf/out74_en.pdf 
5  Ohtsubo, K., Ryu, LC., Nakamura, K., Izumiyama, N., Tanaka, T., Yamamura, H., Kobayashi, T., and Ueno, Y. (1989) 
Chronic toxicity of of nivalenol in female mice: a 2-year feeding study with Fusarium nivale Fn 2b moulded rice. Food 
Chem Toxicol. 27, 591-598. 
6  Opinion of the Scientific Committee on Food on Fusarium toxins – Part 6: Group evaluation of T-2 toxin, HT-2 Toxin, 
nivalenol and deoxynivalenol adopted on 26 February 2002. (SCF/CS/CNTM/MYC/26 Final) 
http://ec.europa.eu/food/fs/sc/scf/out88_en.pdf Nivalenol in food and feed
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•  signs of toxicity can be observed (animal health / impact on animal health) or 
•  the level of transfer/carry over of nivalenol from the feed to the products of animal origin for 
human consumption results in unacceptable levels of nivalenol. 
•  identify feed materials which could be considered as sources of contamination by nivalenol 
and the characterisation, insofar as possible, of the distribution of levels of contamination for 
the different (groups of) feed materials. 
d) assess the co-occurrence of nivalenol with deoxynivalenol in feed and food and assess whether an 
approach of protecting animals and/or humans against deoxynivalenol exposure is regarded as 
sufficient for protection against exposure to nivalenol, or if on the basis of exposure scenarios a 
separate approach for the protection of animals and/or humans against exposure to nivalenol is 
appropriate. Nivalenol in food and feed
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ASSESSMENT 
 
1.  Introduction 
Nivalenol (12,13-epoxy-3,4,7,15-tetrahydroxytrichothec-9-en-8-one)  is a trichothecene, type B, 
mycotoxin produced by fungi of the Fusarium genus, i.e. F. cerealis (F. crookwellence) and F. poae 
and to a lesser extent also F. culmorum and F. graminearum (Eriksen, 2003). Nivalenol was first 
successfully isolated from F. nivale Fn-2B (Tatsuno et al., 1968). The Fusarium species invade and 
grow on crops, and may produce nivalenol under moist and cool conditions. Nivalenol is 
predominantly found in cereal grains and products thereof (Nordic Council of Ministers, 1998).      
The toxicity of nivalenol has been studied in in vitro and in vivo experiments demonstrating 
immunotoxicity, haematotoxicity/myelotoxicity and developmental and reproductive toxicity. IARC 
(1993) concluded on the available data that there was inadequate evidence of carcinogenicity of 
nivalenol in experimental animals and that nivalenol was not classifiable as to its carcinogenicity to 
humans (Group 3).   
There are reports of human toxicosis incidences possibly linked to intake of Fusarium fungi and 
trichothecene contaminated food but this cannot be conclusively linked to any single toxin (IARC, 
1993; SCF, 2000; FAO/WHO, 2001; Sudakin, 2003; van der Fels-Klerx and Stratakou, 2010). 
However, exposure to dietary nivalenol has been associated with an increased incidence of esophageal 
and gastric cancers in certain regions of China (Hsia et al., 2004). 
1.1.  Previous risk assessments 
The SCF (SCF, 2000) assessed nivalenol primarily based on the report by Nordic Council of Ministers 
(1998). It concluded that general toxicity, immunotoxicity and haematotoxicity are the critical effects 
of nivalenol, but there was limited information on genotoxicity. The LOAEL of 0.7 mg/kg body 
weight (b.w.) from the long-term mouse feeding studies (Ryu et al., 1988; Ohtsubo et al., 1989) was 
used to derive a temporary tolerable daily intake (t-TDI) of 0.7 µg/kg b.w. per day with an uncertainty 
factor of 1000 being applied because of the use of the LOAEL and also the limited database available.   
The SCF subsequently assessed the group-combined effect of common trichothecenes including T-2 
and HT-2 toxins, deoxynivalenol and nivalenol. Conflicting results on both additive and antagonistic 
effects have been reported for T-2 toxin, deoxynivalenol and nivalenol in vitro. No combined effects 
of nivalenol and other toxins were examined in vivo. The SCF concluded to keep the t-TDI for 
nivalenol at 0.7 μg/kg b.w. per day (SCF, 2002). 
The National Institute for Public Health and the Environment (RIVM) in the Netherlands carried out a 
hazard assessment for nivalenol as part of a study in which toxicology and occurrence of six 
trichothecenes were reviewed (Pronk et al., 2002). Using the same data and critical endpoints as those 
used by the SCF they confirmed the t-TDI of 0.7 µg/kg b.w. per day.  
The International Agency for Research on Cancer (IARC) reviewed the available data and evaluated 
the carcinogenicity of nivalenol. Nivalenol was tested in one feeding study in female mice and the 
tumour incidence did not increase. IARC concluded that ‘There is inadequate evidence in 
experimental animals for the carcinogenicity of nivalenol’. Therefore nivalenol was not classifiable as 
to its carcinogenicity to humans (Group 3) (IARC, 1993). 
In Japan, the Food Safety Commission assessed nivalenol risk in 2010 (FSCJ, 2010). It considered that 
a TDI can be established for nivalenol because no clear evidence of cancer promotion or 
carcinogenicity was observed in animal studies, and nivalenol is not classifiable as to its 
carcinogenicity to humans (Group 3) as classified by the IARC assessment (IARC, 1993). Various 
toxicity studies were considered before the decision to use the 90-day subacute toxicity study in rats 
(Takahashi et al., 2008) for establishing the TDI. Decreases in white blood cell (WBC) count were Nivalenol in food and feed
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observed in female rats at 6.25 mg/kg feed and male rats at 100 mg/kg feed. At 100 mg/kg significant 
decreases in body weight, organ weights, platelet and red blood cell count, and histological changes 
were observed in both male and female rats. The TDI was established based on the LOAEL of 
6.25 mg/kg feed corresponding to 0.4 mg nivalenol/kg b.w. per day for the decreased WBC counts. As 
with the SCF approach, an uncertainty factor of 1000 (10 for interspecies differences, 10 for inter-
individual variation, and 10 for the use of the LOAEL in the subacute toxicity study) was applied and 
a TDI for nivalenol was established at 0.4 μg/kg b.w. per day. The Food Safety Commission 
concluded that it was not feasible to set a group TDI for deoxynivalenol and nivalenol, ‘due to the 
limited data on combined-toxicological effect, and considerable discrepancies in dose outcome, and 
the fact that the mode of action of the two toxins are unclear’. The estimated exposure in Japan was 
expected to be below the TDI level and considered to have no risk on public health.   
Recently the Norwegian Scientific Committee for Food Safety (VKM) carried out human and animal 
risk assessment on various mycotoxins in cereal grains in Norway (VKM, 2013). Due to the limited 
occurrence data, dietary exposures to nivalenol were estimated by applying scenarios. It was 
concluded using the t-TDI of 0.7 µg/kg b.w. per day established by the SCF that the exposure to 
nivalenol is not of concern for human health. Based on limited data on nivalenol occurrence in feed 
and toxicity, VKM concluded that for farm and companion animals the risk for adverse effects from 
nivalenol in feed is either negligible or low.   
1.2.  Chemistry of nivalenol 
Nivalenol (see Figure 1) is a mycotoxin belonging to a large group of trichothecenes which are 
produced by Fusarium species. Trichothecenes have a common tetracyclic, sesquiterpenoid 
12,13 epoxytrichothec-9-ene ring system and are divided into four groups (A-D) according to different 
chemical functionalities. The epoxide group between C12 and C13 seems to account for many of the 
typical toxic effects of trichothecenes (Betina, 1989). Epidemiological surveys have demonstrated that 
the predominant type A and B trichothecenes are widely distributed in cereals and feeds as natural 
pollutants, whereas C (characterised by a second epoxide at C 7,8 or C 9,10) and D trichothecenes 
(containing an ester-linked macrocycle at C 4,16) occur rarely in food and feed. Type A trichothecenes 
include T-2 toxin, HT-2 toxin and 4,15-diacetoxyscirpenol, and type B toxins include nivalenol, 
fusarenon-X, deoxynivalenol (Figure 1)
7, 3-acetyl-deoxynivalenol and 15-acetyl-deoxynivalenol. 
Nivalenol was first successfully isolated from F. nivale Fn-2B, an atypical strain of 
F. sporotrichioides, in 1967 (Tatsuno et al., 1968), but it is also produced by other Fusarium species 
such as F. poae and to a lesser extent F. culmorum and F. graminearum (Weidenbörner, 2001; Eriksen 
et al., 2003). 
                                                      
7    Deoxynivalenol is the trivial name for (3 α,7  α)-12,13-epoxy-3,7,15-trihydroxytrichothec-9-en-8-one (CAS registry 
number 51481-10-8). Nivalenol in food and feed
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Figure 1:   Chemical structures of nivalenol, de-epoxy nivalenol and Deoxynivalenol. 
Nivalenol is the trivial name for (3α,4β,7α)-12,13-epoxy-3,4,7,15-tetrahydroxytrichothec-9-en-8-one 
(Chemical Abstracts Service (CAS) registry number 23282-20-4). Corresponding to the molecular 
formula C15H20O7, its molecular weight is 312.3 g/mol. Nivalenol is a white crystalline powder with 
a melting point of 222-223 °C and its specific rotation has been determined as [α]24D = + 21.54° 
(c  =  1.3 mmol/L in ethanol) (Tatsuno et al., 1968). Nivalenol can be metabolised to de-epoxy 
nivalenol ((3α,4β,7α)-3,4,7,15-tetrahydroxytrichothec-9,12-dien-8-one (CAS registry number 
118298-08-1) (Figure 1).  
Nivalenol is soluble in organic solvents with medium to high polarity, such as acetonitrile, methanol, 
ethanol, ethyl acetate and chloroform, and slightly soluble in water (Budavari, 1989). In acetonitrile, 
nivalenol shows a maximum ultraviolet (UV) absorption at 220 nm (Sydenham et al., 1996) and a 
molar absorption coefficient (ε) of 6955 +/- 205 L/mol (Krska et al., 2007). 
Calibrants (standard solutions) of nivalenol in acetonitrile are stable at temperatures up to 25 °C for at 
least 24 months, whereas keeping nivalenol for a period longer than 12 months in ethyl acetate or as 
thin film at temperatures above freezing should be avoided (Widestrand and Petterson, 2001). 
2.  Legislation 
Worldwide no legal maximum levels have been set for nivalenol in food (Leatherhead Food Research, 
2010; Sugita-Konishi and Nakajima, 2010) or feed products (FAO, 2004). In the European Union 
(EU) Community procedures for the establishment of maximum levels in food are laid down in 
Council Regulation (EEC) No 315/98
8. Article 2 of this Regulation stipulates that if necessary in order 
                                                      
8  Council Regulation (EEC) No 315/93 of February 1993 laying down Community procedures for contaminants in food . OJ 
L 37, 13.2.1993, p. 1-5. 
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to protect public health the EC may establish maximum levels for specific contaminants. Once 
adopted they are laid down in the Annex of Commission Regulation (EC) No 1881/2006
9. Nivalenol is 
not included in this Annex. 
Council Directive 2002/32/EC
10 regulates undesirable substances in animal feed. Annex I of this 
Directive contains maximum levels of a number of inorganic and organic contaminants in feed. 
Nivalenol is not regulated under this Directive, neither is it mentioned in Commission 
Recommendation 2006/576/EC
11, in which guidance values are listed for various mycotoxins in 
products intended for animal feeding. 
In contrast, detailed maximum levels and guidance values for deoxynivalenol have been included in 
Commission Regulation (EC) No 1881/2006
9, and in Commission Recommendation 2006/576/EC
11, 
respectively. These are listed in Tables 1 and 2. This information is relevant to the terms of reference 
provided by the EC: to assess the co-occurrence of nivalenol with deoxynivalenol in feed and food 
(see Section 8.3). 
Table 1:   Maximum levels for deoxynivalenol in foodstuffs in the EU (Commission Regulation 
(EC) No 1881/2006
9). 
Point   Foodstuff   Maximum level  
(µg/kg) 
1.  Unprocessed cereals other than durum wheat, oats and maize  1250 
2.  Unprocessed durum wheat and oats  1750 
3.  Unprocessed maize, with the exception of unprocessed maize intended to be 
processed by wet milling 
1750 
4.  Cereals intended for direct human consumption, cereal flour, bran and germ as 
end product marketed for direct human consumption, with the exception of 
foodstuffs listed in points 7, 8 and 9 
750 
5. Pasta  (dry)  750 
6.  Bread (included small bakery wares), pastries, biscuits, cereal snacks and 
breakfast cereals 
500 
7.  Processed cereal-based foods and baby foods for infants and young children  200 
8.  Milling fractions of maize with particle size > 500 micron falling within CN code 
1103 13 or 1103 20 40 and other maize milling products with particle size > 500 
micron not used for direct consumption falling within CN code 1904 10 10. 
750 
9.  Milling fractions of maize with particle size ≤ 500 micron falling within CN code 
1102 20 and other maize milling products with particle size ≤ 500 micron not 
used for direct consumption falling within CN code 1904 10 10. 
1250 
CN: Combined Nomenclature (Maize milling  fractions are classified according to the particle size in different headings in 
the Combined Nomenclature based upon a rate of passage through a sieve with an aperture of 500 microns.). 
 
                                                      
9  Regulation (EC) No 1881/2006 of the European Parliament and the Council of 19 December 2006 setting maximum levels 
for certain contaminants in foodstuffs. OJ L 364, 20.12.2006, p. 5-24. 
10   Directive 2002/32/EC of the European Parliament and the Council of 7 May 2002 on undesirable substances in animal 
feed. OJ L140, 30.5.2002, p. 10-21. 
11    Commission Recommendation 2006/576/EC of 17 August 2006 on the presence of deoxynivalenol, zearalenone, 
ochratoxin A, T-2 and HT-2 and fumonisins in products intended for animal feeding. OJ L 229, 23.8.2006, p. 7-9. Nivalenol in food and feed
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Table 2:   Guidance values for deoxynivalenol in products intended for animal feed in the EU 
(Commission Recommendation 2006/576/EC
11). 
 
Products intended for animal feed 
Guidance value in mg/kg 
relative to a feeding stuff with 
a moisture content of 12 % 
Feed materials   
Cereals and cereal products with the exception of maize by-products  8 
Maize by-products  12 
Complementary and complete feeding stuffs with the exception of:  5 
Complementary and complete feeding stuffs for pigs  0.9 
Complementary and complete feeding stuffs for calves (< 4 months), 
lambs and kids 
2 
 
3.  Analysis 
3.1.  Sampling and storage 
Due to the possible inhomogeneous distribution of trichothecenes in lots (of grains), sampling may 
contribute to a significant extent to the variability in analytical results. In the Commission Regulation 
(EC) No 401/2006 of 23 February 2006
12 methods of sampling for the official control of the levels of 
mycotoxins are laid down. In Annex I of this Regulation general provisions for sampling are stated in 
part A, and specific provisions for the sampling of cereals and cereal products in part B. After 
sampling, the samples are stored under appropriate conditions (dry, preferably frozen) until analysis in 
order to prevent Fusarium fungi from further growth and toxin production. 
3.2.  Determination of nivalenol  
Since nivalenol usually occurs as a co-contaminant especially with other type B trichothecenes it is 
often analysed simultaneously with this group of mycotoxins rather than alone. Analytical approaches 
to determine nivalenol in general do not differ from procedures applied to other trichothecenes.  
Many analytical methods for the determination of type B trichothecenes including nivalenol have been 
published in the last decade. Suitable analytical methodology, which has been summarised in some 
earlier published reviews (Langseth and Rundberget, 1998; Krska et al., 2001; Sforza et al., 2006) 
relied until recently predominantly on gas chromatography coupled with electron capture detection 
(GC-ECD), flame ionisation detection (GC-FID), and gas chromatography coupled with to mass 
spectrometric detection (GC-MS). Recent trends in mycotoxin analysis, also for nivalenol, have led to 
the development of fast highly efficient and accurate analytical methods based on liquid 
chromatography coupled with mass spectrometry (LC-MS) techniques with simple minimal clean-up, 
which are applicable for a wide range of matrices (Lattanzio et al., 2009; Rahmani et al., 2009; 
Shephard et al., 2010, 2011).  
3.2.1.  Analyte isolation  
For the extraction of nivalenol from food and feed, including grains and grain-based products, mostly 
organic solvent/water mixtures are used such as methanol/water and acetonitrile/water, with the 
organic solvent predominating. A high amount of organic phase in the extraction solvents significantly 
reduces unwanted ion suppression phenomena observed in LC/MS (Klötzel et al., 2005).  
Following extraction, the resulting extract is usually further processed to remove impurities and often 
concentrated to make determination of trichothecenes, including nivalenol, at low concentrations 
possible. The clean-up procedures usually involve the use of various types of multifunctional solid 
                                                      
12   Regulation (EC) No 401/2006 of the European Parliament and the Council of 23 February 2006 laying down the methods 
of sampling and analysis for the official control of the levels of mycotoxins in foodstuffs – OJ L 70, 9.3.2006, p. 12-34. Nivalenol in food and feed
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phase extraction (SPE) columns which are commercially available, and may contain silica, charcoal, 
Florisil®, C8, C18 and aluminium oxide (Lattanzio et al., 2009). Immunoaffinity columns, designed 
for the simultaneous purification of nivalenol and deoxynivalenol have been introduced on the market 
only recently. 
Another option, only recently introduced in multi-mycotoxin analysis, is the use of the various 
modifications of the QuEChERS approach (Quick, Easy, Cheap, Effective, Rugged and Safe 
approach) (Anastassiades et al., 2003). This approach is currently widely being used in multi-pesticide 
analysis, for very fast extraction and purification. The key principle is the partitioning of an 
acetonitrile-water mixture induced by addition of inorganic salts. While the analytes are largely 
transferred into an organic phase, more polar matrix impurities and a part of the nivalenol are left in an 
aqueous layer. Up to now, the QuEChERS approach has been successfully applied for the extraction 
of nivalenol from cereals with recoveries ranging from 37 to 100 % depending on the type of matrix 
and the QuEChERS method used. Clearly, recoveries are lower, ranging from 54 % to 86 %, for 
complex matrices such as silage (Rasmussen et al., 2010) or 37-75 % for cereal-based product 
(Desmarchelier et al., 2010; Tamura et al., 2011; van Pamel et al., 2011) and higher (95-100 %) for 
cereals (Cunha and Fernandes, 2010; Sospedra et al., 2010; Zachariasova et al., 2010a; Kadota et al., 
2011). 
3.2.2.  Chromatographic methods 
Chromatographic methods have been developed for the identification and quantification of several 
trichothecenes including nivalenol in various matrices including food and feed as well in samples of 
human and animal origin.  
In the past, methods based on GC were routinely used for the determination of nivalenol together with 
other trichothecenes. However, GC-based methods suffer from some significant drawbacks. The major 
one is the need to carry out rather time-consuming derivatization of analytes prior to determination. 
The majority of the GC methods for the determination of nivalenol in food and cereals have been 
based on the derivatization of hydroxyl groups forming trimethylsilyl (TMS) derivates with 
subsequent electron capture detection (GC-ECD) (Tanaka et al., 1990; Liu et al., 1997; Weingärtner et 
al., 1997). Typical limits of detection of GC-ECD methods for all trichothecenes are usually in the 
range of 20-50 µg/kg (Weingärtner et al., 1997). Another drawback is that GC-based methods tend to 
show a higher response for samples spiked with trichothecenes including nivalenol than for pure 
calibrants at the same concentration level. This ‘matrix response enhancement’ seems to be even more 
pronounced for gas chromatographs equipped with MS-detectors (Krska et al., 2001; Pettersson and 
Langseth, 2002a,b).  
Although the number of newly published applications of GC-MS in the analysis of nivalenol and other 
trichothecenes is small, recently heart-cutting GC-MS
13 for the determination of nivalenol together 
with four other trichothecene mycotoxins after QuEChERS extraction/purification has been developed 
and validated for breakfast cereals (Cunha and Fernandes, 2010). Recently Ibañez-Vea et al. (2011) 
employed a GC-MS based method for the determination of nivalenol and seven other trichothecenes in 
barley grains. Nivalenol was determined as a pentafluoropropionic-derivate with a limit of detection of 
1.3 µg/kg and a recovery of 63 %.  
High performance liquid chromatography (HPLC) currently represents the dominating separation 
strategy in nivalenol determination. Although methods based on HPLC followed by UV detection 
and/or fluorescence detection (FLD) have been published, the small number of publications indicates a 
less frequent use of this ‘classic’ approach. UV detection does not require derivatization but can only 
be performed at 220 nm (Sforza et al., 2006). Using this approach nivalenol has been determined 
(together with deoxynivalenol) at levels down to 50 µg/kg in cereals. The major drawback of 
                                                      
13   In the heart-cutting technique, one or more unresolved fractions from a first column (first dimension) are transferred to a 
second one having a different polarity (second dimension) where the separation of the compounds will be achieved. This 
leads to substantially increased resolving power. Nivalenol in food and feed
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HPLC-UV detection is the high background noise caused by co-extracted compounds (MacDonald et 
al., 2005; Stroka et al., 2006). FLD detection generally leads to lower detectability and selectivity of 
the measurement compared to HPLC-UV. However, this approach requires pre- or post-column 
derivatization by reagents containing fluorophores (Langseth and Rundberget, 1998; Young et al., 
2006). These methods are usually limited by incomplete or irreproducible derivatization which has 
especially been observed for nivalenol, as a result of the presence of a higher number of hydroxyl 
groups in the molecule (Mateo et al., 2002).  
High and ultra-high performance liquid chromatography (HPLC/U-HPLC) coupled to various mass 
spectrometric (MS) detectors has become the most frequently employed hyphenated technique in 
mycotoxin determination and especially for the simultaneous determination of multiple groups of 
mycotoxins, including nivalenol. The majority of HPLC-MS-based methods for the quantification of 
nivalenol and other B-trichothecenes is based on tandem mass spectrometry (MS/MS) in combination 
with selected reaction monitoring (SRM) (Gottschalk et al., 2009; Jin et al., 2010; Rasmussen et al., 
2010; Sulyok et al., 2010). Monitoring two transitions (precursor ion → product ion) using SRM-LC-
MS/MS also provides a sufficient number of identification points for reliable identification of 
nivalenol. Moreover, the high selectivity of the LC-MS/MS measurements enables the reduction or 
even omission of the clean-up procedure, thus increasing sample throughput. Acetic acid, ammonium 
acetate, formic acid and ammonium formate are commonly applied as additives to the mobile phase 
either to improve the chromatographic separation or to enforce adduct formation for improving MS 
sensitivity or structural elucidation.  
Both atmospheric pressure chemical ionization (APCI) and electrospray ionization (ESI) modes have 
been successfully applied in the positive as well as in the negative ion mode for the determination of 
nivalenol and other type B trichothecenes. The sensitivity of APCI was reported to be inferior to ESI 
probably due to APCI in-source fragmentation. Moreover, ESI seems to be more robust in comparison 
to APCI and is thus the more frequently employed interface for analysis of mycotoxins including 
nivalenol (Monbaliu et al., 2009; Santini et al., 2009;  Desmarchelier et al., 2010; Han et al., 2010; 
Sospedra et al., 2010; Zachariasova et al., 2010a). Recently, the applicability of atmospheric pressure 
photoionization (APPI) for the determination of nivalenol and deoxynivalenol in wheat has been 
studied (Tanaka et al., 2009). The main benefit of using APPI is the significant reduction of matrix 
effects that allows achievement of high-selective and high-sensitive determination of nivalenol 
(LOD = 0.2 µg/kg).  
Although solid phase extraction (SPE) columns and/or multifunctional columns are so far included in 
almost all extract purification procedures (Gottschalk et al., 2009; di Mavungu et al., 2009; Monbaliu 
et al., 2010), recently also the application of the simple ‘dilute and shoot’ approaches (Sulyok et al., 
2006) and QuEChERS-based methods have been introduced for the determination of nivalenol 
(Desmarchelier et al., 2010; Rasmussen et al., 2010; Sospreda et al., 2010; Vaclavik et al., 2010; 
Zachariasova et al., 2010a). Nivalenol, together with 86 other mycotoxins, was determined in a diluted 
extract of acetonitrile-water-acetic acid mixture by means of an in-house validated LC-MS/MS 
method (Sulyok et al., 2007). Although this ‘dilute and shoot’ approach is fully applicable for 
mycotoxin determination including nivalenol in relatively simple matrices, such as cereals, its 
employment in the analysis of complex matrices such as feed is still challenging and often requires 
matrix matched calibration and/or isotopically labelled internal standard to compensate the matrix 
effects.  
A more recent development is the use of approaches that enable retrospective data analysis and 
identification of unknown signals in sample extracts. In this context the performance of two sample 
preparation approaches, employing a raw extract and QuEChERS-like extract, has been tested and 
validated for the determination of 11 Fusarium toxins including nivalenol (Zachariasova et al., 2010a). 
In both cases, UHPLC coupled with high-resolution mass spectrometry (HRMS) was employed. For 
time-of-flight mass spectrometry (TOF-MS), the use of QuEChERS modified by acidification and 
omission of primary-secondary amine (PSA) sorbent was required to decrease the LOD for nivalenol 
significantly (50 µg/kg compared to 125 µg/kg for the analysis of the raw extract). Direct analysis of Nivalenol in food and feed
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crude extracts of cereals achieved an LOD of 25 µg/kg using Orbitrap technology (Zachariasova et al., 
2010a). 
Examples of recently published in-house validated chromatography – MS methods for the 
determination of nivalenol are given in Table 3. 
 Nivalenol in food and feed
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Table 3:   Examples of in-house validated chromatography-mass spectrometry methods for the determination of nivalenol. 
Matrix Extraction Clean-up  Detection  Analyte  LOD 
(µg/kg) 
LOQ 
(µg/kg) 
Recovery 
(%)  Reference 
cereals ACN-H2O  home-made cartridges (silica gel, 
florisil and kieselguhr)  U-HPLC-ESI-MS/MS  Multitoxin method 
including NIV  0.25 0.74 91-104  Jin  et  al.  (2010) 
cereals  Quechers-like 
method  not reported  U-HPLC-ESI-TOF-MS  Multitoxin method 
including NIV  50 100  95-99  Zachariasova et 
al. (2010)a 
cereals ACN-H2O home-made  columns  U-HPLC-MS/MS  Multitoxin method 
including NIV  0.25-0.53 0.74-1.58 79-93  Jin  et  al.  (2010) 
cereals  ACN-H2O, ASE 
extraction  no HPLC-ESI-MS/MS  Multitoxin method 
including NIV  185-300 400-620 77  Kokkonen et al. 
(2009) 
wheat ACN-MetOH  no  GCxGC-TOF  MS Multitoxin method 
including NIV  10  not reported  not reported  Jelen and 
Wasowicz (2008) 
maize, 
wheat 
ACN-H2O-
AcOH  no HPLC-ESI-MS/MS  Multitoxin method 
including NIV  20-30 not  reported  67-80 Sulyoket al. 
(2006) 
wheat ACN-H2O  home-made cartridges (silica gel 
and florisil)  HPLC-APPI-MS/MS  NIV and DON  0.2  not reported  86  Tanaka et al. 
(2009) 
wheat and 
maize  ACN-H2O no  HPLC-APCI-MS/MS  Multitoxin method 
including NIV  3.6 5  80  Santini et al. 
(2009) 
barley ACN-H2O multifunctional  columns  GC-MS  Multitoxin method 
including NIV  1.3 10  72  Ibanez-Vea et al. 
(2011) 
barley, malt  ACN-H2O  no HPLC-APCI-MS/MS  Multitoxin method 
including NIV  5 10  68-75  Malachova et al., 
2010 
wheat flour  Quechers-like 
method  not reported  HPLC-ESI-MS/MS  Multitoxin method 
including NIV  30 100  100  Sospreda et al. 
(2010) 
cereal-based 
products 
Quechers-like 
method  not reported  U-HPLC-APCI-MS/MS  Multitoxin method 
including NIV  not reported  25  86  Malachova et al., 
2011 
cereals, 
cereal-based 
products 
ACN-H2O  SPE-cartridges, multifunctional 
columns  HPLC-APCI-MS/MS  Multitoxin method 
including NIV  2.5-3.6 not  reported  71.8-99.1  Lattanzio et al., 
2008 
cereal-based 
products 
Quechers-like 
method  not reported  HPLC-ESI-MS/MS  Multitoxin method 
including NIV  not reported  100  54-60  Desmarchelier et 
al. (2010) Nivalenol in food and feed
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Table 3:  Continued. 
Matrix Extraction Clean-up  Detection  Analyte  LOD 
(µg/kg) 
LOQ 
(µg/kg) 
Recovery 
(%)  Reference 
beer  addition of 
ACN  no  U-HPLC-APCI-
Orbitrap MS 
Multitoxin method 
including NIV  4-6
(a) not  reported  96-107  Zachariasova et. 
al (2010b) 
silages  Quechers-like 
method  not reported  HPLC-ESI-MS/MS  Multitoxin method 
including NIV  122 not  reported  68  Rasmussen et al. 
(2010) 
 
MetOH: methanol; H2O: water; ACN: acetonitrile; AcOH: acetic acid; EtOAc: ethyl acetate; HCOOH: formic acid; QuEChERS: quick, easy, cheap, effective, rugged and safe; ACE: accelerated 
solvent extraction; GC: gas chromatograph; MS: mass spectrometer; HPLC: high performance liquid chromatograph; APPI: atmospheric pressure photoionisation; MS/MS: tandem mass 
spectrometer; U-HPLC: ultra high performance-liquid chromatograph; TOF-MS: Time-of-flight mass spectrometer; APCI: atmospheric pressure chemical ionisation; ESI: electrospray 
ionisation; NIV: nivalenol; DON: deoxynivalenol; SPE: solid phase extraction. 
(a):  Reported lowest calibration levels (LCL). Nivalenol in food and feed
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3.2.3.  Immunochemical methods  
Immunochemical methods selective to detect nivalenol have not been developed, as nivalenol is not a 
regulated mycotoxin and because the development of a nivalenol-specific antibody has been shown to 
be difficult. Some of the currently available immunochemical tests developed for deoxynivalenol also 
detect nivalenol but information about the LOD is not available (Meneely et al., 2011), except for a 
surface plasmon resonance (SPR) immunoassay developed to measure nivalenol and deoxynivalenol 
contamination in wheat. For this method an LOD for nivalenol of 0.2 mg/kg wheat was reported 
(Kadota et al., 2010).  
3.2.4.  Other approaches 
Apart from the MS techniques described in Section 3.2.2 an emerging technique is direct analysis in 
real time (DART). Like other ambient techniques, (chromatographic) separation and clean-up are 
omitted. This method employs excited-state helium atoms to produce reactive species for APCI-like 
ionization of the analytes that occur in vapour phase following their thermo-desorption from the test 
portion. Vaclavik et al. (2010) demonstrated the potential of DART coupled to ultra high resolving 
power orbitrap MS to quantify selected trichothecenes (including nivalenol), Alternaria toxins, 
zearalenone, and sterigmatocystin in QuEChERS-based extracts prepared from cereals. The lowest 
calibration level of 70 µg/kg for nivalenol in wheat and maize is comparable with LC-MS methods.  
Whereas matrix interferences in extracts can have a significant effect on response in MS detectors, 
electroactive interferents are relatively rare. This offers advantages, in principle, for electrochemical 
measurements. Of interest is the finding of Hsueh et al. (1999) that group B trichothecenes give rise to 
electroactive compounds after a hydrolysis step performed in basic solution. Ricci et al. (2009) applied 
this approach in an analytical method involving a microwave hydrolysis procedure for the production 
of electroactive compounds from deoxynivalenol and nivalenol in combination with screen-printed 
electrodes and a new 96 well electrochemical plate. Screen-printed electrodes offer several advantages 
to the classic electrode surfaces usually adopted in analytical chemistry applications. They are 
inexpensive, easy to produce and require only low extract volumes. However, the method of Ricci et 
al. (2009) is not able to distinguish between deoxynivalenol and nivalenol and, despite the above-
mentioned advantages, electrochemical methods for nivalenol may currently found only in academic 
research circles and (commercial) applications of this approach are not available yet.  
3.3.  Analytical Quality Assurance: performance criteria, reference materials and 
proficiency testing 
In Annex II of the Regulation (EC) No 401/2006 of 23 February 2006 laying down the methods of 
sampling and analysis for the official control of the levels of mycotoxins in foodstuffs
14, criteria for 
methods of analysis are laid down. Performance criteria for methods of analysis of nivalenol are, 
however, not yet established.  
  The quality of analytical results in regard to accuracy, precision and comparability is essentially 
linked to the use of reference materials (RMs) and certified reference materials (CRMs). So far, no 
matrix CRMs are available for nivalenol. However, calibrant solutions of nivalenol are commercially 
available, and a certified calibrant solution of 24.0 µg nivalenol/g acetonitrile) has become available 
(Buttinger et al., 2006). Nivalenol has recently also entered the market as fully 
13C-labelled (internal) 
standard offered by a commercial supplier. Proficiency tests for nivalenol have not been organised yet. 
3.4.  Conclusions 
The described analytical methods for the determination of nivalenol have been applied to various 
matrices including cereals, food and feed as well as to samples of human and animal origin. 
                                                      
14   Commission Regulation (EC) No 401/2006 of 23 February 2006 laying down the methods of sampling and analysis for the 
official control of the levels of mycotoxins in foodstuffs OJ L 70, 9.3.2006, p. 12-34. Nivalenol in food and feed
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Quantification of nivalenol is mostly carried out by LC coupled with (multi-stage) MS often within a 
multianalyte approach. However, complex matrices and the resulting signal suppression effects as 
observed particularly in ESI-MS methods owing to matrix effects, may require the careful 
optimisation of the clean-up, the usage of matrix matched calibrants, or the use of isotopically labelled 
internal standards. Due to the scarcity of appropriate antibodies, no rapid immunochemical methods 
(ELISAs) specific for nivalenol have become available or are being sold as commercial test kits. A 
surface plasmon resonance immunoassay allows the possibility to determine nivalenol selectively, but 
this method is currently still at research stage and not yet suitable for routine applications. None of the 
chromatographic or the immunochemical methods has been formally validated in interlaboratory 
validation studies. Despite the availability of a certified calibrant for nivalenol, there are no certified 
reference matrix materials available for this mycotoxin.  
4.  Occurrence of nivalenol in food and feed 
4.1.  Previously reported occurrence data   
The occurrence of nivalenol in cereal grains and food products in Europe during the period 2001-2009 
has been reported in the literature from 2001 to 2010.  
4.1.1.  Occurrence of nivalenol in cereal grains  
The data available from published studies are summarised in Appendix A, Table A1. In several of the 
studies incomplete datasets were reported, and it was not always clear how mean and median values 
were calculated (e.g. based on all data or based on positive data only) and how analytical data below 
the LOD/LOQ were treated. Specific observations on some studies (studies with data of the most 
concern in terms of incidence and levels) from Northern, Western, Central and Southern Europe are 
presented below. 
In an overview of occurrence data submitted to EC within the Scientific Co-operation (SCOOP) 
project by seven European countries mainly from the northern region of Europe
15, it appears that there 
is a variety of crops likely to be affected by nivalenol. The toxin was found in 16 % of 4 166 grain 
samples (collected since 1990) that were analysed with the highest occurrence of nivalenol noted in 
maize, oats and wheat (Gareis et al., 2003).  
Another study was performed in the United Kingdom (UK) in which 1624 wheat samples were 
analysed for nivalenol contamination and 67 % of the samples were positive with mean and maximum 
concentrations of all samples being 27 µg/kg and 430 µg/kg, respectively. The maximum 
concentration of nivalenol reported in the literature from 2001 to 2010 for oats from the UK was 
847 µg/kg and it was noted that nivalenol was among the most commonly detected Fusarium toxins 
after DON, T-2 and HT-2 toxins (Edwards, 2009a). In a total of 458 oats samples collected and 
analysed over a 4-year period (from 2002 to 2005) in the UK, nivalenol was detected in 72 % of all 
samples with a mean concentration of 49 µg/kg (Edwards, 2009a). Another 3-year study (2006-2008) 
from the UK in which freshly harvested wheat was analysed reported very low levels of nivalenol with 
mean concentrations in all samples of 7.7 (n = 40), 13 (n = 50) and 8.6 µg/kg (n = 50) in 2006, 2007 
and 2008, respectively (Baxter et al., 2009). The maximum levels reported were 38 µg/kg and 
46 µg/kg in 2006 and 2008 while the maximum level in 2007 was 164 µg/kg). In freshly harvested 
malting barley samples from the same study the levels of nivalenol were reported to be low in this 
study, with mean concentrations in all samples at 4.2 (n = 20), 9.8 (n = 40) and 15 µg/kg (n = 36) for 
the years 2006, 2007 and 2008, respectively. In another study of barley samples (n = 446) collected in 
the UK nivalenol was detectable in 25 % of all samples (Edwards, 2009c). 
In Germany, Schollenberger et al. (2006) reported data on nivalenol in wheat, oats and maize. In the 
years 2000/2001, the highest mean and maximum levels for positive samples were 406 and 
1388 µg/kg respectively in maize (n = 24) (Schollenberger et al., 2005a). Nivalenol was also reported 
                                                      
15   Austria, Denmark, Finland, France, Norway, Sweden and United Kingdom (UK). Nivalenol in food and feed
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in 23 % (n = 44) and 48 % (n = 40) of maize samples randomly collected from different maize fields 
in Germany in the years 2006 and 2007 (Goertz et al., 2010). The mean (of positive samples) and 
maximum concentrations were 160 and 4410 µg/kg, respectively, in 2006. In the year 2007 the mean 
(of positive samples) and maximum concentrations were 210 and 2120 µg/kg, respectively. In 
Luxembourg, nivalenol was detected in winter wheat samples at a maximum concentration of 
293 µg/kg (Giraud et al., 2010).  
A study conducted in the Czech Republic on wheat samples (n = 41), showed 78 % to be positive for 
nivalenol (Hajšlová et al., 2007). Barley samples collected soon after harvesting in a 4-year study from 
the Czech Republic were reported to be contaminated by nivalenol at mean concentration levels in 
positive samples of 4, 2, 45, and 4 µg/kg for the years 2005, 2006, 2007 and 2008, respectively 
(Malachova et al., 2010).  
In Southern Europe a rather high mean concentration of 549 µg/kg in positive samples was reported in 
maize samples (n = 46) from Italy, in the year 2002 (Cavaliere et al., 2005). In barley samples from 
Spain, collected in 2007 and 2008 (n = 123) the mean nivalenol concentration in positive samples was 
reported to be 21 µg/kg, while the maximum concentration was found to be 143 µg/kg (Ibañez-Vea et 
al., 2012).  
Generally there are more data reported on the incidence of nivalenol in wheat (products) than in the 
other cereals (products) during the last decade. From Appendix A, Table A1 it can be seen that the 
highest maximum levels of nivalenol have been reported in maize and oats. The incidence of 
nivalenol-positive samples seems to be higher in oats, than maize. With the data presented in the table 
it is difficult to draw further conclusions, since regions and/or commodities cannot be compared 
meaningfully. This is due to the nature of the data that are available, that is, the data are collected over 
varying time periods and this could induce bias in occurrence data, since weather conditions naturally 
differ between countries, seasons and years.  
4.1.2.  Occurrence of nivalenol in food products 
Data on the occurrence of nivalenol in food products are limited. The reported studies are summarised 
in Appendix A, Table A2. In some of the studies incomplete data sets were reported, and it was not 
always clear how mean and median values were calculated (e.g. based on all data or based on positive 
data only) and how analytical data below the LOD/LOQ were treated. A large variety of products was 
investigated. Specific observations on some selected studies from Germany, Spain and the Netherlands 
have been made below. 
In an analysis of the Fusarium toxin content of foodstuffs of plant origin marketed in Germany, 
nivalenol was found in 40 %, 100 % and 4 % of wheat germ (n = 5), wheat bran (n = 5) and gluten free 
food (n = 23) samples, respectively. The mean concentrations in the positive samples were 26, 37 and 
21 µg/kg, respectively (Schollenberger et al., 2005b). In 130 samples of wheat and wheat products 
(comprising wheat flour, whole wheat flour, wheat kernels, wheat bran, semolina and wheat-based 
infant food) from Germany, nivalenol was reported at a mean concentration in all samples of 
6.8 µg/kg (Gottschalk et al., 2009). The wheat products (see Appendix A, Table A2). In the same 
study, nivalenol was not detected in rye flour (n = 15) and whole rye flour (n = 9) but was detected in 
rye kernels (n = 37) at a mean concentration of 0.1 µg/kg and a maximum concentration of 1.8 µg/kg 
in all samples (Gottschalk et al., 2009). In samples of oat products from Germany (n = 98) nivalenol 
was reported with the highest concentrations in fine oat flakes (mean concentration of 2 µg/kg and 
maximum concentration of 17 µg/kg in all samples (n = 31) (Gottschalk et al., 2009). The other oats 
products analysed were oat bran, oat kernels and oat-based infant food, and the individual means and 
maximum concentrations for each product are summarised in Appendix A, Table A2. Nivalenol was 
not detected in samples of refined edible oil (n = 61) and non-refined oil (n = 49) produced from 
soybean, sunflower and corn germ which was obtained from the German market in 2004 and 2005 
(Schollenberger et al., 2008). Nivalenol was also not detected in any of the samples (n = 45) of soy 
food marketed in Germany and analysed in a separate study (Schollenberger et al., 2007).  Nivalenol in food and feed
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Nivalenol was reported in 11 % of maize-based breakfast cereals (n = 55) and 1.7 % of maize-based 
baked snacks (n = 57) analysed in a Spanish study at median levels for positive samples of 67.8 µg/kg 
and 55.7 µg/kg, respectively (Castillo et al., 2008). 
The types of samples available from the published literature for grain based food products varied 
largely such that it was difficult to make meaningful conclusions. Moreover there are uncertainties 
with some of the data, for which reporting was unclear and incomplete. The highest concentrations of 
nivalenol were found in wheat and maize food products, and they were much lower than the highest 
concentrations found in cereal grains. The data do not provide evidence that certain cereal based food 
products are particularly susceptible to nivalenol contamination. 
4.1.3.  Occurrence of nivalenol in feed  
Cereal grains and the by-products of cereal processing are widely used as feeds for livestock. As 
reported above, several studies have identified nivalenol in these products, and often the intended end-
use – as food or feed – is not known at the time of sampling. It is therefore not possible to identify the 
occurrence of nivalenol specifically in feeds and therefore it could be assumed that the concentrations 
of nivalenol are at least at the same level as reported for food (Appendix A, Table A1). 
4.1.4.  Co-occurrence of nivalenol with deoxynivalenol    
Published data on the co-occurrence of nivalenol and deoxynivalenol have shown that in practically all 
cases where nivalenol occurrence was reported in grains and grain products, deoxynivalenol was 
present as well (often with other trichothecenes), usually at (much) higher concentrations than 
nivalenol (Rasmussen et al., 2003; Jestoi et al., 2004; Cavaliere et al., 2005; Schollenberger et al., 
2005; Schollenberger et al., 2006; Hajšlová et al., 2007; Krysinska-Traczyk et al., 2007; Castillo et al., 
2008; Baxter et al., 2009; Edwards, 2009a, 2009b; 2009c; Gottschalk at al., 2009; Macri et al., 2009; 
Scudamore and Patel, 2009; Bernhoft et al., 2010; Giraud et al., 2010; Malachova et al., 2010). In 
approximately 10 % of the relevant data sets mean concentrations of nivalenol were found to be higher 
than mean concentrations of deoxynivalenol where the ratio of mean nivalenol level/mean 
deoxynivalenol level varied between 1.13 and 4.45. These data sets related to barley, oats and maize-
based breakfast cereals (Castillo et al., 2008; Edwards, 2009a; Malachova et al., 2010). While it seems 
to be common that deoxynivalenol occurs at (much) higher incidences and levels than nivalenol in 
grains and grain products, these findings show that exceptions do occur (see also Section 4.2.15).  
It should also be noted that F. graminearum and F. culmorum on wheat are both co-producers of 
nivalenol and deoxynivalenol (Bottalico, 1998; Bottalico and Perrone, 2002; Logrieco et al., 2002). 
They are dominant in both the North/Centre and the South of Europe. F. poae and F. cerealis, reported 
to produce nivalenol (but no deoxynivalenol), have a lower (North/Centre) or very low (South) 
significance. In the case of red ear rot in maize, F. graminearum (deoxynivalenol/nivalenol co-
producer) is dominant in the North/Centre of Europe (Logrieco et al., 2002). F. culmorum, also a 
deoxynivalenol/nivalenol co-producer, and both nivalenol producers F. poae and F. cerealis have a 
lower level of occurrence in maize grown in some regions of Europe.  
4.1.5.  Masked (conjugated) nivalenol 
The existence of deoxynivalenol-3-glucoside in maize and wheat samples was reported for the first 
time by Berthiller et al. (2005). Such conjugated forms of mycotoxins are believed to escape 
conventional analytical routine methods due to their higher polarity and are therefore often referred to 
as masked mycotoxins. Whereas research on masked mycotoxins in general has increased over the last 
decade (De Saeger and van Egmond, 2012; Berthiller et al., 2013), information on masked forms of 
nivalenol is very scarce. Although the possible existence of nivalenol-glucoside was suggested in a 
previous report (Matthes and Meyer, 2010), the level formed in maize cell culture was estimated to be 
less than 0.04 % of nivalenol. However, in a very recent paper it was estimated that more than 15 % of 
nivalenol and its precursor fusarenon-X were converted to its conjugated forms in wheat grain that had Nivalenol in food and feed
 
EFSA Journal 2013;11(6):3262  26
been artificially inoculated with F. graminearum in a field (Nakagawa et al., 2011). Due to the lack of 
chemical standards only semi-quantitative analysis has been possible so far.  
4.2.  Current occurrence results in food and feed 
4.2.1.  Data collection summary  
Data on occurrence of nivalenol in food and feed were collected by EFSA following a public call for 
data. European national food authorities and similar bodies, research institutions, academia, food and 
feed business operators and any other stakeholders were invited to submit analytical data on nivalenol 
in food and feed. The present assessment includes data submitted up to November 2011. The data 
submission to EFSA followed the requirements of the EFSA Guidance on Standard Sample 
Description for Food and Feed (EFSA, 2010a). It cannot be excluded that samples described in 
Section 4.1 were also submitted to EFSA during this call for data. 
Data received covered food, feed but also unprocessed grains of undefined end-use. Data reported 
were on samples collected from 2001 to 2011 with the vast majority collected after 2005 (Figure 2). 
The year 2011 was not a complete sampling year, as the closing date for including nivalenol data in 
the assessment was November 2011. 
 
Figure 2:   Distribution of analytical results for nivalenol in food, unprocessed grains of undefined 
end-use and feed over the sampling years 2001-2011. 
In total 15 774 results were reported from 2001 to 2011 for nivalenol in food (n = 4 655), feed 
(n  =  1  915) and unprocessed grains (n = 9 204). Data were obtained on samples collected in 
18 European countries (Figure 3). It should be noted that the sampling country is not necessarily the 
same as the country that submitted the data to EFSA, nor the country of origin of the samples.  
To ensure the quality of data included in the assessment, several data cleaning and validation steps 
were applied. Analytical results with incomplete or incorrect description of the relevant variables (e.g. 
parameter type, food classification, result value, LOD or LOQ) were not included in the data sets used 
in this assessment. Nivalenol in food and feed
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Figure 3:   Distribution of analytical results for nivalenol in food, unprocessed grains of undefined 
end-use and feed across the European countries. 
4.2.2.  Data collection on food 
In a preliminary evaluation it was noted that the detection capabilities of the methods used for the 
determination of nivalenol were not always sufficient, having high LODs and LOQs (up to 200 µg/kg) 
and thus resulting in a large number of left-censored results (results below LOD or LOQ). It was also 
noted that those data would bias the outcome of the assessment. Therefore, only results obtained by 
methods with an LOQ ≤ 50 µg/kg were included in the assessment. By this approach, about 17 % of 
the nivalenol data in food were not included in the data set to be used for occurrence analysis and 
dietary exposure assessment. The final food data set included 3 846 results.  
Data on food were obtained on samples collected in 10 European countries (Figure 4). The majority of 
data (59 %) were from Germany. The distribution of occurrence data over the sampling years is 
presented in Figure 5. A higher number of samples were available for the period 2006 to 2010.  
 
 
 
 
 
 
 
 Nivalenol in food and feed
 
EFSA Journal 2013;11(6):3262  28
 
Figure 4:   Distribution of analytical results for nivalenol in food across the European countries (after 
excluding non-qualifying data). 
 
Figure 5:   Distribution of analytical results for nivalenol in food over the sampling years 2001-2011 
(after excluding non-qualifying data). 
4.2.3.  Data collection on feed 
From the data collected on feed (n = 1 915), 208 results on cereal grains and their by-products were 
excluded from the assessment as a result of applying the same cut-off LOQ as for food (50 µg/kg). For 
more complex feed matrices (e.g. compound feed, forages and roughage), LOQs higher than 50 µg/kg 
were considered to be acceptable and thus no LOQ cut-off has been applied to these feed groups. Data 
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on feed were reported by 7 European countries (Figure 6). Most of the data on feed were reported by 
Hungary (65 %). The distribution of occurrence data (n = 1 707) over the sampling years is presented 
in Figure 7. A higher number of samples were available from the period 2007 to 2009. 
 
Figure 6:   Distribution of analytical results for nivalenol in feed across the European countries. 
 
Figure 7:   Distribution of analytical results for nivalenol in feed over the sampling years 2004-2010. 
4.2.4.  Data collection on unprocessed grains of undefined end-use 
In addition to food and feed, a significant number of data were reported for unprocessed grains of 
undefined end-use. Since the samples analysed cannot be considered to be either food or feed, and the 
processing might influence the concentration of the toxin in the end-product, these data were 
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considered separately. Similarly to food, from the total number of data submitted (n = 9 204), only 
data obtained by methods with LOQ ≤ 50 µg/kg were considered in the evaluation (n = 7 611). The 
distribution of unprocessed grain samples across the European countries and over the sampling years 
is presented in Figure 8 and Figure 9, respectively. Most of the samples were reported by the United 
Kingdom (54 %). The sampling period covered the years 2001 to 2010. 
 
Figure 8:   Distribution of analytical results for nivalenol in unprocessed grains of undefined end-use 
across the European countries. 
 
Figure 9:   Distribution of analytical results for nivalenol in unprocessed grains of undefined end-use 
over the sampling years 2001-2010. 
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4.2.5.  Distribution of samples across food groups 
The food samples were classified according to the FoodEx classification system (EFSA, 2011a). 
FoodEx is a food classification system developed by EFSA Dietary and Chemical Monitoring (DCM) 
Unit in 2009 with the objective of simplifying the linkage between occurrence and food consumption 
data when assessing the exposure to hazardous substances. It contains 20 main food groups (first 
level), which are further divided into subgroups having 140 items at the second level, 1 261 items at 
the third level and reaching about 1 800 end-points (food names or generic food names) at the fourth 
level. The spread of the analytical results for nivalenol across the several FoodEx groups prevented 
calculation of summary statistics at a very detailed level of the food classification system. Broad food 
groups with only a limited number of samples or not classifiable foods were all included in the group 
‘Other foods’. 
The vast majority of data were on grains and grain-based foods. The groups ‘Grain milling products’ 
and ‘Grains for human consumption’ dominated the product coverage. The distribution of samples 
across the aggregated food groups is shown in Figure 10. A more detailed distribution in less 
aggregated food groups is presented in Table 4. 
 
Figure 10:  Distribution of nivalenol data across the food groups. 
4.2.6.  Analytical methods used for food 
Data on nivalenol in food were obtained by LC-MS/MS (26 %), other HPLC methods (5 %) and GC 
methods (17 %). For 52 % of the food samples, the method of analysis was not reported.  
LODs and LOQs were reported for 14 % and 86 % of observations, respectively. To enable a 
comparison of the LOQs applied across food groups, missing LOQs were estimated by multiplying the 
reported LODs by three. All the measurements were converted to µg/kg or µg/L.  
The LOQs varied with the method applied, the food matrix and the laboratory. A wide range of LOQs 
was observed with the minimum of 0.11 µg/kg and the maximum of 200 µg/kg. Therefore, as detailed 
in Section 4.2.2, only results obtained by methods with an LOQ ≤ 50 µg/kg were included in the 
assessment (Figure 11). The left-censored data accounted for 90 % of the results in food. A detailed 
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presentation of the proportion of left-censored data across food groups is given in Table 4, Section 
4.2.7. 
 
Figure 11:  Distribution of the limits of quantification (LOQ) for nivalenol across food groups (Box-
plot: whiskers at minimum and maximum, box at 25
th percentile and 75
th percentile with line at 50
th 
percentile. For beer and beer-like beverages: 25
th percentile, 50th percentile, 75
th percentile and 
maximum were equal. For food for infants and small children: 50
th percentile was equal to 
25
th percentile. For legumes, all LOQs had the same value). 
4.2.7.  Occurrence data on food 
In the analysis of nivalenol occurrence data the left-censored data (results below LOD or below LOQ) 
were treated by the substitution method as recommended in the ‘Principles and Methods for the Risk 
Assessment of Chemicals in Food’ (WHO, 2009). The same method is indicated in the EFSA 
scientific report ‘Management of left-censored data in dietary exposure assessment of chemical 
substances’ (EFSA, 2010b) as an option in the treatment of left-censored data. The guidance suggests 
that the lower-bound (LB) and upper-bound (UB) approach should be used for chemicals likely to be 
present in the food (e.g. naturally occurring contaminants, nutrients and mycotoxins). The LB is 
obtained by assigning a value of zero (minimum possible value) to all samples reported as lower than 
the LOD (< LOD) or LOQ (< LOQ). The UB is obtained by assigning the numerical value of LOD to 
values reported as < LOD and LOQ to values reported as < LOQ (maximum possible value), 
depending on whether LOD or LOQ is reported by the laboratory.  
The analytical results were submitted by the data providers as either corrected for recovery or not 
corrected for recovery. Data were used as submitted by the data providers. 
An overview on the number of samples and nivalenol concentrations in food groups is given in Table 
4. The vast majority of data received for nivalenol were on grains and grain-based products. The food 
group ‘Grains for human consumption’ consists of samples (n = 836) covering only processed grains 
for human consumption. The highest mean concentration for nivalenol was observed in oats (LB 
mean = 15 µg/kg; UB mean = 17 µg/kg), maize (LB mean = 9.9 µg/kg; UB mean = 18 µg/kg) and 
barley (LB mean = 9.7 µg/kg; UB mean = 15 µg/kg). Lower mean concentrations were found in wheat 
(LB mean = 2.8 µg/kg; UB mean = 23 µg/kg) and in rye (LB mean = 1.1 µg/kg; UB mean = 16 µg/kg) 
(Table 4). 
‘Grain milling products’ was the dominating food group (n = 1 455) and had 87 % left-censored data. 
Wheat milling products showed the highest mean concentration (LB mean = 5 µg/kg; UB 
mean = 15 µg/kg) mainly due to the wheat bran included in this group and having the highest mean 
concentration among grain products (LB mean = 37 µg/kg; UB mean = 45 µg/kg). Maize milling 
products were also more highly contaminated compared to other milling products.  
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‘Bread and rolls’ food group (n = 400) was less contaminated compared to ‘Grain milling products’ 
(LB mean = 0.67 µg/kg; UB mean = 14 µg/kg). It should be noted that the UB mean concentration is 
much influenced by the high proportion of left-censored data in ‘Bread and rolls’ (97 %). Foods in the 
group ‘Pasta’ (n = 127) were contaminated in a similar range as ‘Bread and rolls’ (LB 
mean = 0.59 µg/kg; UB mean = 13 µg/kg) and the proportion of left-censored data accounted for 96 % 
of results. Similarly low contamination frequency and low mean concentrations were observed in 
‘Breakfast cereals’ (n = 383) and in ‘Fine bakery wares’ (n = 292). 
The group ‘Legume beans, dried’ was represented by only a limited number of data on lentils and peas 
(n = 24). All results were left-censored. Similarly, ‘Beer and beer-like beverages’ included only 
53 samples which were all left-censored data.  
The group ‘Food for infants and small children’ (n = 205) contained mostly cereal-based food (98 % 
left-censored data with LB mean concentration = 0.4 µg/kg and UB mean concentration = 15 µg/kg).  Nivalenol in food and feed
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Table 4:   Concentration of nivalenol in food. 
Food group 
N 
(a) 
 
LC % 
 
Concentration range (LB – UB) (µg/kg) 
Mean Median  P75  P95  Maximum 
Grains for human consumption  836  85  4.1 - 20  0 - 12  0 - 31  21 - 50  504 
Barley   94  68  9.7 - 15  0 - 3.6  5.6 - 12  38 - 50  317 
Buckwheat   5  100  0 - 16  -
(b) -
(b) -
(b)  0 - 25
(c) 
Maize  31  68  9.9 - 18  0 - 5.0  12 - 42  49 - 50  66 
Millet   5  100  0 - 27  -
(b) -
(b) -
(b)  0 - 50
(c) 
Oats  61  66  15 - 17  0 - 3.0  13 - 13  40 - 40  504 
Other grains  7  86  0 - 14  -
(b) -
(b) -
(b)  0 - 25 
Rice  44  100  0 - 27  -
(b) -
(b) -
(b)  0 - 50
(c) 
Rye   186  97  1.1 - 16  0 - 12  0 - 25  0 - 50  88 
Spelt   53  89  2.7 - 16  0 - 4.8  0 - 25  20 - 50  78 
Wheat   350  85  2.8 - 23  0 - 25  0 - 40  17 - 40  123 
Grain milling products  1455  87  3.7 - 14  0 - 5.0  0 - 25  15 - 40  795 
Corn milling products  220  80  3.2 - 13  0 - 3.0  0 - 15  17 - 50  125 
Grain milling products  20  95  0.55 - 15  0 - 12  0 - 25  5.5 - 30  11 - 30
(c) 
Oat milling products  35  89  0.89 - 3.6  0 - 3.0  0 – 3.0  7.3 - 15  15 - 30
(c) 
Rye milling products  175  98  0.49 - 15  0 - 12  0 - 25  0 - 50  42 - 50
(c) 
Spelt milling products  90  94  0.37 - 6.2  0 - 3.0  0 - 3.0  3.8 - 25  12 - 50
(c) 
Wheat milling products  914  86  5.0 - 15  0 - 5.0  0 - 25  22 - 40  795 
      Wheat bran  88  48  37 - 45  7.5 - 21  32 - 40  171 - 171  795 
Bread and rolls  400  97  0.67 - 14  0 - 3.0  0 - 25  0 - 50  66 
Bread and rolls (unspecified)  74  96  2.6 - 28  0 - 25  0 - 50  0 - 50  66 
Mixed wheat and rye bread and rolls  106  99  0.47 - 5.6  0 - 0.73  0 - 3.0  0 - 40  50 
Multigrain bread and rolls  9  100  0 - 22  -
(b) -
(b) -
(b)  0 - 50
(c) 
Other bread  13  100  0 - 3.3  -
(b) -
(b) -
(b)  0 - 12
(c) 
Rye bread and rolls  50  100  0 - 8.2  -
(b) -
(b) -
(b)  0 - 50
(c) 
Unleavened bread, crisp bread and 
k
23  100  0 – 3.0  -
(b) -
(b) -
(b)  0 - 3.0
(c) 
Wheat bread and rolls  123  93  0.24 - 18  0 - 0.73  0 - 50  2.2 - 50  7 - 50
(c) 
Pasta (Raw)  127  96  0.59 - 13  0 - 4.2  0 - 25  0 - 40  47 - 50
(c) 
Breakfast cereals  383  92  0.93 - 9.9  0 - 3  0 - 16  4.7 - 30  61 
Breakfast cereals (unspecified)  25  100  0 - 8.1  -
(b) -
(b) -
(b)  0 - 30
(c) 
Cereal bars  2  100  0 - 14  -
(b) -
(b) -
(b)  0 - 25
(c) 
Cereal flakes  258  89  1.2 - 8.7  0 - 3.0  0 - 10  6.3 - 30  61 
Grits  14  93  3.4 - 11  -
(b) -
(b) -
(b) 47 
Mixed breakfast cereals  7  100  0 - 6.3  -
(b) -
(b) -
(b)  0 - 15
(c) 
Muesli  66  100  0 - 16  -
(b) -
(b) -
(b)  0 - 40
(c) 
Popped cereals  10  100  0 - 6.4  -
(b) -
(b) -
(b)  0 - 40
(c) 
Fine bakery wares  292  95  1.4 - 9.9  0 - 2.1  0 - 25  1.7 - 25  205 
Biscuits (cookies)  189  94  1.0 - 8.9  0 - 3.0  0 - 25  5.2 - 25  26 - 50 
Fine bakery wares (unspecified)  27  96  7.6 - 29  0 - 25  0 - 25  0 - 50  205 
Pastries and cakes  76  96  0.10 - 5.8  0 - 0.73  0 - 1.2  0 - 25  2.9 - 40
(c) 
Legume beans, dried (lentils, peas)  24  100  0 - 0.73  -
(b) -
(b) -
(b)  0 - 0.73
(c) 
Beer and beer-like beverage  53  100  0 - 7.9  -
(b) -
(b) -
(b)  0 - 10
(c) 
Food for infants and small children  226  98  0.36 - 14  0 - 12  0 - 25  0 - 30  37 - 50
(c) 
Food for infants and small children 
(unspecified) 
10  100  0 - 7.4  -
(b) -
(b) -
(b)  0 - 10
(c) Nivalenol in food and feed
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Table 4:  Continued. 
Food group 
N 
(a) 
 
LC % 
 
Concentration range (LB – UB) (µg/kg) 
Mean Median  P75  P95  Maximum 
Cereal-based food for infants and 
young children
205  98  0.40 - 15  0 - 12  0 - 25  0 - 30  37 - 50
(c) 
Ready-to-eat meal for infants and 
young children 
11  100  0 - 9.1  -
(b) -
(b) -
(b)  0 - 10
(c) 
N: number of samples; LC: left-censored data (values below the limit of detection or limit of quantification); LB: lower-
bound; UB: upper-bound; P75: 75
th percentile; P95: 95
th percentile. 
(a):  If N < 60 then the calculated P95 should be considered as an indicative value only due to limited number of data (EFSA, 
2011b);  
(b):  not calculated where all data were left-censored or the number of data was very limited;  
(c):  value represents the left-censoring limit. 
 
4.2.8.  Occurrence data on unprocessed grains of undefined end-use 
The category ’Unprocessed grains’ comprised grains of undefined end-use. Since the end use of the 
grains at harvest is frequently not established, and grains for human and animal consumption usually 
undergo several processing steps before being used it was considered appropriate to evaluate them 
separately. The left-censored data in the group ‘Unprocessed grains’ were handled by the substitution 
method as described for food in Section 4.2.7. Results below LOD or LOQ accounted for 56 % of the 
data. High concentrations of nivalenol were reported in oat grains (LB mean = 64 µg/kg; UB 
mean  =  68 µg/kg) followed by maize (LB mean = 56 µg/kg; UB mean = 58 µg/kg), wheat (LB 
mean = 30 µg/kg; UB mean = 36 µg/kg) and barley (LB mean = 27 µg/kg; UB mean = 34 µg/kg) 
(Table 5). The frequency of contamination and the concentration of nivalenol were consistently higher 
in unprocessed grains compared to grains for human consumption (Figure 12). 
Table 5:   Concentrations of nivalenol in unprocessed grains of undefined end-use. 
 Commodity  N 
(a) 
 
LC % 
 
Concentration range (LB – UB) (µg/kg whole weight) 
Mean Median  P75  P95  Maximum 
Wheat  4 671  55  30 - 36  0 - 10  23 - 25  97 - 97  9 515 
Barley  1 190  71  27 - 34  0 - 10  13 - 14  81 - 81  2 700 
Maize  356  42  56 - 58  13 - 13  44 - 46  202 - 202  3 385 
Oats  1 092  38  64 - 68  19 - 23  57 - 57  248 - 248  2 760 
Rye  234  99  0.28 - 11  0 - 10  0 - 10  0 - 15  40 
Rice  43  65  7.5 - 14  0 - 10  15 - 15  21 - 21  71 
Spelt  25  96  2.6 - 12  0 - 10  0 - 10  0 - 12  65 
N: number of samples; LC: left-censored data (values below the limit of detection or limit of quantification); LB: lower-
bound; UB: upper-bound; P75: 75
th percentile; P95: 95
th percentile;  
(a):  If N < 60 then the calculated P95 should be considered as an indicative value only due to limited number of data (EFSA, 
2011b). 
 Nivalenol in food and feed
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Figure 12:  Comparison of nivalenol concentrations (µg/kg; lower-bound) in unprocessed grains (a) 
and in grains for human consumption (b). 
 
4.2.9.  Comparison of the occurrence of nivalenol in foods from organic and conventional 
farming 
A direct comparison of the occurrence of nivalenol in food from organic farming and conventional 
farming was not possible because for 84 % of data the production method was missing or reported as 
“unknown”. Further, considering the high percentage of left-censored data in all food groups such a 
comparison cannot lead to a solid conclusion. 
A sufficient number of samples with clear specification of the farming method was available in the 
data set on unprocessed grains. The comparison of the concentrations of nivalenol is presented in 
Table 6. Since the number of samples of the organic commodities was considerably smaller than for 
the conventional ones and the sampling-countries and sampling years were not the same, it was not 
possible to draw a firm conclusion. Nivalenol in food and feed
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Table 6:   Nivalenol concentrations (µg/kg) in unprocessed grains of organic farming (a) and 
conventional farming (b) (lower-bound scenario). 
Commodity  Concentration (µg/kg) 
Mean  P50 P75 P95 
Lower-bound         
Wheat (n=228) (a)  26  15  33  83 
Wheat (n=2476) (b)  19  0  24  76 
Barley (n=109) (a)  11  0  14  52 
Barley (n=733) (b)  30  0  11  65 
Oats (n=117) (a)  38  17  42  140 
Oats (n=646) (b)  54  26  63  208 
Upper-bound      
Wheat (n=228) (a)  31  17  34  83 
Wheat (n=2476) (b)  24  11  25  76 
Barley (n=109) (a)  18  10  14  52 
Barley (n=733) (b)  37  10  11  65 
Oats (n=117) (a)  42  18  42  140 
Oats (n=646) (b)  57  26  63  208 
P50: 50
th percentile; P75: 75
th percentile; P95: 95
th percentile. 
(a):  organic farming;  
(b):  conventional farming. 
 
4.2.10.  Comparison of occurrence of nivalenol over the sampling years 
An important factor for the development of Fusarium spp. and the production of Fusarium toxins are 
the climatic conditions, mainly low temperature and high humidity. As these conditions can vary 
between the years, it is expected that Fusarium toxins may occur with higher frequency and at higher 
concentrations in the years when the climatic conditions are favourable for fungal invasion. The 
prevalence of F. graminearum, one of the nivalenol producers, in cereal grain has already increased in 
Central Europe, and is likely to further increase in the North of Europe, due to expected changes in 
weather conditions and agricultural practices (Parikka et al., 2012). Although the CONTAM Panel 
considered that it might be of interest to evaluate the contamination frequency and concentrations of 
nivalenol over the years 2001 to 2010, it was decided that this would not yield meaningful data 
because of the overlapping of more than one harvests in one sampling year and the varying lengths of 
times that grains take to enter the food chain. It should be noted that in the submitted data the sampling 
year was not necessarily the same as the harvest year. 
4.2.11.  Classification of occurrence data on feed 
Feed was classified according to the catalogue of feed materials specified in the Commission 
Regulation (EU) No 575/2011 of 16 June 2011 creating the Catalogue of feed materials. Where 
information was available compound feedingstuffs were classified in groups according to the 
species/production categories for which the feed is intended. Results were reported on whole weight 
(98 % of samples) or on 88 % dry matter (1.6 % of samples). For consistency in the assessment, all 
results on feed were expressed on whole weight.  
4.2.12.  Distribution of samples across feed groups 
The vast majority of samples were in the groups ‘Compound feedingstuffs’ (n = 888) and ‘Cereal 
grains, their products and by-products’ (n = 668) (Figure 13). Fewer results were available for 
‘Forages and roughage, and products derived thereof’ (n = 119), and for ‘Oil seeds, oil fruits, their 
products and by-products’ (n = 23). A more detailed distribution of the samples in feed sub-groups is 
presented in Table 7. Nivalenol in food and feed
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Figure 13:  Distribution of feed samples across feed groups. 
 
4.2.13.  Analytical methods used for feed  
The most common analytical method reported for the analysis of nivalenol in feed was LC MS/MS 
(73.9 %) followed by other HPLC methods (14.5 %) and GC MS (0.4 %). For 11.2 % of results the 
analytical method was not provided. Similarly to food, in the case where the LOQs were not available 
(1.3 % of data), they were estimated by multiplying the LODs by three. The LOQs varied with the 
method applied, the feed matrix and the laboratory. However, the majority of the LOQs were in the 
range of 30 to 150 µg/kg (Figure 14). 
 
Figure 14:  Distribution of the limits of quantification (LOQ) for nivalenol across feed groups (Box-
plot: whiskers at minimum and maximum, box at 25
th percentile and 75
th percentile with line at 
50
th percentile. For forages and roughage, and products derived thereof: 25
th percentile, 50
th percentile, 
75
th percentile and maximum had the same value. For oil seeds and oil fruits: all LOQs were equal. 
For compound feed: minimum, 25
th percentile and 50
th percentile had the same value). 
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4.2.14.  Occurrence data on feed by feed group 
The left-censored data in feed were handled by the substitution method as described for food in 
Section 4.2.7. Results below the LOD or LOQ accounted for 94.2 % of results in feed. In most of the 
feed groups the left-censored data accounted for 100 % and for several feed groups e.g. maize bran, 
maize germ expeller, maize gluten, mixed grains, oat feed, oat flakes, oat middlings, rye bran, 
sorghum, spelt, wheat feed, wheat bran,  forages and roughage other than maize silage only a limited 
number of data was available. Therefore, the occurrence data are presented in Table 7 for the 
aggregated feed groups. 
Table 7:   Concentrations of nivalenol in feed (all results are expressed in µg/kg whole weight). 
 Feed group  N 
(a) 
 
LC % 
 
Concentration range (LB – UB) (µg/kg whole weight) 
Mean Median P75  P95  Maximum 
Cereal grains, their products 
and by-products 
668  90  11 - 43  0 - 40  0 - 40  66 - 66  789 
     Oats  123  82.9  10 - 37  0 - 30  0 - 35  70 - 72  103 - 150
(c) 
Forages and roughage, and 
products derived thereof  119  78.2  74 - 163  0 - 122  0 - 122  407 - 407  1 022 
      Maize silage  109  77.1  80 - 174  0 - 122  0 - 122  407 - 407  1022 
Oil seeds, oil fruits, and 
products derived thereof  23  100  0 - 40  -
(b) -
(b) -
(b) 40
(c) 
Compound feed  888  99.5  1.8 - 72  0 - 40  0 - 150  0 - 150  534 
Other feed (animal fat, products 
of animal origin, sugar beet,  9  100  0 - 40  -
(b) -
(b) -
(b) 40
(c) 
N: number of samples; LC: left-censored data (values below the limit of detection or limit of quantification); LB: lower-
bound; UB: upper-bound; P75: 75
th percentile; P95: 95
th percentile;  
(a):  If N < 60 then the calculated P95 should be considered as an indicative value only due to limited number of data (EFSA, 
2011b);  
(b):  not calculated where all data were left-censored or the number of data was very limited;  
(c):  value represents the left-censoring limit. 
 
4.2.15.  Co-occurrence of nivalenol and deoxynivalenol 
The terms of reference as provided by the EC required EFSA to assess the co-occurrence of nivalenol 
with deoxynivalenol in feed and food and assess whether an approach of protecting animals and/or 
humans against deoxynivalenol exposure is regarded as sufficient for protection against exposure to 
nivalenol or if on the basis of exposure scenarios a separate approach for the protection of animals 
and/or humans against exposure to nivalenol is appropriate. In this context, food, feed and 
unprocessed grain samples where analytical results on both toxins were available, were extracted from 
the EFSA database on chemical contaminants. In total, out of 13 164 samples only 783 samples were 
available from the European countries that provided data on both nivalenol and deoxynivalenol. In 
most of these samples the concentrations of nivalenol were lower than LOQs. Deoxynivalenol was 
quantified in 82 % of the samples while nivalenol was quantified in only 9 % of the samples 
suggesting a substantially lower prevalence of the latter. Concentrations for both nivalenol and 
deoxynivalenol were quantified in only 67 samples. In 57 of the samples concentrations of 
deoxynivalenol were much higher (on average 25 times) than nivalenol. In ten samples (one sample of 
cereal-based food for infants and young children, one sample of wholemeal wheat flour and eight 
samples of unprocessed barley grains) the concentrations of nivalenol were higher than those of 
deoxynivalenol. This finding on co-occurrence is in line with the findings reported in the literature 
(Section 4.1.4). Nivalenol in food and feed
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4.3.   Food and feed processing 
4.3.1.  Food processing 
4.3.1.1.  Cleaning and sorting  
Sorting of cereals by removing those extensively damaged or infected kernels such as those with 
visible mould growth or shrivelled kernels, has the effect of lowering the concentrations of 
mycotoxins in products that are subsequently produced (Ryu et al., 2008). Reduction of nivalenol 
levels by cleaning is significant in those grains that are heavily contaminated initially (Hazel and Patel, 
2004). In a Slovenian study on the effects of milling on nivalenol concentrations in bread, a 34.8 % 
and 15.5 % reduction in concentrations of nivalenol was observed in the cleaning stage of wheat 
containing between 130 and 200 µg/kg using industrial and traditional cleaning methods, respectively 
(Lešnik et al., 2008). The difference in the cleaning methods is that the industrial cleaning method 
employs several industrial separators, sieves and aspirator devices while the traditional cleaning 
method employs a simple screen device and an integrated aspirator (Lešnik et al., 2008). A similar 
study from the Czech Republic on wheat samples (n = 3) reported initial levels of nivalenol in 
uncleaned grain of 23, 81 and 30 µg/kg and in the cleaned grain nivalenol was reported in the first two 
samples to be below 1 µg/kg and at 16 µg/kg in the last sample (Lancova et al., 2008). Whereas the 
results of these studies indicate a reduction in levels due to cleaning, the results also point to an 
inconsistency in the magnitude of reduction due to cleaning.  
4.3.1.2.  Rolling and milling  
Milling has the effect of reduction and redistribution of nivalenol. Ryu et al. (2008) described the 
effect of dry milling as causing a redistribution of nivalenol into separate milling fractions, and 
causing a higher concentration of nivalenol in particular fractions such as the bran and shorts. Wet 
milling resulted in dissolving and redistribution of nivalenol in by-products and steep water (Ryu et 
al., 2008). The redistribution of nivalenol during milling is dependent upon the location of nivalenol in 
intact grains prior to milling (Scudamore, 2008). During milling, nivalenol is expected to concentrate 
in the fractions containing the outer parts of the grain rather than in those fractions containing the 
inner parts of the grain (Lešnik et al., 2008). Thus the highest levels of nivalenol are observed in the 
germ, screenings, dust and bran while the flour and grits contain lower levels than those found in the 
grain before dry milling (Hazel and Patel, 2004). High accumulation of nivalenol in the waste fraction 
(bran) was also reported in one of three wheat samples at a level of 62 µg/kg, while the concentration 
in the other two samples was below 1 µg/kg (LOD) (Lancova et al. 2008). The initial concentrations 
are reported in Section 4.3.1.1. As observed in the section on cleaning and sorting there is a 
discrepancy in the magnitude of effect of milling. 
The flour derived from the three wheat samples of Lancova et al. (2008) contained nivalenol at levels 
below LOD (1 µg/kg) indicating that in products produced from flours obtained through dry milling, 
the levels of nivalenol may be lower than in the original grain. However, dry milled flour with high 
ash content tends to contain higher levels of nivalenol than flour with lower ash content (Lešnik et al., 
2008) and these authors suggested that ash content and nivalenol occurrence are correlated. In the 
same study the effects of three types of milling processes on the nivalenol levels in wheat 
(130-200 µg/kg) were examined. Industrial milling of wheat by a roller grinder was reported to result 
in a 68 % reduction in the concentrations of nivalenol from the grain to the flour due to the fact that 
only flour fractions obtained from layers close to the endosperm (containing no or low levels of 
nivalenol) entered into the fine bread flour stream. The reduction due to industrial roller milling was 
found to be higher than that caused by industrial hammer crush and millstone milling methods, which 
resulted in a 47 % and 45 % reduction, respectively). Nivalenol in food and feed
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4.3.1.3.  Cooking  
A number of studies have been performed to determine the effect of cooking on nivalenol using both 
flour from naturally contaminated grains and artificially contaminated (spiked) flour. In a New 
Zealand study in which treatments that mimicked simple cooking conditions were applied to ground 
maize (nivalenol concentration: 670 µg/kg), no significant reduction in the content of nivalenol was 
observed at temperatures reaching up to 110 °C and at flour moisture content of 50 % (Lauren and 
Smith, 2001). Bretz et al. (2005) isolated four thermal degradation products of nivalenol each of which 
did not contain the epoxy group. In the same study it was established that wet and dry heating did not 
result in major differences with respect to degradation products. In a Japanese study in which naturally 
contaminated barley grain (nivalenol concentration not indicated) was roasted, a 50 % decrease in 
concentrations of nivalenol was reported at time-temperature conditions of 52, 42 and 9 minutes at 
150, 180 and 220 °C, respectively (Yumbe-Guevara et al., 2003). In a study from the UK in which 
whole meal wheat grain (containing nivalenol at approximately 200 µg/kg) was exposed to extrusion 
processing at temperatures of 140, 160 and 180 °C, higher concentrations of nivalenol were reported 
(8.85, 39.9 and 33.1 %, respectively) (Scudamore et al., 2008). According to the authors, there is no 
clear explanation of the increase in nivalenol and this result could be attributed to the release of bound 
nivalenol during the extrusion process (Scudamore et al., 2008). 
Flour spiked with varying concentrations of nivalenol (200, 500 and 1000 µg/kg) was used to 
determine the effect of baking on nivalenol under laboratory conditions (Valle-Algarra et al., 2009). In 
this study, baking temperatures employed ranged between 190 °C and 240 °C with times ranging 
between 30 and 50 minutes, and an average reduction in nivalenol of 76.9 % was observed. The 
stability of nivalenol under food processing conditions was also investigated in a model heating 
system using a sugar model (α-D-glucose), a starch model (methyl-α-D-glucopyranoside) and two 
protein models (N-α-acetyl-L-lysine and BOC-L-cysteine methyl ester) which were exposed to baking 
temperatures of 150-200 °C for different time periods (10-60 min) (Bretz et al., 2005). Of the initial 
concentrations (25 µg/250 µg model substance), 40-70 % of nivalenol remained in the various models 
after 10 minutes at 175 °C. After 60 minutes only trace amounts of nivalenol were observed with the 
N-α-acetyl-L-lysine model, and 20-45 % with the other models. In another study, the effect of baking 
wheat flour from naturally contaminated sources (nivalenol concentrations ranging from 130 to 
200 µg/kg) in an industrial oven was investigated at temperatures between 185 °C and 205 °C and a 
reduction in initial levels of nivalenol ranging from 27.1 % to 29.8 % was observed (Lešnik et al., 
2008). However, the reduction in levels during baking was attributed to a dilution of the levels of 
nivalenol due to the incorporation of other ingredients rather than to a thermal degradation of 
nivalenol (Scudamore et al., 2009). In this study, which was performed on a pilot scale commercial 
bakery using naturally contaminated UK grown wheat, the authors reported a 33 % and 28 % decrease 
in levels of nivalenol in biscuits (made from flour contaminated with nivalenol at a mean 
concentration of 32 µg/kg) that were baked at 245 °C for 5 minutes and crackers (made from flour 
contaminated with nivalenol at a mean concentration of 23 µg/kg) that were baked at 280 °C for 
3 minutes, respectively (Scudamore et al., 2009).  
Apart from the thermal effect of baking on nivalenol, the effect of baking products (potassium 
hydrogen tartrate and sodium bicarbonate) on nivalenol have also been investigated and it was 
concluded that the latter have a minimal effect on the concentrations of nivalenol (Lauren and Smith, 
2001). It has also been concluded that the dough fermentation process involved during bread baking 
does not affect the concentrations of nivalenol (Valle-Algarra et al., 2009). 
4.3.1.4.  Malting process 
Only one study was identified on the effects of malting on the concentrations of nivalenol (Malachova 
et al., 2010). The results of this study were inconclusive.   Nivalenol in food and feed
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4.3.2.  Feed processing 
Cereal grains intended for use as animal feed are subject to many of the processes used for processing 
grains for human consumption (cleaning, sorting, drying, rolling/grinding and/or extrusion) before 
being fed to livestock. In addition, a number of by-products of processing grains for human 
consumption are widely used as feeds for livestock. 
4.3.2.1.  Cereal grains  
The effects of processing of cereal grains, including cleaning, sorting and rolling, are described above 
(Section 4.3.1) and apply equally for grains used for livestock feed. 
Depending on the moisture content of the grains at harvest and the length of storage period, cereals 
may be dried using hot air. The temperature of air used to dry the grains, and the temperature of the 
grains themselves, will vary according to the equipment being used, the ambient temperatures and 
humidity, and the intended end moisture content. For long-term storage, a moisture content of 
approximately 12 % is generally recommended. In order to achieve this, air temperatures of up to 
125-130 °C may be used, resulting in grain temperatures of up to 45 °C for wheat, and slightly lower 
for other cereal grains. Drying temperatures higher than this are likely to result in deterioration in 
grain quality, particularly the protein fraction. Heat stability experiments have shown that nivalenol 
decomposes with increasing temperature, but not completely (Kamimura et al., 1987), but it is likely 
that levels of nivalenol remain largely unchanged at these temperatures (Schwake-Anduschus et al., 
2010). 
After drying and storage, cereal grains may be fed with or without further processing. While whole 
grains may be fed to some livestock (e.g. barley or oats to sheep and goats), other livestock require the 
grains to be rolled, milled, extruded or flaked. These processes involve the application of pressure (e.g. 
rolling, extruding) and/or heat (e.g. cooking, flaking), but nivalenol is stable under these conditions 
(Scudamore et al., 2008).  
The application of an alkali to whole cereal grains has been used as an alternative to rolling them, 
since this has the effect of making the outer husk more digestible to ruminants. There is no 
information available on the influence of this process on nivalenol.   
4.3.2.2.  Cereal by-products 
When cereal grains are processed for human consumption, by-products that remain are widely used in 
livestock diets. The EC has produced a Catalogue of Feed Materials
16 that lists over 80 cereal by-
products used as animal feeds. These include by-products from the major cereals (wheat, barley, oats 
and maize) used in the manufacture of foods for human consumption, as well as in the production of 
alcohol.  
As discussed above (Section 4.3.1.2), dry milling results in a redistribution of nivalenol into separate 
milling fractions, and an increase of nivalenol in particular fractions such as the bran and shorts. The 
highest levels of nivalenol are observed in the germ, screenings, dust and bran while the flour and grits 
contain lower levels than those found in the grain before milling (Hazel and Patel, 2004). Wet milling 
results in dissolving and redistribution of nivalenol in by-products and steep water (Ryu et al., 2008).   
Cereal grains may also be extruded to improve their digestibility, particularly in young animals. 
Extrusion does not reduce the concentration of nivalenol (Scudamore et al., 2008). 
                                                      
16    Commission Regulation (EU) No 242/2010 of 19 March 2010 creating the Catalogue of feed materials. OJ L 77, 
24.3.2010, p. 17-32. Nivalenol in food and feed
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In many countries in Europe, feed compounders operate to quality assurance standards that include a 
requirement for routine analysis for mycotoxins in both raw materials and the finished product
17. Such 
quality assurance schemes, where implemented, clearly reduce the exposure of farm livestock to 
nivalenol toxins. 
4.3.2.3.  Compound feeds   
Compound feeds consist of a mixture of feed materials and additives formulated to meet the specific 
nutritional requirements of the livestock to which they are fed. They may be complete feeds that 
provide all of the daily requirements of nutrients, or complementary feeds that provide part of the 
ration (e.g. protein and energy). For ruminants and horses, compound feeds usually represent part of 
the ration and are supplemented with forages, while for pigs, poultry, rabbits, fish, cats and dogs they 
are usually the sole feed. Approximately 151 million tonnes of compound feed were manufactured in 
the EU-27 in 2011 (FEFAC, 2012).  
One of the final stages in the compound feed manufacturing process is the production of feed pellets. 
This involves forcing the mixture of feed ingredients through the holes of a die, which results in an 
increase in temperature. The extent of the temperature rise will depend on a number of factors, 
including the types of ingredients used in the formulation, the amount of moisture added and the 
equipment used, but pellets generally leave the die at temperatures ranging between 60 and 95 °C 
(Thomas et al., 1997). As with most trichothecenes, nivalenol is stable at these temperatures 
(Schwake-Anduschus et al., 2010). 
4.3.3.  Conclusions 
In conclusion, the reduction of levels of nivalenol is evident in the cleaning and sorting step of 
processing as the majority of infected kernels are removed (eliminated due to undesirable quality 
attributes such as shrivelling and discolouration). However, this is only significant when the initial 
contamination is high, and the contamination is localised in the infected grain. Milling does not reduce 
levels of nivalenol per se, but rather results in a redistribution of nivalenol into different fractions, thus 
causing a concentration in the outer part fractions (e.g. bran, shorts, which are used predominantly in 
animal feed) and a reduction in other fractions (e.g. flour, which is used for human consumption). 
Consequently nivalenol levels in these products may show an increase or a reduction as compared to 
the levels in the original seeds. Therefore, it is important to consider the end-use of each fraction. 
Normal cooking conditions appear to have little influence on the reduction of nivalenol concentrations 
in contaminated raw materials. 
Nivalenol is stable throughout most commercial processing that contaminated cereals will undergo. It 
is unstable under high temperatures (> 150 °C) and alkaline conditions, and the rate of degradation 
increases with increased time and/or temperature conditions.  
5.  Food and feed consumption  
5.1.  Food consumption 
In 2010, the EFSA Comprehensive European Food Consumption Database (Comprehensive Database) 
was built from existing national information on food consumption at a detailed level. Competent 
authorities in the European countries provided EFSA with data from the most recent national dietary 
survey in their country at the level of consumption by the individual consumer. This included food 
consumption data concerning infants (2 surveys from 2 countries), toddlers (8 surveys from 
8 countries), children (17 surveys from 14 countries), adolescents (14 surveys from 12 countries), 
adults (21 surveys from 20 countries), elderly (9 surveys from 9 countries) and very elderly (8 surveys 
from 8 countries) for a total of 32 different dietary surveys carried out in 22 different countries. 
                                                      
17    Universal Feed Assurance Scheme (UFAS), United Kingdom; Good Manufacturing Practice (International) (GMP+), 
Netherlands; Good Manufacturing Practice (GMP) Animal Feed, Belgium and Qualitätssicherungssystem (QS), Germany. Nivalenol in food and feed
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Surveys on children were mainly obtained through the Article 36 project ‘Individual food 
consumption data and exposure assessment studies for children’ (acronym EXPOCHI) (Huybrechts et 
al., 2011).  
Overall, the food consumption data gathered at EFSA in the Comprehensive Database are the most 
complete and detailed data currently available in the EU. However, consumption data were collected 
by using different methodologies and thus they are not suitable for direct country-to-country 
comparison. 
5.1.1.  EFSA’s Comprehensive European Food Consumption Database 
The CONTAM Panel considered that only repeated exposure to nivalenol need be assessed, as its 
critical toxic effects are chronic rather than acute (Sections 7.2 and 7.4). Therefore, as suggested by 
the EFSA Working Group on Food Consumption and Exposure (EFSA, 2011b) dietary surveys with 
only one day per subject were not considered for the calculation of chronic dietary exposure, since 
they are not adequate to assess repeated exposure. Similarly, subjects who participated on only one 
day in the dietary studies although the protocol prescribed more reporting days per individual were 
also excluded. Thus, for the present assessment, food consumption data were available from 
28 different dietary surveys carried out in 17 different European countries.  
Within the dietary studies, subjects were classified in different age classes as defined below:  
1.  Infants:     < 12 months old 
2. Toddlers:   ≥ 12 months to < 36 months old 
3. Other  children:      ≥ 36 months to < 10 years old 
4. Adolescents:      ≥ 10 years to < 18 years old 
5. Adults:        ≥ 18 years to < 65 years old 
6. Elderly:      ≥ 65 years to < 75 years old 
7.   Very elderly:    ≥ 75 years old 
Consumption records were coded according to the FoodEx classification system, which has been 
developed by the DCM Unit in 2009 (EFSA, 2011a). 
The dietary surveys considered for the chronic dietary exposure assessment and the numbers of 
subjects in the different age classes are presented in Table 8. Further details on how the 
Comprehensive Database is used are published in the Guidance of EFSA (EFSA, 2011b). Nivalenol in food and feed
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Table 8:   Dietary surveys considered for the dietary exposure assessment and number of subjects in the different age classes. 
Country  Dietary survey
(a) Abbreviation
(b) Number of subjects 
       Total  Infants  Toddlers  Other children  Adolescents  Adults  Elderly  Very elderly 
Belgium Diet_National_2004  BE/1 3 118 584 1 304 518 712 
 Regional  Flanders  BE/2  661    36 
(c) 625         
Bulgaria NUTRICHILD  BG  1  721  860  428  433         
Cyprus  Childhealth  CY  303      303      
Czech Republic  SISP04  CZ  2 353      389  298  1 666     
Denmark  Danish_Dietary_Survey  DK  4 120      490  479  2 822  309  20
(c) 
Finland DIPP  FI/1  1  430   497  933        
  FINDIET_2007  FI/2  2 038          1 575  463   
  STRIP  FI/3  250     250        
France  INCA2  FR  4 079      482  973  2 276  264  84 
Germany DONALD_2006  DE/1  303    92  211         
 DONALD_2007  DE/2  311    85  226        
 DONALD_2008  DE/3  307    84  223        
  National_Nutrition_Survey_II  DE/4  13        1 011  10 419  2006  490 
Greece  Regional_Crete  GR  839     839        
Hungary  National_Repr_Surv  HU  1 360          1 074  206  80 
Ireland  NSIFCS  IE  958         958    
Italy INRAN_SCAI_2005_06  IT  3  323  16
(c) 36
(c) 193  247  2  313  290 228 
Latvia  EFSA_TEST  LV  1 965      189  470  1 306     
Netherlands  DNFCS_2003  NL/1  750         750    
 VCP_kids  NL/2  1  279    322  957        
Spain AESAN  ES/1  410         410    
  AESAN_FIAB  ES/2  1  067       86  981    
  NUT_INK05  ES/3  1  050     399 651      
 enKid  ES/4  382    17
(c) 156  209       
Sweden  Riksmaten_1997_98  SE/1  1 210          1 210     
  NFAn  SE/2  2 491      1473  1 018       
United Kingdom  NDNS  UK  1 724              1 724       
BE: Belgium; BG: Bulgaria; CY: Cyprus; CZ: Czech Republic; DK: Denmark; FI: Finland; FR: France; DE: Germany; GR: Greece; HU; Hungary; IE: Ireland; IT: Italy; LV: Latvia; NL; The 
Netherlands; ES: Spain; SE: Sweden; UK: United Kingdom;  
(a): More information on the dietary surveys is given in the Guidance of EFSA ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment’ (EFSA, 
2011b);  
(b): Abbreviations to be used consistently in all tables on exposure assessment;  
(c): 95
th percentile calculated over a number of observations lower than 60 require cautious interpretation as the results may not be statistically robust (EFSA, 2011b) and therefore for these 
dietary surveys/age classes the 95
th percentile estimates will not be presented in the exposure assessment. Nivalenol in food and feed
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5.2.  Feed consumption 
Nivalenol originates principally from cereal grains, and may be present in the by-products produced as 
a result of processing. Cereal grains and their by-products are widely used in feeds for livestock. In 
2011, European feed manufacturers produced over 151 million tonnes of compound feed of which 
almost half (48 %) was cereal grains. In addition, over 17 million tonnes of by-products from the food 
industry – principally cereal by-products – were used (FEFAC, 2012). 
In addition to cereals and cereal by-products, other feeds include oilseed meals (28 %), pulses, dried 
forages, dairy products, minerals, vitamins and additives (FEFAC, 2010). 
Mycotoxin-producing  Fusarium species can infect other growing crops, including grass, hay and 
straw, all of which are sources of animal fodder and silage. When directly consumed by animals these 
forage crops could give rise to mycotoxicosis (Scudamore and Livesey, 1998). In silage, however, 
Fusarium species are not major contaminants because most are aerobic and are unable to grow under 
the anaerobic conditions used in silage making (Scudamore and Livesey, 1998). 
There is considerable variation in both the feeds used and the feeding systems adopted throughout 
Europe for farm livestock, companion animals and fish. This variation is largely due to the availability 
of feeds and market demands for specific animal products. The amount of feed consumed is also 
closely linked to its digestibility and the levels of activity or production of the animal.   
Exposure to nivalenol (Section 6.2) requires estimates of feed intake. Estimates of intake by farm 
livestock, companion animals and fish are given in Appendix B. It should be stressed that they do not 
represent ‘average’ diets, nor are the feeding systems ‘typical’ for all of Europe. Instead, they are used 
to estimate levels of exposure to nivalenol toxins that might not be atypical. They are based on 
published guidelines on nutrition and feeding (e.g. AFRC, 1993; Carabano and Piquer, 1998; NRC, 
2007a,b; Leeson and Summers, 2008; EFSA, 2009a; OECD, 2009; McDonald et al., 2011), data on 
EU manufacture of compound feeds (FEFAC, 2009) and expert knowledge of production systems in 
Europe. In the absence of sufficient occurrence data for individual types of feed, exposure to nivalenol 
has been calculated using the data for the category ‘cereal grains, their products and by-products’. 
5.2.1.  Dairy cows 
In common with other ruminants, forages – either fresh or conserved – represent the main feed for 
dairy cows, and typically account for between 60 and 100 % of daily dry matter intake (AFRC, 1993), 
depending on the level of production and the quality of the forage. They are predominantly grasses 
and legumes, but whole-crop maize and cereals are also fed after ensiling. Forages are supplemented 
with commercial compounds or other non-forage feeds in those situations where the forages on their 
own do not provide the necessary nutrients to meet the animals’ requirements. The amounts of non-
forage feed given are adjusted according to the amount and quality of the forage available and the milk 
yield of the cow, and adjusted for pregnancy and live weight gain, but will typically be about 
0.25 - 0.35 kg feed/kg milk production (Nix, 2010).  
Cereal grains are an important constituent of dairy cow diets. In Northern Europe, barley and wheat 
are most commonly used, while in Southern Europe maize (corn) is more widely used. The actual 
amounts used can vary considerably, depending on their price and the availability of other feeds, but 
levels of up to 30 % of total dry matter intake are not uncommon. Because of their lower energy 
content relative to other cereals, oats are less widely used in diets for dairy cows.  
For this Scientific Opinion, exposure is estimated for a 650 kg dairy cow, with a milk yield of 
40  kg/day. In addition, exposure has been calculated for dairy cows (milk production 30,40 and 
50 kg/day) fed a diet based on maize silage and variable compound feeding rates of 0.28, 0.30 and 
0.32 kg/kg of milk (equivalent to 8.4, 12 and 16 kg/day of non-forage feed intake). Assumptions on 
the proportions of forages and non-forage feed, and the proportions of cereal grains, their products and 
by-products in the non-forage component of the diet, are given in Appendix B, Tables B1, B4 and B5. Nivalenol in food and feed
 
EFSA Journal 2013;11(6):3262  47
5.2.2.  Beef cattle 
There is a wide variety of beef production and husbandry systems in Europe. They may be categorised 
broadly as pasture-based and cereal-based systems, although combinations of these systems are 
commonly found. They aim to produce animals for slaughter from less than 8-months of age (veal 
production), to 12 month ‘cereal beef’ or for slaughtering at up to 24 months of age (or more).  
For many beef cattle, forages represent the major - and often only - ingredient in their diets. The 
forage may be fed fresh (i.e. grazed) or conserved as silage, hay or cereal straws to be fed when fresh 
forage is not available. The amount of forage consumed is determined by a number of factors, 
including the age/size of the animal, forage digestibility, the quality of the fermentation (when ensiled) 
and the availability of other feeds. 
Other non-forage feeds, including cereals and vegetable proteins, are given when forages alone, 
because of their quality or availability, do not provide sufficient nutrients to achieve intended growth 
rates.   
For the exposure estimates for forage-based beef production, the CONTAM Panel assumed a live 
weight of fattening (beef) cattle of 400 kg and a daily intake 9.6 kg dry matter (1.4 kg dry matter/day 
of non-forage feeds) for the cattle fed grass silage and non-forage feeds. Maize silage-based rations 
generally have higher intakes than grass silage, and an intake of 9.5 kg dry matter/day forage and 
1.0 kg dry matter/day of non-forage feeds has been assumed by the CONTAM Panel based on Browne 
et al. (2004). Assumptions on the proportions of forages and non-forage feed, and the proportions of 
cereal grains, their products and by-products in the non-forage component of the diet, are given in 
Appendix B, Tables B1 and B4. 
In contrast, intensive cereal-based systems of beef production provide diets that consist almost entirely 
of rolled cereal grains, supplemented with vegetable proteins (McDonald et al., 2011). In this system 
of production, high levels of daily gain may be achieved, and feed intake may be as high as 2.5 % of 
body weight (NRC, 2000). In this Scientific Opinion, it has been assumed that, a 400 kg bull 
consumes 8.4 kg of dry matter feed per day (AFRC, 1993), of which 85 % is non-forage feed 
containing 75 % cereal grains, their products and by-products (Appendix B, Tables B1 and B4). 
5.2.3.  Sheep and goats 
Domestic sheep and goats are primarily raised for the production of meat, milk or wool.  As a result, a 
large number of breeds and systems of management have been developed to suit the land, climate and 
husbandry conditions in the EU. As for other ruminants, good quality forage is the most important 
dietary ingredient and for many of these livestock forages may be the only feeds used after weaning 
(NRC, 2007a). Exceptions to this are: 
Pregnant and lactating animals: supplementation with non-forage feeds or commercial compound 
feeds usually occurs in late pregnancy, up to a maximum of 2.5 kg/day, and often continues into 
lactation, depending on the quality and availability of forages, and the number of lambs or kids 
produced (AFRC, 1993; NRC, 2007a). They usually consist of cereals, cereal by-products and 
vegetable proteins supplemented with minerals and vitamins (McDonald et al., 2011). 
For lambs and kids: some compound feeds may be given around the time of weaning to encourage the 
intake of solid feed. The amounts consumed are generally small, particularly if there is forage 
available.  
Sheep and goats reared for meat production: diets consist predominantly of forage, with additional 
feeds given to achieve levels of live weight gain required. Total daily dry matter intakes can range 
from 1.9-3.8 % of their body weight (Devendra and Burns, 1983), of which forages typically account 
for 75 % or more of total intake. In commercial practice, goats reared for meat production and with a Nivalenol in food and feed
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body weight > 10 kg are often fed green fodder ad libitum (AFRC, 1993) supplemented with cereal 
grains (barley, oats or maize), cereal by-products and vegetable proteins (McDonald et al., 2011). 
Milking sheep and goats: compound feeding usually commences in late pregnancy and continues into 
lactation. For an 80 kg lactating ewe, compound or other non-forage feeds may be fed at a flat rate of 
1.0-1.3 kg/day for the first 60-70 days of lactation, reducing to 0.9 to 1.0 kg/day for the next 60 days, 
and 0.5 kg/day in late lactation (AFRC, 1993). Due to physiological and metabolic differences, goats 
are able to consume diets with higher proportions of non-forage feeds without adversely affecting feed 
intake or production (Avondo et al., 2008). The actual amounts depend on the quality of the forage 
available. Non-lactating animals usually receive only forage feeds. 
The CONTAM Panel has used a daily dry matter intake of 2.8 kg for an 80 kg lactating sheep feeding 
twin lambs to estimate the exposure to nivalenol. For a 60 kg milking goat producing 6 kg milk/day, a 
daily feed intake of 3.4 kg dry matter per day has been assumed. 
The dry matter intakes of goats reared for meat and fed ad libitum can be as high as 3.8 % of body 
weight (Devendra and Burns, 1983). The CONTAM Panel has used a daily dry matter intake of 1.5 kg 
for a 40 kg goat for fattening to estimate the exposures to nivalenol. For all categories of sheep and 
goats, the proportions of cereal grains, their products and by-products in the non-forage feeds are 
given in Appendix B, Table B4. 
5.2.4.  Pigs 
There is a considerable range of pig production systems and diets fed to pigs in Europe. A common 
feature is that diets for fattening pigs and sows consist predominantly of cereals and cereal by-
products, supplemented with vegetable proteins (e.g. soybean meal, peas and beans, rapeseed meal). 
For breeding pigs, the relative proportions of these ingredients in the diets will be different during 
pregnancy and lactation. Diets for breeding pigs also tend to include greater proportions of fibrous 
feeds such as cereal by-products and sugar beet pulp (McDonald et al., 2011). 
Exposure estimates have been made for piglets (20 kg b.w.), fattening pigs (100 kg b.w.) and lactating 
sows (200 kg b.w.) using feed intakes proposed by EFSA (2009a). The proportions of cereal grains, 
their products and by-products used in estimating the exposure for pigs are given in Appendix B, 
Table B6. 
5.2.5.  Poultry 
Poultry have limited ability to digest fibre
18, and therefore cereal grains form the major part of their 
diets. In Europe, wheat, maize and barley are most commonly used, with rye, sorghum triticale and 
oats used less widely. Other ingredients include cereal by-products and vegetable proteins, 
supplemented with minerals, trace elements and vitamins (Leeson and Summers, 2008; McDonald et 
al., 2011). 
The amount of feed consumed is largely determined by the size and age of the bird. Under ad libitum 
feeding, daily intake increases as the birds get older, although relative to body weight it declines with 
age. For meat producing and egg laying birds, ad libitum feeding is widely practiced, but for breeding 
stock feed intake is frequently restricted to maintain a steady body weight (Leeson and Summers, 
2008). 
The CONTAM Panel applied the live weights and feed intakes reported for different poultry (broilers, 
laying hens and turkeys) by EFSA (2009a) and for ducks by Leeson and Summers (2008) for the 
exposure estimations. The proportions of cereal grains, their products and by-products used in 
estimating the exposure for poultry are given in Appendix B, Table B6.  
                                                      
18   An exception to this is geese, which can live entirely on grass and similar forage. Nivalenol in food and feed
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5.2.6.  Rabbits 
Commercial rabbit production takes place in at least 14 EU member states, including the Czech 
Republic, Slovakia, Poland and Hungary. The largest producers are Italy, France and Spain. The EU is 
responsible for about 0.5 million tonnes, representing 55 % of world rabbit meat production
19.  
Young rabbits are normally kept with the mother to around 4-5 weeks old, then moved to a fattening 
cage, until 10-12 weeks old before slaughter at about 2 kg b.w.
19  
Rabbits are usually fed a pelleted diet of dried forages, cereals and vegetable proteins supplemented 
with minerals, vitamins and trace elements. Lebas and Renouf (2009) reviewed diet formulations used 
in experimental studies: in 58 diets, cereals and cereal by-products (mostly wheat bran) accounted for 
up to 40 % of all ingredients. In these studies, maize was a major cereal grain and was included in 
more than one-third of all diets. In northern Europe, however, maize may be replaced by barley and 
wheat.  Feed intakes of 65-80 g/kg b.w. have been reported (Carabano and Piquer, 1998).  
For the exposure estimates, the CONTAM Panel assumed a live weight of 2 kg, and a feed intake of 
75 g/kg b.w. The proportions of cereal grains, their products and by-products used in estimating the 
exposure are given in Appendix B, Section B2.3. 
5.2.7.  Farmed fish 
Atlantic salmon is economically the most important farmed fish in Europe, although other 
commercially reared species include rainbow trout, sea bass, sea bream, cod, halibut, tuna, eel and 
turbot. Given the wide range of species and environmental conditions for farmed fish, many different 
feeding strategies have been developed. However, given its predominance in EU aquaculture, feed 
intake and exposure to nivalenol toxins have been estimated for salmon in this Scientific Opinion. 
Traditionally, the principal raw materials used for the manufacture of fish feeds in Europe have been 
fish meals and fish oils, and although alternative sources of oil and protein (e.g. soybean meals and 
vegetable oils) are increasingly being used fish-derived feeds still remain the major ingredients. Since 
cold-water fish do not utilize carbohydrates as energy sources as efficiently as warm-water species, 
there is less use of cereals. Berntssen et al. (2010) provided details of the composition of a diet for 
growing Salmonids, and the CONTAM Panel used these to estimate exposure to nivalenol toxins for 
salmon (2 kg) with a feed intake of 0.04 kg dry matter/day (EFSA, 2009a). The proportions of cereal 
grains, their products and by-products used in estimating the exposure are given in Appendix B, 
Section B2.4.  
5.2.8.  Horses 
Horses are complete herbivores. They will generally consume 2-3.5 % of their body weight in feed 
(dry matter) each day, of which a minimum of 50 % should be as forage (pasture or hay) (NRC, 
2007b). Mature horses with minimal activity can be fed forage alone, but for growing and active 
horses supplementary feeding with cereal grains, cereal by-products (e.g. oats, barley, and wheat bran) 
and vegetable proteins is necessary. Although oats are the preferred cereal for many horse owners, 
other cereal grains and cereal by-products are also routinely used. The CONTAM Panel estimated the 
exposure for a 450 kg horse, with a daily intake of 9 kg dry matter/day, of which half is in the form of 
forages and where cereal grains, their products and by-products represent 75 % of the non-forage 
component of the daily ration (Appendix B, Section B2.5).  
5.2.9.  Feed consumption by companion animals (dogs and cats) 
Most small companion animals derive their nutritional needs from processed food, and in 2010 EU 
annual sales of pet food products was approximately 8.3 million tonnes
20. Although a wide range of 
                                                      
19   Source: http://faostat.fao.org 
20   www.Fedif.org Nivalenol in food and feed
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ingredients is used in commercial diets, most dog and cat diets contain at least some animal protein. 
Other ingredients include cereals (predominantly wheat, rice or maize), cereal by-products, vegetable 
proteins and by-products of human food production.   
Many pet food manufacturers produce standard and premium quality brands for dogs and cats. While 
both normally contain some cereals, levels tend to be higher in the standard brands, and may be as 
high as 65 %
21. Dog food also tends to contain more cereals than cat food (J.M. Fremy, 2011, personal 
communication). In the absence of any general information on ingredients used in dog and cat food in 
the EU, data from France
21 have been used in this Scientific Opinion to estimate exposure to nivalenol 
by cats and dogs. These values, together with estimates of intake (Appendix B, Section B1.5) should 
be regarded as being indicative only, and will vary depending both on the availability of feed materials 
and on the nutrient requirements of the animals. The proportions of cereal grains, their products and 
by-products used in estimating the exposure are given in Appendix B, Section B2.6.  
The amounts of food consumed by dogs and cats are influenced by many factors, including breed, 
size, level of activity and their reproductive state. In this Scientific Opinion the CONTAM Panel has 
assumed a live weight 4 kg and feed intake 60 g/day of standard pet food quality for cats (Appendix B, 
Section B1.5). For the dogs, it has assumed a live weight 25 kg and feed intake of 360 g/day of 
standard quality (Appendix B, Section B1.5.). 
6.  Exposure assessment of nivalenol in humans and animals  
6.1.  Human exposure assessment 
6.1.1.  Previously reported human exposure assessments 
Previous reports on nivalenol exposure assessment include the SCOOP, the Finish Food Safety 
Authority report in 2008, the French Food Safety Agency (AFSSA) in 2009 and National Agency for 
Sanitary Safety (ANSES) in 2011, the Nordic Council report in 1998; as well as reports from Japan 
and New Zealand. Nivalenol exposure in these populations is presented in Table 9. The SCF (2000, 
2002) conducted risk evaluations on nivalenol, alone and together with other trichothecenes with a 
t-TDI level being established at 0.7 µg/kg b.w. per day. The SCF (2000) based its exposure assessment 
for nivalenol on the exposure assessment reported by the Nordic Council (Nordic Council of 
Ministers, 1998). The majority of the estimated mean exposures in EU countries were below this 
t-TDI. In 2002, the SCF did not conduct an exposure assessment.  
                                                      
21    B.M. Paragon (2011), Personal communication. Based on statistics of 2010 of French association of pet food 
manufacturers (FACCO), http://www.facco.fr Nivalenol in food and feed
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Table 9:   The average and high consumer exposure to nivalenol.  
Country 
 Population groups 
Estimated exposure for 
average consumer
(a) 
(ng/kg b.w. per day) 
Estimated exposure for 
high consumer
(b) 
(ng/kg b.w. per day) 
Reference 
 
Finland                  60                 120  Nordic 
Council of 
Ministers 
(1998) 
Denmark                  30 (50)
(c)                 60 (100) 
Norway                  90 (70)                 180 (150) 
Sweden                  70                 140 
Finland    Rautala  et  al. 
(2008)    Women  22  44 
  Men  24 51 
Austria  78 274  Gareis  et  al. 
(2003)  Denmark  30 72 
Finland  27 not  reported 
France    
  Adults  58  199 
  Children  94  307 
Norway    
  Male, consumers  59  113 
  Female, consumers  52  96 
Sweden  6 13 
UK    
  Male adults  25  nr 
  Female adults  17  nr 
  Infant (6-12 months)  62  nr 
  Toddler (1.5-4.5years)  64  nr 
  Children (4-6 years)  64  nr 
  Children (7-10 years)  50  nr 
  Children (11-14 years)  34  nr 
  Children (15-18 years)  26  nr 
  Elderly male > 65 years  27  nr 
  Elderly female > 65 years  21  nr 
France     Leblanc  et 
al. (2005)  Adults > 15 years  88 157 
  Ovo-lacto vegetarians  120 230 
  Lacto-vegetarians  120 190 
  Vegetarian/macrobiotics  210  420 
  Children (3-14 years old)  163 300 
Norway     VKM  (2013) 
  Infant (1 year)  46  92 
  Children (2 years)  34  63 
  Children (4 years)  16  31 
  Children (9 years)  12  23 
  Adolescents (13 years)  8  16 
  Adults  7  14 
New Zealand     Cressey  and 
Thomson 
(2006)  
  General population  56  
Japan      FSCJ (2010)  
  Children (1-6 years) (0.2 mg nivalenol/kg
(d)) 10  260 
  Children (7-14 years) (0.2 mg nivalenol/kg
(d)) 10  190 
  Children (15-19 years) (0.2 mg nivalenol/kg
(d)) 10  150 
  Adults (> 20 years) (0.2 mg nivalenol/kg
(d)) 0  90 
  Children (1-6 years) (0, 0.5, 1 mg nivalenol/kg
(d)) 10  330 
  Children (7-14 years) (0, 0.5, 1 mg nivalenol/kg
(d)) 10  230 
  Children (15-19 years) (0, 0.5, 1 mg nivalenol/kg
(d)) 10  180 
  Adults (> 20 years) (0, 0.5, 1 mg nivalenol/kg
(d)) 0  110 
nr: not reported 
(a):  Average intake is based on average occurrence and average consumption. 
(b):  High consumer is based on average occurrence and 95
th percentile consumption. 
(c):   Data in bracket was calculated using individual questionnaire intake data and was only available in Denmark and 
Norway.  
(d):  Four nivalenol regulation scenarios were used to estimate the exposure: 0.2, 0.5, 1 mg/kg and no regulation. Nivalenol in food and feed
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6.1.1.1.  Exposure assessment in Europe 
In the report of the Nordic Council (Nordic Council of Ministers, 1998) the exposure assessment was 
based on Scandinavian means of concentrations in grains and consumption data from the food balance 
sheets, as well as individual quantitative questionnaires in Denmark and Norway. As food balance 
sheets give only the average intake, the value for high consumers was assigned to be double the 
average intake. Nivalenol estimated exposure for Finland, Denmark, Norway and Sweden was 60, 30, 
90 and 70 ng/kg b.w. per day for average consumers, and 120, 60, 180, 140 ng/kg b.w. per day for 
high consumer groups, respectively (Table 9).  
The Finnish Food Safety Authority (EVIRA) assessed nivalenol exposure in collaboration with 
Agrifood Research Finland (MTT) and the National Public Health Institute (Rautala et al., 2008). The 
exposure was estimated based on the median concentration and average or high (95
th percentile) 
consumption levels available from the MTT survey and the EVIRA’s National FINDIET data. The 
concentration of nivalenol in all cereals was below the LOD and the exposures, based on the UB 
value, of average and high consumers were estimated for women/men at 22/24 and 44/51 ng/kg b.w. 
per day, respectively (Table 9).  
The SCOOP task 3.2.10 assessed nivalenol exposure from seven EU Member States (Gareis et al., 
2003). For each state, the best estimated UB and LB, average and high (95
th percentile consumption) 
exposure for the whole population and/or for specific groups were made. Nivalenol concentrations 
were reported for 4 166 samples, with 16 % of samples positive. The estimated exposure for the whole 
population and/or for specific groups of the population for each of the seven countries is presented in 
Table 9. 
The French Food Safety Agency (AFSSA, 2009), after the first total diet study (TDS1) undertaken in 
the year 2000 led by the French National Institute for Agricultural Research (INRA) in collaboration 
with AFSSA, made a comprehensive exposure assessment of the French population on trichothecenes 
from ‘ready to eat’ foods. In total 238 samples were analysed for nivalenol and only three samples 
were found above the LOQ of 20 µg/kg. The mean LB and UB exposures for average and high (95
th 
percentile) consumers in adults aged 15 years and over, for children aged 3 to 14 years and for the 
vegetarian population have been estimated for nivalenol. The estimated exposure for children was 
nearly double the adult exposure, and the estimated vegetarian exposure was higher than that of the 
general population, especially in vegetarian/macrobiotics who had the highest exposure figure at 
420 ng/kg b.w. per day (Leblanc et al., 2005; AFSSA, 2009).  
The second total diet study (TDS2) was implemented recently by ANSES, formerly AFSSA (ANSES, 
2011) which has expanded the scope of TDS1 both in the number of substances studied and the cities 
studied. Based on the LB and UB occurrence data and the consumption data reported in the French 
individual and national study of food consumption (INCA 2 (AFSSA, 2009)) undertaken in 
2006-2007, the TDS2 study showed that average nivalenol exposure for adults was 20 (LB) and 
34 (UB) ng/kg b.w. per day, and for children 31 (LB) and 59 (UB) ng/kg b.w. per day. For high 
consumers (i.e. 95
th percentiles) the estimated exposure was 45 (LB), 67 (UB) and 72 (LB) and 
119 (UB) ng/kg b.w. per day, for adults and children, respectively. The estimated exposure level of 
TDS2 was lower than that of TDS1.   
In Norway, the VKM recently conducted an exposure assessment of the Norwegian population for 
nivalenol by using different scenarios (VKM, 2013). The scenarios were used due to the high number 
of left censored occurrence data and they were based on national occurrence data from 2008-2011 in 
sieved wheat flour, milled whole wheat flour, wheat bran, oat flakes and infant oat porridges. The 
nivalenol concentrations used were 5 µg/kg (the lowest LOD) in milled wheat whole flour, wheat bran 
and oat flakes, 2.5 µg/kg (half of the lowest LOD) in sieved wheat flour and 4.4 µg/kg in infant oat 
porridges. The food consumption data used for sieved wheat flour, milled whole wheat flour, wheat 
bran, oat flakes and infant oat porridges were from the national food consumption surveys. For the 
different Norwegian population groups the exposure estimates were 7-46 ng/kg b.w. per day (average Nivalenol in food and feed
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consumers) and 14-92 ng/kg b.w. per day (high consumers at 95
th percentile). The exposure was the 
highest for infants aged 1 year (Table 9). 
6.1.1.2.  Exposure assessment in the countries outside Europe 
In the New Zealand dietary exposure report, based on maize based food concentration data Cressey 
and Thomson (2006) estimated that dietary exposure to nivalenol in New Zealand in 1996 was 
5.6 ng/kg b.w. per day. The authors indicated that the estimate is likely to be an underestimate because 
it was based on maize food only, which is not highly consumed in New Zealand.  
The Food Safety Commission of Japan conducted a dietary exposure assessment of deoxynivalenol 
and nivalenol for the Japanese population (FSCJ, 2010). The surveillance data of nivalenol occurrence 
in domestically produced wheat conducted by the Health and Labour Sciences Research program in 
2007 was used and applying the Monte-Carlo simulation approach the daily exposure of different age 
groups to nivalenol during 2002-2007 was estimated under 4 different nivalenol maximum level 
scenarios (A = 200 µg nivalenol/kg, B = 500 µg nivalenol/kg, C = 1000 µg nivalenol/kg, and D = no 
regulation). The estimated median exposure level was 10 ng/kg b.w. per day for those aged under 
20 years, and even lower for adults. The 95
th percentile exposures were 330, 230, 180 and 110 ng/kg 
b.w. per day for age group 1 - 6, 7-14, 14-20, and above 20 years, respectively under the B, C and D 
scenarios. In regulation scenario A of 200 µg/kg, the estimated 95
th percentile exposures were 260, 
190, 150, and 90 ng/kg b.w. per day for the four age groups, respectively (Table 9).  
6.1.1.3.  Important dietary sources of human exposure to nivalenol   
The major food sources for nivalenol exposure were wheat and wheat products, which contributed 
50-90 % of total exposure in the Nordic populations, based on various reports (Nordic Council of 
Ministers, 1998; Gareis et al, 2003; Rautala et al., 2008; VKM, 2013). In the UK, breakfast cereals 
contributed up to 54 % of total nivalenol intake, and in France bread and pasta contributed 57 % of the 
total nivalenol intake according to SCOOP report (Gareis et al., 2003). Similarly the two TDS studies 
reported that contribution from bread and breakfast rusks was up to 50 % in the French population 
(AFSSA, 2009; ANSES, 2011). Oats, rye and barley were other important contributors to nivalenol 
intake. For example oats contributed up to 20 % of total intake in Nordic countries (Nordic Council of 
Ministers, 1998) and rye up to 20-40 % in the Finish population (Gareis, et al., 2003; Rautala, 2008). 
Oat-based foods were also considered as important contributors to the nivalenol exposure in Norway 
(VKM, 2013). In Japan, wheat was considered to be the main source of nivalenol exposure (FSCJ, 
2010).  
6.1.2.  Current mean and high dietary exposure to nivalenol 
For calculating the chronic dietary exposure to nivalenol, food consumption and body weight data at 
the individual level were accessed in the Comprehensive Database. For each country, exposure 
estimates were calculated per dietary survey and age class (see Section 5.1.1). Exposure estimates 
were therefore calculated for 28 different dietary surveys carried out in 17 different European 
countries. Not all countries provided consumption information for all age groups or in some cases the 
same country provided more than one consumption survey.  
The mean dietary exposure (average consumption in total population) and the high dietary exposure 
(95
th percentile food consumption in total population) to nivalenol were calculated separately for each 
dietary survey using consumption data recorded at the individual level. Individual food consumption 
data were combined with the mean occurrence values in order to provide mean and high percentile 
exposure estimates (95
th percentile). Exposure estimates were calculated for both LB and UB 
scenarios. The LB and UB mean concentrations of the food groups used in the exposure calculation 
are presented in Table 4. It should be noted that 90 % of the data were left-censored resulting in a 
large difference between the dietary exposure estimates in LB and UB scenarios. Nivalenol in food and feed
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Minimum, median and maximum exposure estimates across dietary surveys are reported in Table 10. 
Detailed mean and 95
th percentile dietary exposure estimates calculated for each of the 28 dietary 
surveys are presented in Table 11. In accordance with the specifications of the EFSA Guidance on the 
use of the Comprehensive database (EFSA, 2011b), 95
th percentile estimates for dietary surveys/age 
classes with less than 60 observations may not be statistically robust and therefore they should not be 
considered in the risk characterisation.  
6.1.2.1.  Infants (< 12 months old)  
Only two dietary surveys reported consumption data for children younger than 1 year, therefore the 
dietary exposure estimate cannot be considered as representative of the European infant population. 
One of the surveys did not qualify for the calculation of the 95
th percentile exposure (number of 
subjects < 60). The mean dietary exposure to nivalenol was 2.4 and 140 ng/kg b.w. per day (minimum 
LB to maximum UB) in these two surveys. The 95
th percentile dietary exposure in the one qualifying 
study was 16 ng/kg b.w. per day in LB and 389 ng/kg b.w. per day in UB (Tables 10 and 11).  
6.1.2.2.  Children and adolescents (≥ 1 to < 18 years old) 
The estimated dietary exposure to nivalenol in toddlers, other children and adolescents decreased with 
increasing age due to the higher intake of food per kg b.w. in younger age groups. The highest 
exposure was estimated in toddlers (age ≥ 12 months to < 36 months), for which mean chronic dietary 
exposure ranged from 4.3 to 202 ng/kg b.w. per day (minimum LB to maximum UB) and the 
95
th percentile dietary exposure ranged from 12 to 484 ng/kg b.w. per day (minimum LB to maximum 
UB) (Tables 10 and 11).  
6.1.2.3.  Adults (≥ 18 to < 65 years old) 
In the adult population, the mean dietary exposure to nivalenol across dietary surveys ranged from 
0.4 to 75 ng/kg b.w. per day (minimum LB to maximum UB). The 95
th percentile dietary exposure 
ranged from 1.1 to 224 ng/kg b.w. per day (minimum LB to maximum UB) (Tables 10 and 11). 
6.1.2.4.  Elderly and very elderly (≥ 65 years old) 
The mean dietary exposure estimates in elderly and very elderly across the dietary surveys ranged 
from 0.8 to 58 ng/kg b.w. per day (minimum LB to maximum UB). The 95
th percentile dietary 
exposure ranged from 1.9 to 127 ng/kg b.w. per day (minimum LB to maximum UB) (Tables 10 and 
11). 
6.1.2.5.  Conclusions 
Dietary exposure to nivalenol in the adult population across 14 European countries, using LB and UB 
concentrations, ranged from 0.4 to 75 ng/kg b.w. per day for average consumers, and 1.1 to 224 ng/kg 
b.w. per day for high consumers. The highest chronic exposure was estimated in toddlers (age 
> 12 months to < 36 months) ranging from 4.3 to 202 ng/kg b.w. per day for average consumers, and 
12 to 484 ng/kg b.w. per day for high consumers. A relatively high variation between the exposure 
estimates across the dietary surveys within each age class was observed. The exposure estimates in 
this assessment are generally in the same range as those reported in previous assessments (see Section 
6.1.1.1). A summary of the dietary exposure to nivalenol in all age classes is presented in Table 10.  Nivalenol in food and feed
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Table 10:   Summary statistics of the chronic dietary exposure to nivalenol (ng/kg b.w. per day) 
across European countries. 
Age class  Summary statistics of exposure (ng/kg b.w. per day) 
 Minimum  Median  Maximum 
  LB  UB LB UB  LB  UB 
  Mean dietary exposure in total population 
Infants 2.4  136  -
(a) -
(a) 4.4 140 
Toddlers 4.3  81  6.3  152  8.8  202 
Other children  1.3  56  5.5  97  12  132 
Adolescents  1.0 45  2.1  60 6.4  80 
Adults 0.40  37  1.6  56  4.8  75 
Elderly 0.81  31  1.7  49  4.7  55 
Very elderly  0.80  43  1.6  49  3.9  58 
 95
th percentile dietary exposure in total population
(b) 
Infants 16  -
(c) -
(c) -
(c) -
(c) 389 
Toddlers  12 203  15  317 23  484 
Other children  3.0  121  12  179  22  259 
Adolescents 3.0  99  6.0  124  15 147 
Adults 1.1  89  4.0  112  10  224 
Elderly 2.3  60  3.5  102  11  127 
Very elderly  1.9  79  3.8  100  7.8  111 
b.w.: body weight; LB: lower-bound; UB: upper-bound;  
(a):  Not calculated; estimates available only from two dietary surveys;  
(b): The 95
th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011b) and therefore they should not be considered in the risk characterisation. Those 
estimates were not included in this table;  
(c):  Not calculated; estimates available only from one dietary survey. 
 Nivalenol in food and feed
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Table 11:   Mean and 95
th percentile (P95) chronic dietary exposure to nivalenol (ng/kg b.w. per day) for total population (lower-bound – upper-bound 
scenarios) for each dietary survey. 
Dietary 
survey
(a) 
Infants Toddlers  Other  children  Adolescents  Adults  Elderly  Very  elderly 
Mean P95 Mean  P95  Mean  P95  Mean  P95  Mean  P95  Mean  P95  Mean  P95 
BE/1   1.8-62 4.8-137 1.4-59 4.0-139 0.81-47 2.3-117 0.8-44 2.1-96 
BE/2     6.3-149  17-248
(b) 5.8-121  16-221                 
BG  4.4-140 16-389 7.1-152  17-265  5.5-128  15-245                 
CY           3.1-54  7.9-114            
CZ          7.9-89  19-161  6.4-69 15-142 3.3-75  8.7-224         
DK        6.2-97  12-154  3.9-62  9.0-112  2.1-57 4.8-121  1.7-53  3.4-102  2.0-54 5.0-135
(b) 
FI/1     8.7-81  23-203  12-67  22-121                 
FI/2               4.8-40  10-93  4.7-31  11-60    
FI/3        1.3-62  3.0-137                 
FR        4.3-88  9.4-162  2.7-58  6.5-115  1.6-47 4.3-98 1.0-45  2.8-98  0.94-43 1.9-79 
DE/1     4.6-202  12-483  5.1-101  12-182                 
DE/2     4.8-171  12-368  5.8-102  13-179                 
DE/3     4.3-178  13-484  5.5-104  11-182                 
DE/4           1.8-57  5.6-132  1.2-55  3.9-140 1.1-50  3.5-127  1.1-43  3.8-101 
GR        6.7-85  15-192                 
HU               4.0-56  7.9-111  3.4-49  7.7-88  3.9-53  7.8-100 
IE               1.6-75  3.5-199        
IT  2.4-136  12-485
(b)  8.8-188  30-375
(b)  7.6-132 18-259 5.9-78  14-147 4-59  9-106 2.6-55  6.4-102  2.4-58 5.5-111 
LV        1.7-56  5.1-161  1.0-47  3.0-110  0.5-37  1.7-91         
NL/1               0.8-65  1.8-185        
NL/2     8.8-140  20-264  6.9-120  17-225                 
ES/1               1.7-48  4.8-112        
ES/2           1.5-51  4.1-103  1.4-43  3.4-89        
ES/3        3.4-118  8.2-226  2.2-80  5.3-146             
ES/4     4.6-123  27-331
(b) 2.8-94  7.6-166 2.0-71  5.4-142             
SE/1        2.0-67  4.2-144  1.4-45  3.1-99             
SE/2               0.4-42  1.1-89        
UK               1.4-64  3.3-159        
BE: Belgium; BG: Bulgaria; CY: Cyprus; CZ: Czech Republic; DK: Denmark; FI: Finland; FR: France; DE: Germany; GR: Greece; HU; Hungary; IE: Ireland; IT: Italy; LV: Latvia; NL: the 
Netherlands; ES: Spain; SE: Sweden; UK: United Kingdom; P95: 95
th percentile;  
(a): Original acronyms of the dietary surveys and the number of subjects is given in Table 8; (b): P95 estimates for dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011b) and therefore they should not be considered in the risk characterisation. Nivalenol in food and feed
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6.1.3.  Contributions of different food groups to nivalenol exposure 
The contribution (%) of the individual food groups to dietary exposure to nivalenol for the UB 
scenario was heavily influenced by the high percentage of left-censored data and for this reason the 
CONTAM Panel calculated the contribution only for the LB scenario. The contribution of individual 
food groups to dietary exposure to nivalenol varied between the dietary surveys. This is explained by 
the specific food consumption patterns in the individual European countries and even in the different 
regions of one country. It should be noted that in two dietary surveys, foods (e.g. bread, fine bakery 
wares) were disaggregated to ingredients (flour) and therefore these studies did not qualify for 
calculation of the contribution of food groups to the exposure. The contribution to nivalenol dietary 
exposure for eight individual food groups was assessed separately for each survey and age group. The 
results are reported as a number of surveys for the following contribution ranges: 0-5, 5-10, 10-25, 
25-50, 50-75 % and higher than 75 % (Table 12). A summary of the median values calculated from the 
average contribution of each food group across the dietary surveys and the range of the lowest and 
highest average contribution is shown in Appendix C, Table C1. 
Grains and grain-based foods made the largest contribution to the dietary exposure to nivalenol in all 
age classes. The most important contributors within this food category were bread and rolls and grain 
milling products. Although the concentration of nivalenol in bread and rolls was relatively low, due to 
their high consumption this food category had very high contribution to exposure in all age classes, 
except infants. A high contribution of grain milling products seen particularly in adults is more likely 
driven by high concentration values measured in wheat bran. Other important contributors were pasta, 
fine bakery wares and breakfast cereals. The contribution of breakfast cereals to the dietary exposure 
to nivalenol was higher in children and adolescents compared to adults. The contribution of pasta was 
important in the European countries with high pasta consumption.  
Similarly to adults, the highest contributors in children were bread and rolls and grain milling 
products. The same pattern was seen also in infants (Appendix C, Table C1), but as mentioned above, 
only two dietary surveys were available for this age group and therefore the exposure estimation could 
not be considered representative for all European infants. In infants and toddlers, also the food for 
infants and small children made an important contribution to the exposure to nivalenol, mainly 
represented by cereal-based foods. Nivalenol in food and feed
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Table 12:   Number of surveys split according to their percentage contribution to chronic dietary exposure of nivalenol using lower bound concentrations 
across age groups.  
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Grains for human consumption  8  1  -  -  -  -  17  -  -  -  -  -  11  1  -  -  -  - 
Grain milling products  1  1  3  2  2  -  5  1  4  2  4  1  3  1  3  1  4  - 
Bread and rolls
(a) 1  1  2  1  3  1  1  1  6  2  5  2  -  1  3  4  3  1 
Pasta
(a)  4  4  1  -  -  -  8  3  5  1  -  -  4  1  7  -  -  - 
Breakfast cereals
(a)  7  2  -  -  -  -  8  7  1  1  -  -  5  3  4  -  -  - 
Fine bakery wares
(a)  2  2  5  -  -  -  2  6  6  3  -  -  3  2  6  1  -  - 
Food for infants and small children
(a)  5  1  3  -  -  -  16  1  -  -  -  -  12  -  -  -  -  - 
Beer and beer-like beverage
(b)  9  -  -  -  -  -  17  -  -  -  -  -  12  -  -  -  -  - 
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Grains for human consumption  13  1  -  1  -  -  5  2  -  -  -  -  6  -  -  -  -  - 
Grain milling products  2  1  2  4  4  2  1  1  -  1  2  2  1  1  -  2  1  1 
Bread and rolls
(a)  1  1  5  5  3  -  1  -  2  2  1  1  -  -  3  1  1  1 
Pasta
(a)  8  2  4  1  -  -  3  1  3  -  -  -  2  1  3  -  -  - 
Breakfast cereals
(a)  10  1  4  -  -  -  6  1  -  -  -  -  6  -  -  -  -  - 
Fine bakery wares
(a)  3  4  6  2  -  -  4  2  1  -  -  -  3  2  1  -  -  - 
Food for infants and small children
(a)  15  -  -  -  -  -  7  -  -  -  -  -  6  -  -  -  -  - 
Beer and beer-like beverage
(b)  15  -  -  -  -  -  7  -  -  -  -  -  6  -  -  -  -  - 
(a):  Calculation based on occurrence data with more than 90 % of left-censored data: for bread and rolls only 13 positive results available, for pasta only five positive results available, for 
breakfast cereals only 30 positive results available, for fine bakery wares only 16 positive results available, for food for infants and small children only four positive results available;  
(b):  Calculation based on occurrence data with 100 % of left-censored data. Nivalenol in food and feed
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6.1.4.  Dietary exposure to nivalenol for specific groups 
Vegetarian diets include more cereal and cereal-based products and thus it was considered that 
nivalenol exposure in this consumer group could be higher. The Comprehensive Database contains 
only limited data on food consumption of vegetarians. Dietary surveys with at least 15 adult 
vegetarians in each survey were selected. Dietary exposure was calculated and compared to the 
exposure of all subjects included in the respective dietary study. The limited data on vegetarians do 
not indicate a marked difference in the dietary exposure to nivalenol between the vegetarians and the 
general population but are insufficient for a firm conclusion (Table 13). 
Table 13:   Comparison of the chronic dietary exposure to nivalenol (ng/kg b.w. per day) between 
adult vegetarians and general adult population. 
Dietary survey  N  
Vegetarians 
N  
General 
adult 
population 
ng/kg b.w. per day 
Mean exposure  95
th percentile exposure 
Vegetarians 
General 
adult 
population 
Vegetarians 
General 
adult 
population 
Lower-bound                   
FI/2 39  1  575  4.2  4.8  10
(a) 10 
FR 15  2  276  2.4  1.6  7.3
(a) 4.3 
DE/4 237  10  419  1.5  1.2  4.5  3.9 
SE/1 18  1  210  0.5  0.4  1.3
(a) 1.1 
UK 77  1  724  1.8  1.4  4.8  3.3 
Upper-bound               
FI/2 39  1  575  34  40  85
(a) 93 
FR 15  2  276  45  47  128
(a) 98 
DE/4 237  10  419  57  55  131  140 
SE/1 18  1  210  57  42  234
(a) 89 
UK 77  1  724  64  64  147  159 
N: number of subjects in the dietary surveys; Vegetarians: adult vegetarians; b.w.: body weight:  
(a):  The 95
th percentile estimates for dietary surveys/age classes with less than 60 observations may not be statistically 
robust (EFSA, 2011b) and therefore they should not be considered in the risk characterisation. 
 
6.2.  Animal exposure assessment  
6.2.1.  Estimation of the levels of nivalenol intake in feeds for farm livestock 
As discussed in Section 5.2, a wide range of feeding systems and feeds are used for livestock in 
Europe. For many livestock, feeds are supplied in the form of commercially produced blends or 
compound feeds, and as indicated above (Section 4.2.13) some data on the nivalenol content of 
compound feeds were provided by the European countries. However, the numbers of samples for any 
particular livestock species were generally small, while for the majority of samples the product 
description was insufficient to identify the target species. As a result, it has not been possible to use 
data on the nivalenol content of compound feeds to estimate exposure. Instead, the CONTAM Panel 
has identified example diets for a range of farm livestock and companion animals, based on general 
principles and practices for animal feeding, the details of which are given in Appendix B, Section B2. 
Nivalenol has been reported in a range of cereal grains and cereal by-products that are widely used, in 
varying proportions, in livestock diets. However, the occurrence data for feed were not equally 
distributed across all feed materials, and there was a very high proportion of left-censored data. For 
this reason, aggregated data for cereal grains, their products and by-products were used for animal 
exposure assessment. The mean LB and UB concentrations were 11 and 43 µg nivalenol/kg, 
respectively for all feeds in the category ‘cereal grains, their products and by-products’ and these, 
together with feed intakes given in  Appendix B, Section B1, were used to estimate exposure. Nivalenol in food and feed
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It must be stressed that the inclusion rates of cereal grains, their products and by-products used in 
estimating exposure are not ‘averages’, nor are they an attempt to describe ‘worst case’ scenarios. 
Rather, they are intended to provide an indication of likely exposure to nivalenol across a range of 
feeding systems in Europe. In some situations, exposure may he higher than described below. For 
example, concentrations of nivalenol are generally higher in oat grains and oat by-products than other 
cereal grains (Table 7, Section 4.2.14), and since these are important feeds for livestock, particularly in 
northern Europe, exposure to nivalenol may be higher in these areas than estimated in this Scientific 
Opinion. 
The exposure estimates below are mainly for adult animals. Based on the previous Scientific Opinions 
on deoxynivalenol as undesirable substance in animal feed (EFSA, 2004a) and T-2 and HT-2 toxin in 
food and feed (EFSA, 2011c), zearalenone as undesirable substance in animal feed (EFSA, 2004b) and 
zearalenone in food (EFSA, 2011d) it is expected that pigs are particularly sensitive to the exposure to 
nivalenol in feed, and therefore the exposure to nivalenol for piglets and fattening pigs has also been 
estimated.  
6.2.1.1.  Ruminants  
Since the levels of nivalenol in grass and legume-based forages are low (Table 7), it is assumed that 
they make no significant contribution to exposure. Table 14 provides estimated exposures by 
ruminants to nivalenol from non-forage feeds. 
Table 14:   Estimated lower-bound and upper-bound exposure by ruminants to nivalenol. 
   Diet concentration 
µg/kg 
Exposure 
µg/day 
Exposure  
µg/kg b.w. per day 
Dairy: high yielding 
 
LB 2.4 50 0.077 
UB 9.5 196  0.30 
Beef: intensive cereal  LB  7.0  70  0.18 
UB 27.4 274  0.69 
Beef: fattening 
  
LB 1.3 13 0.032 
UB 5.2  50  0.12 
Beef fattening (maize 
silage) 
LB 72 760  1.9 
UB 157  1653  4.2 
Sheep: lactating  LB  3.0  8.5  0.14 
UB 11.8  33  0.55 
Goats: lactating 
  
LB 4.3 15  0.24 
UB 16.8  57  0.95 
Goats: fattening  LB  3.1  4.6  0.12 
UB 12.0 18.1  0.45 
b.w.: body weight; LB: lower-bound; UB: upper-bound. 
 
Although data provided by the European countries show that nivalenol is not generally present in fresh 
or conserved grass and legume forages, it may be present in maize silages (Table 7, Section 4.2.14). 
Maize silage is widely used as a feed for ruminants and may account for up to 70 % of the total dry 
matter intake of lactating dairy cows (AFRC, 1993; McDonald, 2011) or more in some beef rations 
(Section 5.2.2). AFSSA (2009) has provided example intakes of dairy cows fed maize silage, maize 
grain and soybean meal. Using these intakes and the mean LB and UB concentrations for nivalenol 
(80 and 174 µg/kg dry matter, respectively (Section 4.2.14), in maize grain estimates of exposure have 
been calculated for lactating cows (milk yields 30, 40 and 50 kg/day, Table 15) fed maize silage-based 
diets. Nivalenol in food and feed
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Table 15:   Estimated lower-bound and upper-bound exposure to nivalenol of lactating dairy cows 
(milk yields 30, 40 and 50 kg/day) fed diets based on different forages, as µg/day and µg/kg b.w. per 
day. 
  Exposure 
  Milk yield (kg/day)/non-forage feed intake (kg dry matter/day) 
 30/8.4  40/12  50/16 
  µg/day 
LB
(a)   1272 1305 1273 
UB
(a)  2851 3019 2936 
  µg/kg b.w. per day
(b) 
LB
(a)   2.0 2.0 2.0 
UB
(a)  4.4 4.6 4.5 
b.w.: body weight; LB: lower-bound; UB: upper-bound;  
(a):  Calculated nivalenol concentrations in diets based on maize silage are reported in Appendix B, Table B5;  
(b):  b.w. of 650 kg. 
 
These calculations illustrate the effects that both level of milk production and type of diet can have on 
exposure to nivalenol, particularly when maize silage and/or maize grains are included in the diet 
(Table 15). For fattening beef, where maize silage accounts for 90 % of feed dry matter consumed, 
mean LB and UB exposure of 1.9 and 4.2 µg/kg b.w. per day, respectively are estimated (based on 
intake assumptions given in Section 5.2.2). 
6.2.1.2.  Pigs, poultry, rabbits, fish and horses  
Based on feed intake data described in Section 5.2, and the mean LB and UB concentrations for 
nivalenol in cereal grains, their products and by-products (see Section 4.2.14), estimates of the 
exposures of nivalenol in diets and exposure by pigs, poultry, rabbits, fish and horses are given in 
Table 16. Nivalenol in food and feed
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Table 16:   Estimated lower-bound and upper-bound concentrations and exposure of pigs, poultry, 
rabbits, fish and horses to nivalenol. 
   Diet  concentration 
µg/kg 
Exposure µg/day  Exposure  
µg/kg b.w. per day 
Piglets LB  8.1  8.1  0.41 
   UB  31.8  32  1.6 
Fattening pigs  LB  7.9  24  0.24 
 UB  31.0  93  0.93 
Lactating sow  LB  8.3  50  0.25 
   UB  32.3  194  0.97 
Chickens for fattening  LB  8.1  0.98  0.41 
 UB  31.8  3.8  1.9 
Laying hens  LB  7.2  0.98  0.43 
   UB  28.0  3.8  1.7 
Turkeys for fattening  LB  7.2  2.9  0.24 
 UB  28.0  11  0.93 
Ducks for fattening  LB  7.9  1.1  0.37 
   UB  31.0  4.3  1.4 
Rabbits LB  3.9  0.39  0.20 
 UB  15.4  1.5  0.77 
Salmonids LB  2.7 0.11  0.054 
   UB  10.6  0.42  0.21 
Horses LB  4.5  41  0.090 
 UB  17.6  159  0.35 
b.w.: body weight; LB: lower-bound; UB: upper-bound. 
 
6.2.2.  Estimation of the sum of nivalenol intake in feed by companion animals (cats and dogs) 
Based on feed intake data described in Section 5.2, and the mean LB and UB concentrations for 
nivalenol in feeds (see Section 4.2.14), estimates of the exposures of nivalenol in diets and exposure of 
cats and dogs are given in Table 17. 
Table 17:   Estimated lower-bound and upper-bound concentrations and exposure of cats and dogs to 
nivalenol. 
   Diet concentration  
µg/kg 
Exposure 
µg/day 
Exposure  
µg/kg b.w. per day 
Cats LB  6.1  0.36  0.091 
 UB  23.7  1.4  0.35 
Dogs  LB  7.2  2.6  0.10 
   UB  28.0  10  0.40 
b.w.: body weight; LB: lower-bound; UB: upper-bound. 
 
7.  Hazard identification and characterisation 
7.1.  Toxicokinetics 
The toxicokinetics of nivalenol in rodents and farm animals has been previously reviewed by SCF 
(2000) and Wu et al. (2010).  Nivalenol in food and feed
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7.1.1.  Experimental animals 
Nivalenol was rapidly absorbed, distributed to and eliminated from all investigated tissues in mice 
given a single oral dose (20 µg/kg b.w.) of radioactively labelled nivalenol with a maximum plasma 
concentration reached after 60 minutes, a distribution half-life of 2.53 hours and an elimination half 
life of 14.34 hours (Poapolathep et al., 2003a). Nivalenol was mainly excreted in faeces in mice with 
no apparent accumulation in any tissue (Poapolathep et al., 2003a). No de-epoxy nivalenol or other 
metabolites of nivalenol were identified in urine or faeces, but the chromatograms contained a minor 
unidentified peak. The tissue levels of nivalenol changed almost in parallel with the plasma 
concentrations (Poapolathep et al., 2003a). Unchanged nivalenol was transported to fetal or suckling 
mice via placenta or milk in mice given a single oral dose. It is not possible to extrapolate details 
regarding the dosing of the animals from this paper, but the levels in the fetus were comparable to the 
maternal levels (Poapolathep et al., 2004a). In the study of Onji et al. (1989) higher doses (5 mg 
nivalenol/kg b.w. 12 times at 2-3 days intervals) were given orally to male Wistar rats. Of the ingested 
nivalenol, 80 % was excreted in the faeces and 1 % in the urine as de-epoxy nivalenol. Seven per cent 
of the ingested nivalenol was detected unmetabolised in the faeces and 1 % in the urine. 
De-epoxidation of nivalenol is believed to be a detoxification reaction. The IC50 value for de-epoxy 
nivalenol for DNA synthesis in 3T3 mouse fibroblasts was 54 times higher than the IC50 for nivalenol 
(Eriksen et al., 2004).   
7.1.2.  Humans 
No de-epoxidation of nivalenol was found in anaerobic incubations of human faeces with nivalenol for 
48 hours (Eriksen and Pettersson, 2003). The CONTAM Panel noted that human faecal microbiota can 
de-epoxide deoxynivalenol (Gratz et al., 2013). No other information on toxicokinetics of nivalenol 
was identified for humans. 
7.1.3.  Farm animals 
7.1.3.1.  Ruminants 
The capacity of the ruminal microflora of cows to metabolise nivalenol has been studied by Hedman 
and Petterson (1997). Anaerobic incubation of nivalenol with rumen fluid produced a de‐epoxidised 
metabolite in a high proportion, suggesting pre-systemic detoxification of nivalenol in ruminants.  
7.1.3.2.  Pigs 
Nivalenol is rapidly absorbed in pigs after oral exposure, and was present in plasma 20 minutes after 
feeding. Hedman et al. (1997a) found that in pigs given 0.05 mg nivalenol/kg b.w. twice per day, with 
sampling on the first and third day, 11-43 % was absorbed during the first 7.5 hours and the plasma 
peak concentrations were low (3-6 µg/L), mostly taking place 4.5 hours after feeding. However, it was 
found that absorption was still occurring from the intestine 16 hours after feeding. Nivalenol was 
mainly excreted in faeces. In this experiment with specific pathogen free pigs no metabolites, neither 
glucuronide conjugates nor de-epoxy-nivalenol, were found in plasma, urine or faeces. 
The capacity of the pig gastrointestinal microflora to metabolise nivalenol was studied by Hedman and 
Petterson (1997). Before feeding nivalenol to six experimental pigs, no metabolites of nivalenol were 
formed in anaerobic incubates with the pigs faeces. However, after one week on a diet containing 
2.5 or 5 mg/kg of nivalenol, nearly all excreted nivalenol in faeces was de-epoxidated in five of six 
pigs. After three weeks on the contaminated diet the sixth pig had also acquired this ability. The de-
epoxidation occurs in the distal parts of the gastrointestinal tract while a large part of the absorption 
already occurs in the proximal gastrointestinal tract. Eriksen et al., (2002) also showed that 
gastrointestinal microflora in anaerobic incubations with pig faeces were able to metabolise nivalenol 
to the de-epoxy metabolite. Although intestinal microorganisms can acquire the de-epoxidation ability Nivalenol in food and feed
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when pigs are exposed to trichothecenes, it is not known if the intestinal de-epoxidation activity will 
have any effect on the toxic effects of trichothecenes (Eriksen and Pettersson, 2003). 
7.1.3.3.  Poultry 
When male broiler chickens (Cobb) were fed 2.5 or 5 mg nivalenol/kg feed ad libitum for three weeks, 
no de‐epoxy nivalenol was found in the faeces, although another unidentified metabolite was found 
(Hedman and Petterson, 1997). In a feeding study performed by Garaleviciene et al. (2002), white 
Leghorn hens (55 week old) were fed for 50 days a basal diet supplemented by several concentrations 
of a pure nivalenol solution to  produce levels of 0, 1, 3 and 5 mg nivalenol/kg feed (5 animals per 
group). The concentration of nivalenol, its metabolites and other trichothecenes were determined in 
diets, organs, body fluids and eggs. The data showed that the basal diet naturally contained 66 µg 
nivalenol/kg and 100 µg deoxynivalenol/kg. Thus the actual nivalenol concentrations in the 
experimental diets were 0.066, 1.19, 2.97 and 4.93 mg/kg feed instead of the assigned levels of 0, 1, 3 
and 5 mg/kg, respectively. Although insignificant traces of fusarenon-X were found in some faeces 
samples, nivalenol and de-epoxy nivalenol were the main substances excreted in the faeces. When the 
diet contained 5 mg nivalenol/kg feed, the highest concentrations of nivalenol and de-epoxy-nivalenol 
were found in faeces collected on days 4-6 of the feeding trial. On days 19-21 and 40-50 of the feeding 
trial, de-epoxy nivalenol was the main detected metabolite in faeces whereas the concentration of 
nivalenol was much lower. Nivalenol and its metabolites were not detected in eggs. Trace 
concentrations of nivalenol and deoxynivalenol were detected in the liver. In the bile the mean 
concentrations of nivalenol and deoxynivalenol were 11 and 27 ng/mL, respectively. The authors 
concluded that the detected deoxynivalenol concentrations in liver and bile were probably due to the 
natural contamination of the basal diet by deoxynivalenol. Neither nivalenol nor any investigated 
metabolites were found in the blood plasma samples. The metabolites were not investigated at the 
lower concentrations in the experimental diets (Garaleviciene et al., 2002). 
7.1.3.4.  Fish 
The gastrointestinal content of fish has been reported to be able to metabolise nivalenol into the 
de-epoxy-nivalenol in in vitro incubation assays (Guan et al., 2009). 
7.1.3.5.  Horses  
No studies on toxicokinetics of nivalenol in horses were identified. 
7.1.3.6.  Companion animals  
No studies on toxicokinetics of nivalenol in companion animals (dogs and cats) were identified. 
7.1.3.7.  Carryover 
The available information on the carryover of nivalenol from feed to animal derived food is very 
limited. Only one experiment performed on hens is reported in the literature. No nivalenol or its 
metabolites were found in eggs from white Leghorn hens fed diet containing up to 5 mg nivalenol/kg 
feed for 50 days (Garaleviciene et al., 2002). Trace concentrations of nivalenol were detected in the 
liver. No information on carryover on nivalenol in animal species other than poultry was identified. 
7.1.4.  Other studies 
Tep et al. (2007) found that nivalenol was a substrate for P-glycoprotein and multi-drug resistance 
associated protein 2 (MRP2) using an in vitro Caco-2 cell model and epithelial cells transfected with 
P-glycoprotein or MRP2 whereas the transport from the apical to the basolateral side was governed by 
passive diffusion. Nivalenol in food and feed
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7.1.5.  Conclusions  
The available information on the toxicokinetics of nivalenol is incomplete. Information on the degree 
of absorption is limited, but in mice it is rapid with a maximum plasma concentration in one hour after 
oral dosing. Nivalenol is rapidly distributed to and eliminated from all examined tissues in mice with 
no apparent accumulation in any organ. In pigs the absorption following oral ingestion was found to 
be 11-43 % of the dose, and after absorption, nivalenol is rapidly distributed to and eliminated from all 
tissues. In ruminants, it is likely that, as for other trichothecenes, extensive de-epoxidation of nivalenol 
may occur in the rumen prior to absorption.  There is evidence of major species-dependent differences 
in the extent of de-epoxidation of nivalenol in non-ruminants, which may occur in the lower parts of 
the gastrointestinal tract in some species. The de-epoxy metabolite has been detected in faeces of rats, 
pigs and laying hens, but not in mice or broiler chickens, and based on in vitro studies, it is unlikely to 
be formed in significant proportions in humans. In vitro studies demonstrated the de-epoxidation of 
nivalenol by ruminal microflora, and by gastrointestinal microflora of pigs but not of humans. No 
phase II metabolites of nivalenol have been reported. The available information on the carryover of 
nivalenol from feed to food products of animal origin is very limited. The CONTAM Panel concluded 
that residues of nivalenol in products of animal origin could only marginally contribute to human 
exposure.  
7.2.  Toxicity in experimental animals 
7.2.1.  Acute toxicity 
The SCF (2000) identified an oral LD50 for nivalenol (99 % pure) of 38.9 mg/kg b.w. in 
C57BL/6CrSlc SPF mice (Ryu et al., 1988). Since then, no additional acute toxicity studies have been 
published.  
Wu et al. (2012) demonstrated that the ED50
22  (single oral dose) for inducing emetic effects in mink, a 
species known for its sensitivity to such effects, was higher for nivalenol (180 µg/kg b.w.) than for 
deoxynivalenol (30 µg/kg b.w.). 
7.2.2.  Sub-acute and sub-chronic toxicity 
Several subacute and subchronic toxicity studies were described by the SCF (2000). Since then, two 
new studies have been published, which are described below.  
In order to identify a NOAEL, Gouze et al. (2007) tested the effects of different oral doses of nivalenol 
for effects on plasma biochemistry, the immune system and hepatic drug metabolism in mice. C57Bl6 
mice (6 groups of 10 animals) received 0.014 to 8.87 mg nivalenol/kg b.w. per gavage three times per 
week for four weeks (i.e. 0.006 to 3.8 mg nivalenol/kg b.w. per day). Only the highest dose of 
nivalenol induced an increase in plasma phosphate, decreases in plasma urea and in activity of selected 
P450 dependent mono oxygenases and in immunoglobulin M (IgM), and additional changes like 
increases in plasma alkaline phosphatase and immunoglobulin G (IgG) (details are presented in 
Section 7.2.5.1.3). The NOAEL was 1.8 mg/kg b.w. per day.  
A 90-day sub-chronic toxicity study of nivalenol was conducted according to test guideline 408 of the 
Organisation for Economic Co-operation and Development (OECD). Male and female F344 rats (10 
animals per sex and per dose) were fed diets containing nivalenol at concentrations of 0 (control 
group), and 6.25, 25 or 100 mg/kg diet (equivalent to 0.4, 1.5 and 6.9 mg/kg b.w. per day in males and 
0.4, 1.6 and 6.4 mg/kg b.w. per day in females). Data have been presented in three different 
publications. Takahashi et al. (2008) presented the design of the study, basic in-life parameters (food 
consumption and body weight), haematology, serum biochemistry and histopathology (for details see 
Section 7.2.6.1). Sugita-Konishi et al. (2008) reported effects on weight gain and organ weights, 
mortality, tumor incidence and immunochemistry, repeating haematological and serum biochemistry 
data from the study of Takahashi et al. (2008). Kubosaki et al. (2008) provided more details on 
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immunotoxicity (for details see Section 7.2.5), and reported a decrease in body weight gain and loose 
stools at the highest dose of 100 mg/kg diet in both sexes from the start of the experiment. A decrease 
in body weight gain was also observed in males at 25 mg/kg diet in week six. At necropsy, many 
organs demonstrated reduced absolute weights at 100 mg/kg diet in both sexes, mostly due to the 
reduction in body growth, with reduction of relative thymus weight also being evident in females.  
Histopathology was performed in control animals, in those at the highest dose level (100 mg/kg diet) 
and in animals at lower dose levels when effects were observed at 100 mg/kg diet. Liver and kidney 
were examined in all groups. Statistically significant treatment-related histopathological changes were 
predominantly observed in the haematopoietic and immune organs and the anterior pituitary in both 
sexes and in female reproductive organs at 100 mg/kg diet. Effects included thymus atrophy, 
hypocellularit and a statistically significant decrease in haematopoietic cells in the bone marrow from 
femur (9/10 male and female rats) and from sternum (7/10 male rats and 10/10 female rats), diffuse 
hypertrophy of basophilic cells with increase of castration cells in the anterior pituitary, and increase 
of ovarian atretic follicles. Haematological and immunological changes were also observed and are 
reported in Section 7.2.6 and Section 7.2.5, respectively. Based on the haematological data, the 
LOAEL of nivalenol was 6.25 mg/kg diet (equivalent to 0.4 mg/kg b.w. per day (calculated based on 
feed consumption)) (Takahashi et al., 2008).  
7.2.3.  Chronic toxicity 
No new studies have been reported since the evaluation of the SCF (2000) which used for its risk 
characterisation a 1-year and a 2-year chronic toxicity studies (Ryu et al., 1988; Ohtsubo et al., 1989). 
The critical effects are haematological disturbance such as leukopenia, as described in detail in Section 
7.2.6.1.   
7.2.4.  Dermal effects 
Trichothecenes are well known skin irritants and nivalenol has been shown in some early studies to 
have weak skin irritancy properties. No further information became available since the SCF 
assessment (SCF, 2000). 
7.2.5.  Immunotoxicity 
7.2.5.1.  In vivo studies  
Since the last SCF evaluation (SCF, 2000), several in vivo studies have been performed to investigate 
the effect of nivalenol on immune parameters. 
7.2.5.1.1. Effect of nivalenol on lymphocyte subsets 
Nivalenol was found to modulate lymphocyte number in both mice and rats. When ICR:CD-1 male 
mice (n = 5 per group) were orally administered with a single dose of 5, 10 and 15 mg nivalenol/kg 
b.w. and examined at 12, 24 and 48 hours after dosing, the number of apoptotic lymphocytes showed a 
dose-dependent increase at 12 hours after dosing in both the thymus and the Peyer's patches, and at 
24  hours after dosing in the spleen (Poapolathep et al., 2002). The same research group also 
investigated the early apoptosis and changes in lymphocyte subsets in lymphoid organs of female 
BALB/c mice (n  = 5 per group) after a single oral administration of 15 mg nivalenol/kg b.w. 
(Poapolathep et al., 2003b). In the thymus, selective damage in CD4
+CD8
+ cells was observed at 
12 and 24 hours after dosing, following the peak of apoptosis at 9 hours after dosing. CD4
+ cell 
numbers were clearly decreased at 3 hours after dosing in Peyer's patches, and at 9 hours after dosing 
in mesenteric lymph nodes, and 3 to 12 hours after dosing in spleen. CD8
+ cell numbers were also 
decreased at 24 hours after dosing in mesenteric lymph nodes and at 12 hours after dosing in spleen. 
As to changes in B lymphocyte subsets, IgG
+ cells significantly decreased from 3 to 12 hours after 
dosing and all B cell subsets at 24 hours after dosing in mesenteric lymph nodes. In spleen, IgM
+ cells 
were suppressed at 9 hours after dosing. On the other hand, in Peyer's patches, there was a clear Nivalenol in food and feed
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decrease in the numbers of pan-T and pan-B cells and viable cells at 3 hours after dosing, all B cell 
subsets, especially IgA
+ cells, showed a significant increase in their numbers at 9 hours after dosing, 
and the numbers of IgA
+ and IgM
+ cells remained at higher values than controls thereafter 
(Poapolathep et al., 2003b).  
In the 90-day sub-chronic toxicity study (see Section 7.2.2) F344 rats were fed diets containing 
nivalenol at concentrations of 0 mg/kg diet (control group), and 6.25, 25 or 100 mg/kg diet (reported 
to correspond to 0.4, 1.5, 6.9 mg nivalenol/kg b.w. per day) (Kubosaki et al., 2008). Lymphocyte 
subsets were characterised in 6 out 10 male rats in each group. While a reduced white blood cell 
(WBC) count was observed a dose-dependent decrease of the T lymphocyte/B lymphocyte 
(CD3
+/B220
+) ratio was observed at the two highest dose groups, and at the highest dose, a reduction 
of the percentage of NKR-P1A(+) splenic cells, which is an indicator of NK cells number, was also 
apparent. In contrast, an elevated CD4
+ helper/CD8
+ cytotoxic T lymphocyte ratio was reported for the 
highest dose group as well as a dose-dependent increase of NK cell activity of splenic cells against 
YAC-1 target cells.  
7.2.5.1.2. Effect of nivalenol on antibody levels 
The SCF reported in 2000, that in mice given nivalenol contaminated feed an increase in serum 
immunoglobulin A (IgA) was observed accompanied by immunopathological changes in kidneys 
analogous to human IgA-nephropathy (SCF, 2000). Nivalenol was also demonstrated to inhibit total 
and antigen specific immunoglobulin E (IgE) production in ovalbumin specific T cell receptor ab 
transgenic mice. Interleukin 4 was suppressed while interleukin 2 was increased in these mice (SCF, 
2000). The increased serum IgA and glomerular deposition of this immunoglobulin was recently 
confirmed in Balb/c mice (5-8 animals per group), receiving highly contaminated feed (12 or 
24 mg/kg feed) for 4 or 8 weeks (calculated to correspond to 1.6 and 3.2 mg nivalenol/kg b.w. per 
day). An increase in serum IgA levels was found at 24 mg/kg feed from 4 weeks. At week 8 of 
treatment, dose-dependent increases in serum IgA levels and glomerular deposition of IgA and 
immunoglobulin G (IgG) were observed without accompanying histopathological glomerular changes. 
In the high IgA strain of mice (HIGA) nivalenol further increased serum IgA, but did not enhance 
glomerular immunoglobulin deposition or histopathological lesion (Dewa et al., 2011). 
Two new reports (see also Section 7.2.2) indicate that low doses of nivalenol only slightly modulate 
total antibody production. In the 90-day sub-chronic toxicity study described earlier, dietary exposure 
of male F344 rats to the highest dose of 100 mg/kg diet induced a slight increase of IgM (26 % 
increase), while levels of IgG and IgA did not fluctuate at any dose (Kubosaki et al., 2008). Similarly, 
in C57Bl6 mice, administration of nivalenol by gavage three times a week for four weeks (0.014, 
0.071, 0.355 and 1.774 mg/kg b.w. per gavage equivalent to 0.006 to 0.76 mg nivalenol/kg b.w. per 
day) did not modulate IgG, IgM or IgA serum level concentrations, whereas a dose of 8.87 mg 
nivalenol/kg b.w. by gavage three times per week (equivalent to 3.8 mg nivalenol/kg b.w. per day) 
increased serum IgG levels (Gouze et al., 2007).  
7.2.5.2.  In vitro studies  
7.2.5.2.1 Rodent cells 
The effects of nivalenol were investigated on murine macrophages, dendritic cells and lymphocytes. 
In the mouse J7741 macrophage cell line, nivalenol (3.12-31.2 µg/mL) induced apoptosis associated 
with a cell cycle blockade, pro-caspase-3 degradation and activation of ERK
23, Bax, and poly-
adenosine diphosphate (ADP)-ribose polymerase (PARP) (Marzocco et al., 2009). In another mouse 
macrophage cell line, RAW264, nivalenol (0.0625-1 µg/mL) reduced in a concentration dependent 
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manner the lipopolysaccharide-induced production of interferon-beta (IFN-beta) and nitric oxide (NO) 
(Sugiyama et al., 2010). 
In lipopolysaccharide (LPS)-treated bone marrow-derived dendritic cells (DCs), nivalenol 
(0.624 µg/mL) down-regulated the expression of major histocompatibility complex (MHC) class II 
and the accessory CD11c molecules but did not modulate the expression of the co-stimulatory CD86 
marker. Nivalenol (0.312-0.936 µg/mL) decreased the production of NO and increased the secretion of 
the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) (Luongo et al., 2010). 
In mouse primary thymocyte nivalenol (0.25, 0.5 and 1.0 µg/mL) decreased the number of viable 
cells, especially CD4
+CD8
+ cells (Poapolathep et al., 2004b). 
7.2.5.2.2. Human cells 
In 2000, the SCF reported that nivalenol inhibits proliferation of human lymphocytes stimulated with 
mitogens (SCF, 2000). These results were later confirmed and extended to other human cell types.  
Nivalenol induced a concentration and time-dependent cytotoxicity in the human T lymphocyte cell 
line, Jurkat (Pestka et al., 2005; Nasri et al., 2006). The mechanism of nivalenol-induced cytotoxicity 
is via apoptosis as determined by phosphatidylserine externalization, mitochondrial release of 
cytochrome c, procaspase-3 degradation and Bcl-2 degradation (Nasri et al., 2006). In this lymphocyte 
cell line, nivalenol at concentrations ranging from 0.063 to 0.5 µg/mL, had no effect on interleukin-8 
(IL-8) production (Pestka et al., 2005). However, when Jurkat T cells were stimulated with phorbol 
myristate acetate and ionomycin, after pre-incubation with increasing concentrations of nivalenol, the 
levels of mRNA encoding for interferon-γ (IFN-γ), interleukin-2 (IL-2) and IL-8 mRNA increased and 
peaked at 0.31-0.62 µg/mL whereas higher concentrations of nivalenol were found to be less 
stimulating (1.25 µg/mL) or inhibitory (2.5 µg/mL) (Severino et al., 2006).  
The effects of nivalenol (0.01-1 µg/mL) were also tested on human peripheral blood mononuclear 
cells from different blood donors (Berek et al., 2001; Taranu et al., 2010). Nivalenol inhibited mitogen 
induced cell proliferation, reduced antibody-dependent cellular cytotoxicity and limited NK cell 
activity (Berek et al., 2001; Taranu et al., 2010). 
Cytotoxic effects of 1 µg/mL nivalenol were also observed on the K562 human erythroleukemia cell 
line (Minervini et al., 2004) and on the promyelocytic cell line HL60 (Nagashima et al., 2006, 2011). 
In this latter cell line, nivalenol elicited IL-8 secretion and reduced the secretion of monocyte 
chemoattractant protein 1 (MCP1) through a nuclear factor-κB dependent mechanism (Nagashima et 
al., 2011). 
7.2.5.3.  Conclusions 
The immune system is one of the targets of nivalenol. In vitro, this toxin induced apoptosis in different 
immune cells, such as lymphocytes, dendritic cells and macrophages and this may decrease their 
functional properties. It is difficult to interpret whether these data reflect cytotoxicity or more 
specifically immunotoxicity (see also Section 7.3). In vivo studies performed in rodents also 
demonstrated an increase in apoptosis of lymphocytes in several immune organs such as thymus, 
Peyer's patches or spleen. As for other trichothecenes, ingestion of nivalenol contaminated feed also 
increased the plasma concentration of IgA that might lead to deposition of IgA in kidney.  
7.2.6.  Haematotoxicity and myelotoxicity  
The SCF (2000) noted that the general toxicity and immunotoxicity/haematotoxicity of nivalenol are 
considered as the critical effects. They observed from long term studies in mice that these effects are 
similar to those of other trichothecenes. Nivalenol in food and feed
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7.2.6.1.  In vivo studies  
A short term toxicity study was performed on female C57BL/6CrSlc SPF mice for 24 days using feed 
supplemented with rice, upon which  F. nivale Fn 2B had been grown and which contained nivalenol. 
A significant erythropenia and slight leukopenia were observed at the highest nivalenol dose of 3.49 
mg/kg b.w. per day, but no marked changes were observed in other parameters (Ryu et al., 1987). In 
the 90-day F344 rat study (see also Section 7.2.2), haematological disturbances and depression of bone 
marrow were reported (Sugita-Konishi et al., 2008; Takahashi et al., 2008). Leukopenia was also 
described in the long term toxicity studies of Ryu et al. (1988) and Ohtsubo et al. (1989).  
A carcinogenicity study was performed in which seven-week-old female C57BL/6CrSlc SPF mice 
were fed diets containing 0, 6, 12, and 30 mg/kg diet nivalenol with interim kills after six months and 
one year. In the 6-month and the 1-year study, the doses were equivalent to 0, 0.76, 1.64 or 3.95 mg/kg 
b.w. per day  and 0, 0.68, 1.51 or 3.84 mg/kg b.w., respectively, and all animals were assessed for 
effects on body weight gain and feed efficiency, terminal organ weights, haematology and 
histopathology (Ryu et al., 1988). A statistically significant leukopenia (decrease in WBC count), was 
observed in the highest dose at six months, and in the lowest and the highest dose at one year (data 
presented in Table 18). No marked changes were observed in the other haematological parameters, 
body weight gain or histopathology.  
In the 2-year study the approximate daily exposure to nivalenol was 0, 0.66, 1.38 or 3.49 mg/kg b.w. 
per day in the four groups, respectively (Ohtsubo et al., 1989). The CONTAM Panel noted the low 
number of surviving animals (29/42 animals in the highest dose group and 22/42 in each of the other 
three groups by 24 months). Decreased body weight gains were seen in all treated groups although the 
terminal weight at two years was statistically significantly lower only in the highest dose group. 
Haematological parameters were determined for ten animals randomly selected among these survivors. 
The haematological data indicated a decrease in WBC count in the two highest dose groups, but the 
findings were not statistically significant (Table 18). The values of red blood cell count, haematocrit 
and haemoglobin in the middle dose showed a statistically significant increase compared with those 
for the control group, but all of the values fell within the normal range. No other haematological data 
showed differences compared with control values. Therefore, the CONTAM Panel concluded that the 
data from the 2-year study in mice did not show a clear dose-response relationship. Biochemical 
studies revealed dose-dependant increases in the serum values for alkaline phosphatase (ALP) and 
non-esterified fatty acids (NEFA), the increases being statistically significant at the highest dose level. 
At the highest dose, the levels of glutamic-oxaloacetic transaminase (GOT) were also significantly 
increased and those for glutamic-pyruvic transaminase (GPT), amylase (AMY), creatinine 
phosphokinase (CPK) and calcium were significantly decreased compared to controls. Nivalenol in food and feed
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Table 18:   Haematological data for female C57BL/6CrSlc SPF mice fed diets containing 0, 6, 12 or 
30 mg nivalenol/kg diet for 6 months, 12 months (Ryu et al., 1988) and 24 months (Ohtsubo et al., 
1989). 
  mg nivalenol/kg diet   
  0 6 12  30   
Study duration of 6 months        Ryu  et  al. 
(1988)  Dose expressed in mg/kg b.w. per day  0  0.76  1.64  3.95 
Number of animals   5  3  4  2 
White blood cells count (×10
3/mm
3)
 (a) 3.4±0.2  4.1±1.1  3.7±1.5  2.7±0.1
(b) 
Study duration of 1 year        Ryu  et  al. 
(1988)  Dose expressed in mg/kg b.w. per day  0  0.68  1.51  3.84 
Number of animals   6  6  6  6 
White blood cells count (×10
3/mm
3)
 (a) 4.7±0.9 2.5±0.7
(c) 2.8±2.2 2.0±0.5
(c) 
Study duration of 2 years        Ohtsubo  et 
al. (1989)  Dose expressed in mg/kg b.w. per day  0  0.66  1.38  3.49 
Number of animals   10  10  10  10 
White blood cells count (×10
3/mm
3)
 (a) 6.4±5.4 10.1±16.5  4.9±2.7  3.0  ±2.4 
(a):  Values for white blood cells count are means ± standard deviation. 
(b):  Significantly different from the control values at P < 0.05.   
(c):  Significantly different from the control values at P < 0.01. 
 
In the 90-day F344 rat subchronic toxicity study (Takahashi et al., 2008) (see also Section 7.2.2) a 
statistically significant decrease in the WBC count was found at the highest dose of 100 mg/kg diet 
(6.9 mg/kg b.w. per day in males and 6.4 mg/kg b.w. per day in females) (Table 19). In addition, at 
this dose, statistically significant decreased platelet counts in both sexes, decreased red blood cell 
counts in males and decreased haemoglobin concentration in females were reported. 
Histopathologically, treatment-related changes were predominantly observed in the haematopoietic 
and immune organs as hypocellularity and decrease in haematopoietic cell number in the bone marrow 
from femur and sternum at the highest dose tested in almost all male and female mice. Based on the 
haematological data, a LOAEL of 6.25 mg/kg diet (equivalent to 0.4 mg nivalenol/kg b.w. per day) 
was identified by the authors. 
Table 19:   Summary of relevant haematological data for F344/DuCrj rats fed diets containing 0, 6.25, 
25 or 100 mg nivalenol/kg diet for 90 days (Takahashi et al., 2008; Sugita-Konishi et al., 2008) (See 
also Section 7.2.3). 
 mg  nivalenol/kg  diet 
 0  6.25  25  100 
Female      
Dose expressed in mg/kg b.w. per day  0  0.4  1.6  6.4 
Number of animals  9
(b) 10 10 10 
White blood cells (×10
2/µL)
 (a) 38.8±7.7  30.5±10.1
(d) 29.7±5.5
(d) 19.6±4.5
(b) 
Red blood cells (×10
4/µL)
(a)  919.2±25.8  917.4±51.2 900±23.7 874.6±59.2 
Platelets (×10
4/µL)
 (a) 76.6±6.5  73.5±3  74.2±3.3  60.7±5.3
(d) 
Haemoglobin (g/dL)
 (a)  16.3±0.6 16.2±0.8 15.5±1.1 15.3±1
(d) 
Male      
Dose expressed in mg/kg b.w. per day  0  0.4  1.5  6.9 
Number  of  animals  10 10 10 9
(c) 
White blood cells (×10
2/µL)
 (a) 38.5±12.2  37±12.2  36.5±6.1  21.6±3.9
(d) 
Red blood cells (×10
4/µL)
(a) 906.5±18.3  927.1±29.7  901.2±25.3  855.7±38.2
(d) 
Platelets (×10
4/µL)
 (a)  66.1±16.7 70.5±3.8 66.3±14.8  59.2±3.4
(d) 
Haemoglobin (g/dL)
 (a)  15.8±0.3 15.6±0.5 14.8±1.1  15±0.7 
(a):  Values for white blood cells, red blood cells, platelets and haemoglobin are means ± standard deviation.  
(b):  Blood sampling failed in one animal.  
(c):  Significantly different from the control values at P < 0.05.   
(d):  Significantly different from the control values at P < 0.01.   Nivalenol in food and feed
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7.2.6.2.  In vitro studies   
The  in vitro effects of nivalenol on mitogen-induced cell proliferation were determined in swine 
whole-blood cultures at a range of final concentrations of 0.0625-2 mM. Nivalenol induced a strong 
concentration-dependent inhibition of cell proliferation that was statistically significant already at the 
lowest concentration (Luongo et al., 2008). No studies have been performed on the effect of nivalenol 
on haematopoietic progenitors.  
7.2.7.  Developmental and reproductive toxicity  
The studies on developmental and reproductive toxicity of nivalenol were carried out prior to 2000. 
The SCF based their conclusions (SCF, 2000) on two publications. In one of these publications 
nivalenol was administered by intraperitoneal (i.p.) injection, and in the other by gavage or in the diet. 
The latter oral administration study is summarised below. 
Thirty ICR mice in three groups of ten animals were given mouldy rice containing 6, 12 and 30 mg 
nivalenol/kg feed throughout the gestation. In addition, purified nivalenol was given to groups of mice 
at doses of 0, 1, 5, 10 or 20 mg nivalenol/kg b.w. per day by gavage on days 7-15 of gestation. The 
LOAELs for developmental toxicity were based on intrauterine growth retardation and were 1.4 mg/kg 
b.w. for the feeding study and 5 mg/kg b.w. for the gavage study, respectively (Ito et al., 1988). 
No further data became available on the developmental and reproductive toxicity of nivalenol since 
the SCF assessment (SCF, 2000). For comparison the CONTAM Panel considered the 
developmental/reproductive properties of the structural analogue deoxynivalenol. The effects on 
developmental and reproductive toxicity reported for deoxynivalenol were seen at higher doses than 
other toxicological effects and were not considered to be critical effects in previous assessments 
(FAO/WHO, 2001, 2011a; FSCJ, 2010). 
Based on the limited available data, the CONTAM Panel concluded that developmental and 
reproductive toxicity is unlikely to be a critical effect for nivalenol. 
7.2.8.  Neurotoxicity  
No data on neurotoxicity of nivalenol were considered by the SCF in their assessment in 2000 (SCF, 
2000) or were identified subsequently by the CONTAM Panel.  
7.2.9.  Genotoxicity  
The SCF concluded in 2000 (SCF, 2000) that the available data did not allow an adequate evaluation 
of the genotoxicity of nivalenol. In summary the information assessed was based on induction by 
nivalenol of sister chromatid exchanges, chromosome aberrations and DNA damage (measured by the 
alkaline single-cell gel electrophoresis (Comet) assay). The limited new data and the relevant 
previously evaluated data are summarised below.  
Takahashi and co-workers showed (study not assessed by the SCF (SCF, 2000)) that nivalenol was 
inactive in the bacterial mutation assay with Salmonella typhimurium strain TA100 in the presence of 
phenobarbital-induced rat liver S9 fraction (Takahashi et al., 1992). Nivalenol was also subsequently 
tested by Barta et al. in the Salmonella typhimurium TA98 and TA100 strains with and without 
metabolic activation with an S9 fraction from PCB-induced rat liver. No mutagenic activity was 
observed (Barta et al., 2001). The mutagenicity of nivalenol was also assessed by Nagashima et al. 
(2009) using an umu test in a Salmonella typhimurium strain. No activity was found in the absence or 
presence of rat liver S9 at doses up to 50 µg/mL nivalenol. 
Thust et al. (1983) showed that nivalenol weakly induced sister chromatid exchanges and clastogenic 
damage in Chinese hamster V79-E cells. Hsia et al. (2004) reported the induction of chromosome 
aberrations in Chinese hamster V79 cells by HPLC-purified fractions with the retention time of 
nivalenol (concentration 30 ng/mL) derived from extracts of wheat flour, barley and corn from Nivalenol in food and feed
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Linxian. This confirmed earlier results (considered by the SCF in 2000) with HPLC-purified fractions 
which had the retention time of nivalenol from a corn extract from Linxian (Hsia et al., 1988). 
Cytotoxicity was not reported for these experiments. However, Ryu et al. (1993) did not detect 
clastogenicity of nivalenol at concentrations up to 0.3 µg/mL with and without rat liver S9 in Chinese 
hamster lung cells. 
The frequency of aberrant cells in bone marrow of male and female Chinese hamsters was assessed 
after  treatment with nivalenol (Barta et al., 2001)
24. The animals were administered a dose of 0.1 LD50 
orally on six occasions at three week intervals. Nivalenol did not statistically significantly increase the 
frequency of aberrant bone marrow cells in comparison with the control group in either male or female 
animals.   
The SCF considered a study by Tsuda et al. (1998) in which nivalenol was tested for DNA damage in 
vitro in Chinese hamster ovary cells (without metabolic activation) and in vivo in male ICR mice 
(seven organs: stomach, jejunum, colon, liver, kidney, thymus and bone marrow) using a modified 
alkaline single-cell gel electrophoresis (Comet) assay. In vitro nivalenol caused a significant increase 
in DNA migration (indicative of DNA damage) at 50 and 100 µg/mL. After oral treatment (male ICR 
mice) with a single dose of 20 mg nivalenol/kg b.w. DNA damage was found in the kidney, bone 
marrow, stomach, jejunum and colon but not in thymus or liver. Upon histopathological examination 
no necrotic changes were observed in the organs with DNA damage indicating that the in vivo findings 
were not secondary to cytotoxicity. The CONTAM Panel considered that this study was not carried 
out according to the requirements defined in the EFSA Scientific Report ‘Minimum Criteria for the 
acceptance of in vivo alkaline Comet Assay Reports’ (EFSA, 2012a).  
In an investigation subsequent to the SCF assessment (SCF, 2000), Bony et al. (2007) assessed the 
genotoxic potential of nivalenol in the human intestinal Caco-2 cell line using the Comet assay. Cells 
were both in the dividing (undifferentiated) stage and 10-12 days post-confluent (differentiated). DNA 
damage was measured using the Comet assay by the tail extent moment (product of tail length of the 
comet and the proportion of DNA in the tail). The concentration range for nivalenol was 0-0.5 µM 
which was in the sub-cytotoxic range (below the IC10
25). DNA damage was observed with a dose-
dependent relationship after 24 and 72 hours exposure of post confluent Caco-2 cells to nivalenol, but 
not after 3 hour exposure or in dividing cells. 
The CONTAM Panel also noted that the FSCJ assessment (FSCJ, 2010) reported another study 
(presented in a grant report
26) of mice treated by gavage with nivalenol at 0 or 6 mg/kg b.w. four times 
at weekly intervals which also showed a positive Comet result. However, the FSCJ assessment 
indicated that while positive results were obtained in some Comet assays, a study on potential 
mutations in transgenic mice gave negative results. The CONTAM Panel considered that the positive 
result in the Comet assays may be due to oxidative stress as reported before for the effects of 
deoxynivalenol in a Comet assay in HepG2 cells (Zhang et al., 2009) and that such an effect would be 
thresholded.  
Zhang et al. (2009) investigated this role of oxidative stress in the DNA damage induced by 
deoxynivalenol using human hepatoma HepG2 cells.  The significant dose-related increase in DNA 
migration in the Comet assay induced upon exposure of the cells to deoxynivalenol was reduced when 
the cells were pre-treated with the antioxidant hydroxytyrosol. Upon pre-treatment of the cells with the 
highest concentration of hydroxytyrosol tested (100 µM) the deoxynivalenol-induced tail length was 
reduced to 19 % of control (p < 0.05), the % tail DNA to 25 % of control (p < 0.05) and the tail 
moment to 6 % of control (p < 0.05). To further support a role for oxidative stress in the mode of 
                                                      
24   The original language is in Czech. Only part of the paper translated to English was available. 
25   IC10 = 10 % inhibitory concentration. 
26   Available in Japanese only. The FSCJ (2010) report states about the grant study: ‘According to the examiner of relevant 
study, after mice were treated with nivalenol in gavage at 0 or 6 mg/kg b.w. 4 times at weekly intervals, the forestomach, 
kidneys, urinary bladder, large intestine, lungs, liver, bone marrow and spleen exhibited negative for the induction of 
mutations. The comet assay showed positive results for the liver and stomach only.’ Nivalenol in food and feed
 
EFSA Journal 2013;11(6):3262  73
action of deoxynivalenol-induced DNA damage, the authors also reported a significant increase in 
production of reactive oxygen species, formation of 8-hydroxydeoxyguanosine and lipid peroxidation 
in the deoxynivalenol exposed cells. The authors concluded that the DNA damage induced by 
deoxynivalenol in HepG2 cells is probably related to oxidative stress. Oxidative stress and apoptosis 
are known to be capable of giving rise to positive Comet assay results (Henderson et al., 1998; 
Choucroun et al., 2001). Genotoxicity has not been considered the critical effect in previous 
assessments of deoxynivalenol (FAO/WHO, 2001, 2011a; FSCJ, 2010). 
Based on the data available, the CONTAM Panel concluded that the overall weight of evidence is that 
nivalenol is unlikely to be genotoxic. 
7.2.10.  Carcinogenicity 
The SCF (SCF, 2000) quoted the conclusion from IARC (1993) which was that there is inadequate 
evidence of carcinogenicity of nivalenol in experimental animals, and that it is not classifiable as to its 
carcinogenicity to humans (Group 3).   
The experimental data assessed at that time included a study by Ohtsubo et al. (1989). F. nivale Fn 2B 
was grown on polished rice which was dried and milled, and the content of nivalenol in this was 
determined (3147±171 mg/kg). Diets containing this mouldy rice were prepared containing 0, 6, 12 or 
30 mg/kg of nivalenol and fed to groups of 42 seven-week-old female C57BL/6CrSlc SPF mice for 
two years to give an approximate daily exposure to nivalenol of 0, 0.66, 1.38 or 3.49 mg/kg b.w. in the 
four groups, respectively. Decreased body weight gains were seen in all treated groups although the 
terminal weight at two years was only significantly lower in the 30 mg/kg diet group. Tumours, mostly 
lymphomas, were of similar incidence in all groups and the authors considered it unlikely that 
nivalenol is carcinogenic. The IARC Working Group noted the limited number of tissues studied 
(liver, thymus, spleen, kidneys and brain). 
A study on Balb/C mice with intermittent application
27 on the skin of nivalenol (as a ‘putative’ 
initiator) alternately with 12-O-tetradecanoylphorbol-13-acetate (TPA) (as a promoter) was carried out 
subsequent to the SCF evaluation (SCF, 2002) by Hsia et al. (2004). In the first experiment almost one 
third of the mice died within 10 weeks. In the mice that survived 11 - 60 weeks 19/44 (43 %) 
developed papillomas in the treated areas and 1/44 (2 %) developed a carcinoma. With an 
administration regime involving a higher dose of nivalenol, 20/25 mice died before 10 weeks. Of the 
five animals that survived 11-60 weeks one developed papilloma and two developed carcinomas (two 
in one of these animals). No tumours were found in control animals applying either TPA or acetone. 
An in vitro short-term transformation assay using v-Ha-ras-transfected BALB/3T3 cells (Bhas 42 
cells) was published after the SCF evaluation (SCF, 2000). This method was developed by Ohmori et 
al. (2004) to detect tumour promoters and modified by Asada et al. (2005) to detect both tumour 
initiators and promoters by using different protocols. Nivalenol was inactive in this assay (Sakai et al., 
2007). The concentration range of nivalenol used in the initiation assay was 0-0.2 µg/mL and in the 
promotion assay was 0-0.1 µg/mL. 
The available studies do not allow conclusions to be drawn on carcinogenicity of nivalenol in 
experimental animals. 
                                                      
27   Nivalenol was applied on mice skin for one week in every seven weeks. 12-O-tetradecanoylphorbol-13-acetate (TPA) was 
applied for six weeks in every seven weeks. Three consecutive experiments were performed. In the first and second 
experiment, the following dosage regimen was used: 5 µg/dose, 3 doses per week for nivalenol during the first week of the 
experiment; 3 µg/dose during the 7
th, 13
th, 19
th, 25
th and 31
st week; 2 µg/dose during the 37
th, 43
rd, 49
th and 55
th week at 
3 doses per week. In the third experiment, the following dosage regimen was used: 5 µg/dose, 3 doses per week of 
nivalenol during the scheduled weeks for nivalenol application. TPA was applied on skin during the weeks when nivalenol 
was not applied on skin at 2 µg/dose, 3 doses per week (Hsia et al., 2004). Fur further details see Hsia et al. (2004). Nivalenol in food and feed
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7.3.  Mode of action 
Few new studies have been performed to elucidate the mechanisms of toxicity of nivalenol since the 
SCF report in 2000 (SCF, 2000). Trichothecenes, such as nivalenol, inhibit peptidyl transferase with 
subsequent inhibition of peptide bond formation. The target organelle of trichothecene action is the 
60S subunit of eukaryotic ribosomes, the protein inhibition activity correlating well with ribosome 
affinity. The mechanism of protein inhibition can be of two types: one is the inhibition of the initial 
step of protein synthesis (I-type) and the other the inhibition of the elongation-termination step 
(ET-type). Nivalenol is acting on the initial step of protein synthesis (reviewed by Rocha et al. (2005)) 
with an ID50 of 2.5 mg/mL in rabbit reticulocytes (SCF, 2000). Being potent direct and indirect 
inhibitors of protein, deoxyribonucleic (DNA) and ribonucleic (RNA) acids synthesis, trichothecenes 
are especially toxic to tissues with a high cell proliferation rate.  
Data obtained either in vitro or in vivo have confirmed that nivalenol induces apoptosis. In a study 
with ICR:CD-1 male mice, nivalenol was orally administered at dose levels of 5, 10 and 15 mg/kg 
b.w. per day. When the animals were examined 12, 24 and 48 hours after dosing, dead lymphocytes in 
the thymus, spleen and Peyer’s patches showed ultrastructural characteristics of apoptosis. Moreover, 
12 hours after dosing, DNA laddering (a typical marker of apoptosis) was first detected in the thymus 
of mice treated with 15 mg/kg b.w. (Poapolathep et al., 2002). In vitro experiments with Jurkat T cells 
(human T lymphocytes) exposed to 0.2 to 10 µM nivalenol, showed signs of apoptosis as indicated by 
phosphatidylserine externalization, mitochondrial release of cytochrome c, procaspase-3 degradation 
and Bcl-2 degradation (Nasri et al., 2006). Activation of Bax and caspase-3 have also been observed in 
J774 murine macrophages exposed to 25 µM nivalenol (Marzocco et al., 2009).  
The effects of nivalenol were also studied recently in an in vitro model system, utilising the rat 
intestinal epithelial cell line IEC-6. Nivalenol (5-80 µM) significantly affected IEC-6 viability through 
a pro-apoptotic process which mainly involved Bax induction, Bcl-2 inhibition, and caspase-3 
activation (Bianco et al., 2012). Deoxynivalenol also induced similar effects. 
7.4.  Adverse effects in livestock, fish and companion animals 
7.4.1.  Ruminants 
No studies on the adverse effects in ruminants have been identified. 
7.4.2.  Pigs 
Trenholm et al. (1989) reported that pigs are the most sensitive farm animals to tricothecenes, with 
exposure associated with reduced feed intake and liveweight gain. When young pigs (starting weight 
13.3±1.9 kg) were fed diets containing 0, 2.5 or 5 mg nivalenol/kg feed (89 % purity of nivalenol) for 
3 weeks (n = 6), no signs of feed refusal or clinical alterations were observed (Hedman et al., 1997b). 
The exposure to nivalenol via the feed, estimated to be 0.1 or 0.2 mg nivalenol/kg b.w. per day in pigs 
consuming rations corresponding to 2 % of their body weight, did not cause changes in total or 
differential blood leukocyte counts nor changes in mitogen stimulated proliferation of lymphocytes 
from blood, spleen or thymus. Macroscopic examination at necropsy revealed gastrointestinal erosions 
and signs of nephropathy, namely pale kidneys with narrow cortex and dilated pelvis in 4 and 5 out of 
6 pigs in the group fed the diets containing 2.5 and 5 mg nivalenol/kg feed, respectively. In control 
animals no pathological changes were observed. Spleen cell numbers showed a dose-dependent 
decrease which was reflected by a decrease in CD4
+ and CD8
+ cells, which was statistically 
significantly different from control at 5 mg nivalenol/kg feed. Furthermore, the lowest dose group in 
the study showed a time-dependent increase in the plasma concentration of IgA and pathological 
changes in the gastrointestinal tract, the kidneys and the spleen. In another study, a statistically 
significant decrease in the activity of oxoglutarate dehydrogenase was reported in small intestine and 
colon epithelium of 51 day-old male pigs (Landrace x Yorkshire) administered with a diet containing 
2.5 or 5 mg nivalenol/kg for three weeks (Madej et al., 1999). Based on the reported data a LOAEL of 
0.1 mg nivalenol/kg b.w. per day could be identified. Nivalenol in food and feed
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7.4.3.  Rabbits 
No studies on the adverse effects in rabbits were identified. 
7.4.4.  Poultry  
Very few feeding experiments have been performed on poultry species, and only three reports could 
be identified. An experiment including two feeding trials on the effects of nivalenol on male broiler 
chickens was reported in two papers (Hedman et al., 1995; Petterson et al., 1995). For both trials, a 
commercial starter diet was provided for ad libitum consumption throughout the whole experiment. 
When the birds were seven days old they were fed diets to which nivalenol was added. Growth and 
feed consumption were thereafter registered every 5
th day during 20 days. In the first trial diets with 
nivalenol concentrations of 0, 0.5, 2.5 and 5 mg/kg feed were used. Regarding the observed effects, 
the only parameter that significantly differed from the control was the increase uric acid concentration 
in plasma in treatment groups 2.5 and 5 mg/kg feed. In the second trial, nivalenol concentrations of 0, 
3, 6, and 12 mg/kg were used (12 birds per group). Live weight gain for the 20-day period was 
decreased by 11 % for birds fed 6 and 12 mg/kg. During this period there was a decrease of 5.8 and 
6.8 % in feed consumption and of 5.5 and 4.3 % in feed conversion efficiency in the 6 and 12 mg/kg 
feed group, respectively. Slight oral lesions were found in two birds of the control group, and in three, 
one and two birds of the 3, 6 and 12 mg/kg feed groups, respectively. Gizzard erosions were found in 
33 % of the birds fed 12 mg nivalenol/kg feed and in 8 % of those fed 3 or 6 mg nivalenol/kg feed. No 
such erosions were found in the control birds. Treatment-related differences were also seen in liver 
and gizzard weights which were reduced by 5.6 and 12.9 %, 13.2 and 3.6 %, 13.9 and 16.5 %, in the 3, 
6, 12 mg/kg feed groups, respectively. No effects on relative organ weights were found when bursa 
and spleen were compared to control. In the blood, no changes compared to control were found in 
haematocrit or in the plasma concentration of glucose, calcium, cholesterol, triglycerides, and uric 
acid, or in the plasma activity of aspartate amino transferase, alanine amino transferase, or gamma 
glutamyl transpeptidase (Hedman et al., 1995; Petterson et al., 1995). 
The effects of nivalenol on the health and production of poultry were determined in a feeding study by 
Garaleviciene et al. (2002) in which White Leghorn hens  were fed a basal diet containing 66 µg 
nivalenol/kg and 100 µg deoxynivalenol/kg (see Section 7.1.3.3). Feed intake was reduced in the 
nivalenol treated groups, but there were no effects on body weight, egg production or egg quality. 
Pathological examination revealed that 40-75 % of hens fed nivalenol supplemented diet (3 and 
5 mg/kg) showed gizzard lesions, haemorrhages in the duodenum and swollen cloaca and oviducts 
with immature eggs. Three of the five birds fed 1 mg nivalenol/kg diet had light brown coloured, 
enlarged (but not heavier) and fragile livers. The kidney of one bird fed 1 mg nivalenol/kg diet also 
appeared to be enlarged and pale. Such pathological changes or erosions were not found in the control 
birds. 
In conclusion, various effects of nivalenol have been observed in poultry, depending on both age 
group and doses. The lowest concentrations causing adverse effects were 3 mg/kg feed (gizzard 
reduced weights and erosions) in chickens and 1 mg/kg feed (pale and fragile livers and pale kidneys) 
in laying hens. These lowest doses expressed as mg nivalenol/kg feed can be converted into LOAEL 
by using the live weights
28 and feed intake as reported by authors in the respective studies: 0.36 mg 
nivalenol/kg b.w. per day for broiler chickens and 0.053 mg nivalenol/kg b.w. per day for laying hens.  
7.4.5.  Horses 
No studies on the adverse effects in horses were identified. 
                                                      
28   The CONTAM Panel estimated the live weight of 120 g for chicken aged of seven days at the beginning of the experiment 
and used the other values as reported by Hedman et al. (1995) for conversion from mg/kg feed per day to µg/kg b.w. per 
day. The CONTAM Panel used the values as reported by Garaleviciene et al. (2002) for conversion from mg/kg feed per 
day to µg/kg b.w. per day. Nivalenol in food and feed
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7.4.6.  Farmed fish 
No studies on the adverse effects in farmed fish were identified. 
7.4.7.  Companion animals 
No studies on the adverse effects in companion animals (dogs and cats) were identified. 
7.4.8.  Conclusions 
Only a couple of studies on pigs and poultry are available relating to adverse effects of nivalenol in 
farm and companion animals. Regarding pigs, the studies on young pigs showed a dose dependent 
decrease in splenocyte numbers and pathological changes in the gastrointestinal tract, the kidneys and 
spleen, and a dose-dependent decrease in enteric oxoglutarate dehydrogenase. A LOAEL of 0.1 mg 
nivalenol/kg b.w. per day could be identified. Regarding poultry, the available study results showed 
some adverse effects such as gizzard reduced weights and erosions in chickens, and pale and fragile 
livers and pale kidneys in laying hens. Based on these data, LOAELs of 0.36 mg nivalenol/kg b.w. per 
day for broiler chickens and 0.053 mg nivalenol/kg b.w. per day for laying hens could be identified. 
No data were identified for other farm animal or companion animal species. 
7.5.  Combined effects with other mycotoxins  
Co-exposure to more than one mycotoxin in animals and humans through food and feed is likely to 
occur. Previously, SCF (2002) reported the combined effects in vitro of several trichothecenes refering 
only to two publications investigating the interactions between nivalenol and other trichothecenes 
(Madhyastha et al., 1994; Thuvander et al., 1999). Thuvander et al. (1999) examined the inhibitory 
effect of combined exposure to several trichothecenes on the proliferation of human peripheral 
lymphocytes stimulated with phytohaemagglutinin or pokeweed in vitro. Combinations of nivalenol 
with T-2 toxin, diacetoxyscirpenol or deoxynivalenol resulted in additive effects. The interaction 
between trichothecenes has been studied in yeast (Kluyveromyces marxianus) bioassay with inhibition 
of cell growth as the end point (Madhyastha et al., 1994). Combinations of nivalenol and 
deoxynivalenol exhibited apparent synergism. The underlying mechanisms of growth inhibition are 
not known and the relevance of this in vitro assay for human health is uncertain. 
Using a tiered approach to screen a mixture of Fusarium toxins for possible interactions, Tajima et al. 
(2002) reported a synergistic effect of nivalenol in combination with T-2 toxin, deoxynivalenol or 
zearalenone on the inhibition of DNA synthesis in murine fibroblast.  
The effects of nivalenol, deoxynivalenol and combinations of these compounds were studied in an in 
vitro model system, utilising the rat intestinal epithelial cell line IEC-6 (Bianco et al., 2012). Nivalenol 
and deoxynivalenol (5-80 µM) each significantly affected IEC-6 viability through a pro-apoptotic 
process. The presence of nivalenol and deoxynivalenol together in the incubation medium did not 
induce either additive or synergistic effects on IEC-6 viability.  No additive or synergistic effects on 
IEC-6 apoptosis were observed after incubation with nivalenol and deoxynivalenol together. 
Three publications investigated the in vivo effects of nivalenol in combination with aflatoxin B1 or 
deoxynivalenol on immune response, hepatic drug metabolism and carcinogenesis (Ueno et al., 1991, 
1992; Gouze et al., 2005). Using two different low doses of deoxynivalenol and nivalenol (0.071 or 
0.355 mg/kg b.w. three times a week, equivalent to 0.006 or 0.152 mg/kg b.w. per day), Gouze et al. 
(2005) investigated the interaction. Although the lowest dose of nivalenol and the two doses of 
deoxynivalenol used did not affect the plasma levels of uric acid, when used in combination the toxins 
acted in a synergistic manner. Whatever the dose of nivalenol and deoxynivalenol used, when the 
toxins were used in combination an additive effect was observed for the total protein level in plasma. 
Ingestion of deoxynivalenol or nivalenol induces IgA nephropathy in mice. When the two toxins were 
used in combination the interaction was dependent on the dose and ranged from synergistic to additive 
or less than additive on IgA synthesis. The activity and the expression of hepatic drug metabolising 
enzymes (P450 and glutathione S-transferase) was also assessed. When mice were exposed to Nivalenol in food and feed
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deoxynivalenol and nivalenol, the combined toxins caused an increase in pentoxyresorufin 
O-depentylase (PROD) activity, although these effects were not additive or synergistic compared with 
the effects of each single toxin. The effects of the combination of the toxins on ethoxyresorufin 
O-deethylase (EROD) activity were slightly less than the effect observed using the toxins individually. 
By contrast, for the highest doses of deoxynivalenol and nivalenol, a synergistic effect was observed 
on the increased activity of the hepatic glutathione S-transferase with 1,2-dichloro-4-nitrobenzene 
(DCNB) as substrate. 
Two earlier studies were carried out to investigate whether nivalenol was able to modulate the effect 
of aflatoxin B1, a known carcinogenic mycotoxin (Ueno et al., 1991, 1992). The results obtained in 
mice and in rats led to opposite conclusions suggesting a suppressive or an enhancing effect of 
nivalenol on aflatoxin-induced hepatocarcinogenesis. In the first experiment, single doses of 6 mg/kg 
b.w. of aflatoxin B1 were administered by i.p. injection to groups of 38-51 male and female C57Bl/6 x 
C3H F1 mice, one week of age (Ueno et al., 1991). Six weeks later the animals were fed diets 
containing 0, 6 or 12 mg/kg nivalenol for one year, and animals were sacrificed at 71 weeks of age. A 
control group of 56 animals received no aflatoxin B1 or nivalenol. All treated male mice (19 given 
aflatoxin B1 alone, 20 given aflatoxin B1 plus 6 mg/kg nivalenol and 18 mice given aflatoxin B1 plus 
12 mg/kg nivalenol developed liver tumours (mainly hepatocellular carcinomas). In females, the 
incidence of aflatoxin B1-induced hepatocarcinogenesis was reduced by the high dose of nivalenol 
(0/21 in controls, 8/26 in mice given aflatoxin B1 alone, 3/15 in mice given aflatoxin B1 plus 6 mg/kg 
nivalenol and 0/19 in mice given aflatoxin B1 plus 12 mg/kg nivalenol). The other experiment was 
performed in rats using the measurement of glutathione S-transferase placental form (GST-P) positive 
foci in the liver as the end-point (Ueno et al., 1992). F344 rats were initiated with n-nitroso-
diethylamine (NDEA) (i.p. 200 mg/kg b.w. (single dose)), treated two weeks later with aflatoxin B1 
(i.p. 0.5 mg/kg b.w. (single dose)) and then orally exposed to nivalenol (6 mg/kg diet for six weeks). 
These were compared with rats that had no aflatoxin B1 treatment.  In rats initiated with NDEA 
(n = 15), nivalenol did not cause an increased expression of GST-P in contrast to the group given 
aflatoxin B1.  
In conclusion, at present the database describing possible effects of combined exposure to nivalenol 
and other mycotoxins is very weak and not sufficient for establishing the nature of combined effects. 
7.6.  Human data  
7.6.1.  Observations in humans  
No information is available on the impact of nivalenol on human health. Many reports have reviewed 
the human toxicosis incidences possibly linked to intake of Fusarium fungi and trichothecene 
contaminated food historically (IARC, 1993; SCF, 2000; FAO/WHO, 2001; Sudakin, 2003; van der 
Fels-Klerx and Stratakou, 2010). A brief summary of these findings is given below. To date, there is 
no evidence that any human disease is exclusively attributed to nivalenol exposure.  
Human toxicosis related to ingestion of Fusarium infected grain (Scabby grain diseases) was 
previously  reported in several countries, including Japan and Korea during the period of 1946-1963 
(FAO/WHO, 2001; SCF, 2000), China (Luo, 1988; Wang et al., 1993), and India (Bhat et al., 1987, 
1989) and these were well summarised in the previous evaluations of the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA) and SCF (FAO/WHO, 2001; SCF, 2000). Briefly, nausea, 
vomiting, diarrhoea and abdominal pain were common symptoms associated with the toxicosis, 
recovery usually occurred within a few days and no lethal cases were reported. Typically mixtures of 
trichothecenes were detected but no single toxin could be identified as being solely responsible for the 
toxicosis. In the outbreaks in Japan and Korea, F. graminearum was isolated from suspected cereals 
suggesting a possibility of deoxynivalenol and/or nivalenol contamination. The number of cases 
involved was over 100 in both the two Chinese and the two Indian outbreaks, although none was 
lethal. In 1987, an acute outbreak in India affecting approximately 50 000 people was due to 
consumption of bread made from rain-damaged wheat (Bhat et al., 1989). The wheat contained Nivalenol in food and feed
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deoxynivalenol (0.34-8.4 mg/kg in 11 of 24 samples), acetyldeoxynivalenol (0.6-2.4 mg/kg in 4 of 
24 samples), nivalenol (0.03-0.1 mg/kg in 2 of 24 samples) and T-2 toxin (0.55-4.0 mg/kg in 3 of 
24  samples). Cases exhibited mainly minor gastrointestinal symptoms (abdominal pain, diarrhoea, 
bloody stool and vomiting) for approximately two days. 
Long-term effects of nivalenol on human health are unclear. Several ecological studies have shown the 
presence of nivalenol in maize in areas with high cancer incidence, including oesophageal cancer in 
Linxian, China (Hsia et al., 1988, 2004), and hepatocellular carcinoma in Guangxi, China (Li et al., 
2001). Hsia et al. (2004) studied the levels of nivalenol from small numbers of local barley and corn 
samples from Linxin in China and compared these with the nivalenol levels of two rice samples from 
the USA to associate them with mortality of oesophageal cancer in both populations. However, the 
CONTAM Panel noted weaknesses in the design in these studies and could not draw any solid 
conclusions. In addition, the food contained also deoxynivalenol and other mycotoxins, particularly 
fumonisins which are potentially associated with oesophageal cancer; therefore an association of 
disease with nivalenol cannot be made. Nivalenol was also detected in mouldy maize from the former 
Transkei, South Africa with areas of high oesophageal cancer prevalence. However, nivalenol levels 
were higher in maize samples from low prevalence areas compared to high prevalence areas 
(Sydenham et al., 1990). 
In summary, there are reports on human cases of intoxications due to ingestion of trichothecenes. The 
toxicosis cannot be conclusively linked to any single toxin and there is no evidence of linkage to 
dietary nivalenol exposure levels.  
7.6.2.  Biomarkers  
An LC-ESI-MS/MS method for the quantitative measurement of 15 mycotoxins and key metabolites, 
including nivalenol, in human urine has recently been developed using a rapid and simple ‘dilute and 
shoot’ approach (Warth et al., 2012). Nivalenol concentration rangeing from 0.4-40 µg/L were tested 
with recovery of 82 % and between day relative standard deviation of 5 %. The method was applicable 
to human urine samples obtained from Cameroon in which nivalenol and five other mycotoxins were 
detected simultaneously. However, the method was not able to quantify nivalenol (levels below LOQ 
of 1.0 µg/L) in human urine samples. Further optimisation of the method to improve detectability and 
more validation of biomarkers are required. 
7.7.  Dose-response modelling 
The SCF (SCF, 2000) and FSCJ (FSCJ, 2010) both identified immunotoxic and haematotoxic effects 
as critical effects for nivalenol. The SCF used in their evaluation a LOAEL of 0.7 mg/kg b.w. per day 
from the long term dietary studies (1-year and 2-year studies) with mice (Ryu et al., 1988; Ohtsubo et 
al., 1989). The FSCJ used a LOAEL of 0.4 mg nivalenol/kg b.w. per day observed in the sub-acute 
toxicity study in rats with 90-day oral administration (Takahashi et al., 2008). 
Since the evaluation of SCF there is no new evidence that other toxic effects including dermal toxicity, 
developmental, reproductive toxicity or neurotoxicity occurred at doses lower than those inducing 
immunotoxicity and haematotoxicity described in Section 7.2. The overall weight of evidence is that 
nivalenol is unlikely to be genotoxic and there is inadequate evidence of carcinogenicity in 
experimental animals and humans.  
In general, trichothecenes are known to be immunotoxic and haematotoxic/myelotoxic and several in 
vivo studies on nivalenol have been reported before and after the SCF assessment (SCF, 2000) 
(Section 7.2.6.1). After the SCF assessment (SCF, 2000) some immunotoxic effects have been 
described for nivalenol such as an increase of IgA or IgM (Kubosaki et al., 2008; Dewa, 2011), but at 
higher concentrations than those where haematotoxic effects such as neutropenia or leukopenia have 
been described. Therefore the CONTAM Panel considered disturbances in WBC counts to be the 
critical effect.  Nivalenol in food and feed
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The CONTAM Panel identified three studies on female mice (6-month (Ryu et al., 1988), 1-year (Ryu 
et al., 1988) and 2-year (Ohtsubo et al., 1989)) and one study on rats (90-day (Takahashi et al., 2008)) 
that could be used for dose-response modelling. However, the CONTAM Panel noted that the studies 
on mice had a number of weaknesses (see also Section 7.2.6.1):  
•  The data from the 6-month mouse study were insufficient for dose-response modelling. 
•  The data from the 1-year mouse study were not adequate because there was no clear dose 
response relationship. 
•  The data from the 2-year study were considered inadequate because the effects observed were 
not statistically significant. 
 Therefore, the CONTAM Panel decided to use the 90-day rat study as the pivotal study for risk 
characterisation.  
In the 90-day rat study of Takahashi et al. (2008) the mean WBC count decreased from 38.5×10
3/mm
3 
in controls to 21.6×10
3/mm
3 at highest dose in males and from 38.8×10
3/mm3 in controls to 
19.6×10
3/mm
3 at the highest dose in females (Table 19). The CONTAM Panel considered these data to 
be appropriate for a dose-response modelling of haematological disturbances in WBC counts observed 
in rats because they showed a clear dose-response curve. The observed dose-response curves for males 
and females exhibited a high degree of similarity, the dose ranges were by design identical and the 
range of the observed WBC counts was comparable in both sexes. Therefore the CONTAM Panel 
concluded that these data in rats were suitable for BMD modelling by using the PROAST software
29 
which allows a combined analysis of the male and female dose-response data when using sex as 
covariate in the modelling (see Appendix D). 
The CONTAM Panel noted that the WBC count data can be modelled as continuous data where the 
benchmark response (BMR) should be defined as a percent change of the average magnitude of the 
response when compared to that predicted at background, i.e. a relative deviation from background. 
Ideally the BMR should reflect an effect size that is negligible or non-adverse (EFSA, 2009b), but at 
the same time not too small in order to avoid extrapolation outside the range of observation. The 
default value for continuous data recommended by EFSA (2009b) is a BMR of 5 % extra risk. In the 
absence of statistical or toxicological considerations supporting deviation from the default value, the 
CONTAM Panel chose the BMR of 5 % extra risk when applying the BMD approach for the selected 
WBC count data.  
The PROAST software
29 was used applying both the Exponential and the Hill nested model families 
for the data. Using the BMR of 5 % extra risk, the BMD05 and its 95 % lower confidence limit 
(BMDL05), were 0.60 and 0.50 mg nivalenol/kg b.w. per day, respectively for the best fitting models 
of the Exponential family, and 0.46 and 0.35 mg nivalenol/kg b.w. per day, respectively for the best 
fitting models of the Hill family (Appendix D). From these results the CONTAM Panel chose the 
lowest BMDL05 of 0.35 mg nivalenol/kg b.w. per day as a reference point for the risk characterisation 
for nivalenol. The CONTAM Panel noted that this BMDL05 is lower than the doses at which effects 
were reported in the 6-month, 1-year, 2-year mouse studies (Ryu et al., 1988; Ohtsubo et al., 1989). 
In addition, the CONTAM Panel investigated the sensitivity of the combined BMD analysis of male 
and female rat data by fitting these two data sets separately and noted that it was appropriate to 
combine the male and female data for BMD analysis (Appendix D). 
7.8.  Derivation of TDI  
Since nivalenol is unlikely to be genotoxic the CONTAM Panel considered it appropriate to establish 
a TDI.  
                                                      
29   http://www.rivm.nl/en/Library/Scientific/Models/PROAST Nivalenol in food and feed
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The TDI was established on the basis of the BMDL05 of 0.35 mg nivalenol/kg b.w. per day. In addition 
to the default uncertainty factor of 100 for inter- and intra-species differences, the CONTAM Panel 
decided to use two additional uncertainty factors. A first uncertainty factor of 2 for extrapolation from 
sub-chronic to chronic study duration in rodents (EFSA, 2009b; 2012b), and a second uncertainty 
factor of 1.5 due to the limitations of data available on reproductive and developmental toxicity of 
nivalenol. These resulted in an overall uncertainty factor of 300, and a TDI of 1.2 µg/kg b.w. per day. 
The CONTAM Panel also considered the effects of metabolic detoxification of nivalenol through its 
de-epoxidation, for which there is species variation. In view of much lower cytotoxicity of the de-
epoxy nivalenol compared to the parent compound it is possible that de-epoxydation might result in 
different susceptibilities of the species to the effects of nivalenol. The de-epoxy nivalenol has been 
detected in faeces of rats, pigs and hens, but not in broiler chickens and mice. In vitro studies 
demonstrated the de-epoxidation of nivalenol by ruminal microflora, and by gastrointestinal 
microflora of pigs but not of humans. However, the impact of this in vitro metabolism on in vivo 
bioavailability is not fully clear. Hence the CONTAM Panel concluded that no further interspecies 
uncertainty factor is needed over the factor of 10 for inter-species variation which has already been 
incorporated in the default uncertainty factor of 100. 
The CONTAM Panel noted that this TDI is based on a different study than the t-TDI established 
previously by the SCF in 2000 and used the BMDL05 instead of the LOAEL as the point of departure. 
The SCF used the LOAEL of 0.7 mg/kg b.w. per day from the long term (1-year and 2-year) dietary 
studies with mice (Ryu et al., 1988; Ohtsubo et al., 1989). An uncertainty factor of 1000 was applied 
including the default factor of 100 for inter- and intra-species variability and the extra factor of 
10 because of the use of a LOAEL and the limited database. A t-TDI of 0.7 µg/kg b.w. per day was 
established by SCF (2000).  
The CONTAM Panel noted that its TDI of 1.2 µg/kg b.w. per day is higher than the TDI established 
by FCSJ in 2010. In this Japanese assessment, the LOAEL of 0.4 mg nivalenol/kg b.w. per day was 
identified based on the decreased WBC counts observed in sub-acute toxicity study in rats with 90-day 
oral administration. By applying an uncertainty factor of 1000 (10 for inter-species differences, 10 for 
inter-individual variations, and an extra factor of 10 for the LOAEL value identified from sub-chronic 
toxicity study), the TDI of 0.4 μg/kg b.w. per day was established for nivalenol. The CONTAM Panel 
calculated a BMDL05 from the same study and applied an uncertainty factor of 300. The CONTAM 
Panel decided that no further uncertainty factor was required because there is no need for extrapolation 
from LOAEL to NOAEL due to the use of a BMDL05. 
8.  Risk characterisation  
With regard to human risk characterisation, the Scientific Opinion took into account an updated 
dietary exposure assessment of nivalenol which used recent analytical results on the occurrence of 
nivalenol in food and the consumption patterns of specific groups of the population. For animal risk 
characterisation, the daily exposure levels of nivalenol for the different animal species were estimated. 
Only nivalenol was considered in this Scientific Opinion, although combined exposures with other 
trichothecenes and mycotoxins may occur.  
8.1.  Human health risk characterisation 
For calculating the chronic dietary exposure to nivalenol, food consumption and body weight data at 
the individual level were accessed in the Comprehensive Consumption Database. For each country, 
exposure estimates were calculated per dietary survey and age class (see Section 6.1.2). The mean 
dietary exposure (average consumption in total population) and the high dietary exposure 
(95
th percentile food consumption in total population) to nivalenol was calculated separately for each 
dietary survey using consumption data recorded at the individual level. Individual food consumption 
data were combined with the mean occurrence values in order to provide mean and high percentile 
exposure estimates (95
th percentile). Exposure estimates were calculated for both the LB and the UB 
scenarios. Nivalenol in food and feed
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Using LB and UB concentrations, the chronic dietary exposure to nivalenol in adult populations across 
14 European countries has been estimated to range from 0.4 to 75 ng/kg b.w. per day for average 
consumers (range represents the minimum LB to maximum UB from the different countries), and 
1.1 to 224 ng/kg b.w. per day for high consumers. In elderly and very elderly populations, the chronic 
dietary exposure to nivalenol was slightly lower compared to other adults. Toddlers (age ≥ 12 months 
to < 36 months) had the highest exposure to nivalenol, with a range from 4.3 to 202 ng/kg b.w. per day 
for average consumers, and 12 to 484 ng/kg b.w. per day for high consumers.   
All chronic dietary exposures to nivalenol estimated, based on the available occurrence data in food, 
are below the TDI of 1.2 µg/kg b.w. per day, and are therefore not of health concern. 
There are limited data on dietary habits of vegetarians with data available for only five European 
countries, with very few subjects in four of them. These limited data do not indicate a marked 
difference in the dietary exposure to nivalenol between vegetarians and the general population but are 
insufficient for a firm conclusion. 
8.2.  Animal health risk characterisation 
Because of the limited knowledge on the effects of nivalenol on farm and companion animals, and the 
levels of this toxin in feedingstuffs, it has not been possible to properly assess the risks of this toxin for 
animal health. However, the exposure values for the LB and UB values for nivalenol in diets have 
been estimated for a number of farm livestock and companion animal categories, based on estimated 
feed consumptions (Section 5.2). As LOAEL values have only been identified for pigs and poultry, the 
health risk can only be characterised for these species. However, the identified LOAELs for pigs and 
poultry were based on toxicological data reported only in two papers on pigs and two papers on 
poultry. 
For pigs, a LOAEL of 100 µg/kg b.w. per day was only identified for young pigs. Based on the 
available mean UB concentrations, the highest estimated exposure to nivalenol was 1.6 µg/b.w. per 
day for piglets and 0.93 µg/kg b.w. per day for fattening pigs. The predicted exposure is < 2 % of the 
LOAEL (for piglets) indicating that the risk of adverse health effects of feed containing nivalenol for 
pigs is low. 
For poultry, a LOAEL of 360 µg/kg b.w. per day for broiler chickens and a LOAEL of 53 µg/kg b.w. 
per day for laying hens, were compared with estimated mean UB exposures of 1.9 and 1.7 µg/kg b.w. 
per day for broiler chickens and laying hens, respectively. For broiler chickens the UB exposure to 
nivalenol based on the available mean UB concentrations is < 1 % of the LOAEL and for laying hens 
< 3 %. As for pigs, these data suggest that the risk of adverse health effects of feed containing 
nivalenol for poultry is low. 
Due to the lack of data NOAELs or LOAELs cannot be identified for ruminants, rabbits, fish, horses, 
dogs and cats and therefore the health risk from the exposure to nivalenol in feed for these animals 
could not be assessed. The susceptibility of ruminants to nivalenol is likely to be low, as there is 
evidence that nivalenol is detoxified by de-epoxidation by rumen microorganisms. 
8.3.  Adequateness of using an approach to protect consumers against deoxynivalenol as a 
means to additionally protect consumers against nivalenol 
The terms of reference as provided by the EC required EFSA to assess the co-occurrence of nivalenol 
with deoxynivalenol in feed and food and to assess whether an approach of protecting animals and/or 
humans against deoxynivalenol exposure is regarded as sufficient for protection against exposure to 
nivalenol, or if on the basis of exposure scenarios a separate approach for the protection of animals 
and/or humans against exposure to nivalenol is appropriate.  
There is a lack of data on occurrence of nivalenol in representative feed categories, and there is a lack 
of data on toxicity of nivalenol in different farm and companion animal species. Therefore the Nivalenol in food and feed
 
EFSA Journal 2013;11(6):3262  82
CONTAM Panel could not estimate whether the use of the guidance levels set for deoxynivalenol in 
feeds (see Section 2) would be adequate to protect animals against exposure to nivalenol as well.     
In total, there were 783 samples of food, feed and unprocessed grain samples from four European 
countries where analytical results on both nivalenol and deoxynivalenol were reported. Out of these 
samples 425 were food samples of which deoxynivalenol was quantified in 76 % and nivalenol in only 
6 % of the samples, demonstrating a substantially lower prevalence of the latter. The LOQs for 
nivalenol and deoxynivalenol were comparable in these samples. Co-occurrence of nivalenol and 
deoxynivalenol was found in 27 food samples ranging from 8 µg/kg to 86 µg/kg for nivalenol and 
from 8 µg/kg to 610 µg/kg for deoxynivalenol. In 98 % of the 425 samples the deoxynivalenol 
concentrations were below the EU maximum levels set for deoxynivalenol in different foodstuffs (see 
Section 2). For 38 % of the food samples very low concentrations (< 50 µg/kg or < LOD) were 
reported for deoxynivalenol. For 76 % of the samples, the concentrations were below the lowest 
maximum level (200 µg/kg or < LOD). This indicates that the available dataset likely reflects the 
normally occurring situation for deoxynivalenol concentrations in foods which are in compliance with 
the current maximum levels. Thus, it would be justified to conclude that the available dataset also 
reflects the normal situation in relation to nivalenol levels in foods.  
Since the maximum levels for deoxynivalenol vary depending on the food groups, the groups 
contributing to the exposure to nivalenol and deoxynivalenol were compared. This information was 
retrieved from previously reported exposure assessments reported for Europe.  
JECFA (FAO/WHO, 2001) reported exposure data on deoxynivalenol occurrence from UK, Sweden 
and Norway in raw or minimally processed food commodities. In Europe wheat contributed 79 % of 
the total deoxynivalenol exposure; followed by barley contributing 16 % of the total exposure. Maize, 
rice, oat, rye, etc. constituted the remaining % of the total exposure. SCOOP (Gareis et al., 2003), 
Nordic Council (Nordic Council of Ministers, 1998) and AFSSA (Leblanc et al., 2005; AFSSA, 2009) 
reported that wheat flour and bread are the major contributors to deoxynivalenol exposure. In the later 
assessment of JECFA (FAO/WHO, 2011a,b), raw wheat grains or minimally processed wheat 
products were again found to be the main contributors to deoxynivalenol exposure in Europe. Other 
cereal grains including maize, barley, oats, rice and rye also contributed to the deoxynivalenol 
exposure but with large variation between countries. Lately it was reported that wheat and wheat based 
products contributed the most to the deoxynivalenol exposure in Norway but also oat based food 
products were important contributors for the exposure (VKM, 2013). Thus, it can be concluded that 
wheat and wheat based foods made the predominant contributions to deoxynivalenol exposure in 
Europe, as was also the case for nivalenol exposure (Sections 6.1.1.3 and 6.1.3). 
Furthermore, the main food groups reporting positive results for deoxynivalenol, e.g. wheat milling 
products, grains for human consumption (wheat, barley, rye, oats) and cereal based foods for infants 
and small children, were mostly the same groups with reported positive results for nivalenol (Section 
4.2.7). In addition, it should be noted that deoxynivalenol and nivalenol have been reported to co-
occur in the same food commodities (Sections 4.1.4 and 4.2.15). Therefore the food groups 
contributing to the deoxynivalenol exposure appear to be similar to the food groups contributing to the 
nivalenol exposure.  
In the light of the currently available information the chronic dietary exposures to nivalenol are below 
the TDI for populations of all age groups, and are therefore not of health concern (Section 8.1). The 
highest UB exposure for high consumers is about 3-fold lower than the TDI for nivalenol.  
Based on the observations above, the CONTAM Panel concluded that the available information does 
not preclude that the approach used for protecting humans against deoxynivalenol exposure may be 
regarded as sufficient for protection against exposure to nivalenol. The usefulness of this combined 
approach can only be fully validated when more extensive dietary exposure assessments of 
deoxynivalenol and nivalenol become available.  Nivalenol in food and feed
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9.  Uncertainty analysis 
The evaluation of the inherent uncertainties in the assessment of exposure to nivalenol has been 
performed following the guidance of the Opinion of the Scientific Committee related to Uncertainties 
in Dietary Exposure Assessment (EFSA, 2006). In addition, the report on ‘Characterizing and 
Communicating Uncertainty in Exposure Assessment’ has been considered (WHO/IPCS, 2008). 
According to the guidance provided by the EFSA opinion (2006) the following sources of 
uncertainties have been considered: Assessment objectives, exposure scenario, exposure model and 
model input (parameters). 
9.1.  Assessment objectives 
The objectives of the assessment were defined in the terms of reference. There was no uncertainty in 
addressing these objectives. 
9.2.  Exposure scenario and model 
The occurrence data in food, grains of undefined end-use and feed provided were largely from a few 
countries. This may have introduced uncertainties in the overall human and animal exposure estimates. 
For food, the vast majority of occurrence data were on grains and grain-based foods. The groups 
‘Grain milling products’ and ‘Breakfast cereals’ dominated the product coverage.  
The analytical results were submitted by the data providers as either corrected for recovery or not 
corrected for recovery. Data were used as submitted by the data providers for occurrence estimation, 
which leads to uncertainties in these estimates. 
The calculation of exposure was based on very limited number of quantified results in majority of food 
groups considered in exposure assessment and this has introduced uncertainties to these estimates. The 
use of the UB approach for high percentage of occurrence data < LOD and LOQ is conservative, i.e. it 
represents an overestimation of exposure.  
Limited data on food consumption for vegetarians indicate some uncertainty in their exposure 
assessment. There was a lack of dietary surveys reporting consumption data for children younger than 
one year, which led to an uncertainty in this area.  
The numbers of samples were not equally distributed across all feed groups in which nivalenol could 
be present and there was also a very high proportion of left-censored data. For this reason aggregated 
data for cereals and their by-products were used for animal exposure assessment. This introduced 
uncertainties in the animal exposure estimates. The considerable variability that exists between feeds 
and feeding systems used for livestock in Europe add further uncertainty to the overall estimates of 
animal exposure.  
Food and feed processing methods may also introduce uncertainty in exposure assessments in view of 
their known influence on nivalenol concentrations.  
Information on conjugated (masked) nivalenol is lacking and this may add to the overall uncertainty. 
9.3.  Other uncertainties 
The measurement uncertainty of the analytical method employed especially in view of the lack of 
formally validated analytical methods and the lack of certified matrix reference materials contribute to 
the overall uncertainty.  
Combined effects may result through the co-occurrence of nivalenol with deoxynivalenol. There is 
only limited knowledge on the frequency of co-occurrence and the ratio of nivalenol to deoxynivalenol 
in these exposures. In addition, there is only limited knowledge on possible interactions of such Nivalenol in food and feed
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mixtures. Co-exposure of nivalenol with other mycotoxins may also occur. These aspects contribute to 
the overall uncertainty. 
There is uncertainty over the extent to which de-epoxidation of nivalenol occurs in the gastro-
intestinal tract of non-ruminants. 
The conclusion on genotoxicity could be further strengthened by data on the possible role of oxidative 
stress as a thresholded mode of action. A lack of data on reproductive/developmental toxicity and 
neurotoxicity of nivalenol in experimental animals and only limited toxicological data on farm animals 
(only three studies for pigs, laying hens and broiler chickens) contributes to the uncertainty. 
A sub-chronic (90-day) study in rats was used for derivation of the TDI rather than a long-term study, 
which necessitated the use of a further uncertainty factor in the calculation of this TDI.  
9.4.  Summary of uncertainties 
In Table 20, a summary of the uncertainty evaluation is presented, highlighting the main sources of 
uncertainty and indicating an estimate of whether the respective source of uncertainty might have led 
to an over- or underestimation of the exposure or the resulting risk. 
Table 20:   Summary of qualitative evaluation of the impact of uncertainties on the risk assessment of 
the human and animal dietary exposure to nivalenol. 
Sources of uncertainty  Direction
(a)
Uncertainty of the analytical measurements  +/- 
The number of samples were not equally distributed across all feed groups  +/- 
Effect of food and feed processing  +/- 
High variability of feedstuffs used and feeding systems for livestock  +/- 
Use of UB occurrence data in the exposure estimations  + 
Limited exposure data on infants  +/- 
Limited data on exposures for vegetarians  +/- 
Incomplete data on the role of oxidative stress for the mode of action underlying the genotoxicity  - 
Limited toxicokinetic data on nivalenol in humans and in most animal species  +/- 
Limited toxicological data on reproductive/developmental toxicity of nivalenol   - 
The use of a sub-chronic study in rats in the absence of an appropriate long term study  +/- 
No toxicological data on a number of farm animals and companion animals  +/- 
Lack of information on combined effects with other mycotoxins notably deoxynivalenol or other 
toxic substances in food and feed 
+/- 
(a):  + = uncertainty with potential to cause over-estimation of exposure/risk; - = uncertainty with potential to cause under-
estimation of exposure/risk, UB: upper-bound 
 
The CONTAM Panel concluded that given the uncertainties, the risk assessment of human exposure to 
nivalenol is more likely to over- rather than under-estimate the risk, while the uncertainties on the risk 
assessment of animal exposure to nivalenol are much larger than for human risk assessment. Nivalenol in food and feed
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CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
General 
•  Nivalenol belongs to the group of trichothecene mycotoxins, which are produced by fungi of 
the Fusarium genus. These fungi are abundant in various cereal crops (wheat, maize, barley, 
oats, and rye) and grain based food products (bread, malt and beer).  
•  The Fusarium species invade and grow on crops, and may produce nivalenol under moist and 
cool conditions. 
Methods of analysis 
•  Quantification of nivalenol is mostly carried out by liquid chromatography coupled with 
(multi-stage) mass spectrometry often within a multianalyte approach. This methodology can 
be applied for the analysis of cereals, food and feed as well as samples of human and animal 
origin. 
•  Some techniques, such as direct analysis in real time-mass spectrometry and electrochemical 
methods, have shown potential to determine nivalenol, but applications for routine 
measurements are not yet available. 
•  Rapid immunochemical test kits, able to selectively detect nivalenol, have not been developed 
for routine analysis. 
•  None of the applied methods has been formally validated in interlaboratory validation studies. 
•  A certified calibrant for nivalenol is available, but no matrix reference materials have been 
developed. 
Occurrence and effect of processing 
•  A total of 15 774 analytical results for nivalenol collected between 2001 and 2011 from 
18  European countries were evaluated. Overall, 13 164 data on food (n = 3 846), feed 
(n = 1 707) and unprocessed grains (n = 7 611) fulfilled the quality criteria applied and were 
available for the evaluation. 
•  A high proportion of results were below the limit of detection (LOD) or limit of quantification 
(LOQ) in food (90 %) and feed (94 %).  
•  The highest mean concentrations for nivalenol in food, feed and unprocessed grains were 
observed in oats, maize, barley and wheat and products thereof. 
•  Higher concentrations were observed in unprocessed grains compared to grains for human 
consumption.  
•  Physical processing such as cleaning, sorting and milling results in a reduction of the 
nivalenol concentration in the refined product and an increase in the cereal by-products. 
•  At high temperatures (> 150 °C) nivalenol concentrations are reduced in a time-dependent 
manner.  Nivalenol in food and feed
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•  Six percent of the available samples provided data on both nivalenol and deoxynivalenol. The 
concentrations of nivalenol were generally lower than deoxynivalenol although in some cases 
the concentrations of nivalenol were higher. This finding on co-occurrence is in line with the 
data reported in the literature.  
•  Information on masked forms of nivalenol is very scarce. 
Human exposure 
•  The exposure estimations were heavily influenced by the high percentage of left-censored data 
and the upper-bound (UB) exposure estimations are therefore conservative. 
•  The chronic dietary exposure in the adult population across 14 European countries, using 
lower-bound (LB) and UB concentrations, ranged from 0.4 to 75 ng/kg body weight (b.w.) per 
day for average consumers, and 1.1 to 224 ng/kg b.w. per day for high (95
th percentile) 
consumers. In elderly and very elderly populations, the chronic dietary exposure to nivalenol 
was slightly lower compared to other adults. 
•  The highest chronic exposure was estimated for toddlers (age > 12 months to < 36 months) 
ranging from 4.3 to 202 ng/kg b.w. per day for average consumers, and 12 to 484 ng/kg b.w. 
per day for high consumers. 
•  Grains and grain-based foods made the largest contribution to the nivalenol exposure. 
Important contributors were bread and rolls, grain milling products, pasta, fine bakery wares, 
and breakfast cereals. The contribution of bread and rolls is due to high consumption, while 
the contribution of grain milling products is likely due to several high nivalenol concentration 
values.  
•  The limited data on vegetarians do not indicate a marked difference in the dietary exposure to 
nivalenol between vegetarians and the general population but are insufficient for a firm 
conclusion.    
Animal exposure 
•  Animal exposure to nivalenol is primarily from consuming cereal grains and cereal 
by-products. With the exception of forage maize (and maize silage), levels in forages are 
generally low. 
•  For lactating dairy cows and beef cattle, the estimated LB and UB exposures to nivalenol were 
between 0.077 and 0.69 µg/kg b.w. per day. Exceptions to this were dairy cows and beef cattle 
fed on diets consisting predominantly of maize silage. For these, the estimated LB and UB 
exposures to nivalenol were between 1.9 and 4.6 µg/kg b.w. per day.  
•  For small ruminants, the estimated LB and UB exposures to nivalenol were between 0.14 and 
0.95 µg/kg b.w. per day, respectively.  
•  For piglets, fattening pigs and sows, the estimated LB and UB exposures were between 
0.24 and 1.6 µg/kg b.w. per day. 
•  For laying hens, broilers, turkeys and ducks the estimated LB and UB exposures were between 
0.24 and 1.9 µg/kg b.w. per day. 
•  For rabbits, the estimated LB and UB exposures were 0.20 and 0.77 µg/kg b.w. per day, 
respectively.  Nivalenol in food and feed
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•  For horses, the estimated LB and UB exposures were 0.090 and 0.35 µg/kg b.w. per day, 
respectively. 
•  For farmed fish, the estimated LB and UB exposures were 0.054 and 0.21 µg/kg b.w. per day, 
respectively. 
•  For companion animals, estimated LB and UB exposure for dogs (0.10 and 0.40 µg/kg b.w. 
per day, respectively) were marginally higher than for cats (0.091 and 0.35 µg/kg b.w. per 
day, respectively).  
Hazard identification and characterisation 
Toxicokinetics 
•  The available information on the toxicokinetics of nivalenol is incomplete. 
•  Information on the degree of absorption is limited, but the absorption is rapid with a maximum 
plasma concentration in mice in one hour after oral dosing. 
•  Nivalenol is rapidly distributed to and eliminated from all examined tissues in mice with no 
apparent accumulation in any organ.  
•  In ruminants, it is likely that, as for other trichothecenes, extensive de-epoxidation of 
nivalenol may occur in the rumen prior to absorption. However, no in vivo information for 
nivalenol is available. 
•  There is evidence of major species-dependent differences in the extent of de-epoxidation of 
nivalenol in non-ruminants, which may occur in the lower parts of the gastrointestinal tract in 
some species. The de-epoxy metabolite has been detected in faeces of rats, pigs and laying 
hens, but not in mice or broiler chickens and, based on in vitro studies, it is unlikely to be 
formed in humans. 
•  The carryover of nivalenol from feed to food products of animal origin is expected to 
contribute only marginally to human exposure.  
Toxicity of nivalenol 
•  In the assessment of nivalenol by the Scientific Committee on Food (SCF), the reported 
LOAELs for developmental toxicity in mice were based on intrauterine growth retardation. 
No new data are available on the developmental and reproductive toxicity of nivalenol since 
the SCF assessment. The CONTAM Panel concluded, based on the limited available data, that 
developmental and reproductive toxicity is unlikely to be a critical effect for nivalenol. 
•  Based on the data available, the CONTAM Panel concluded that the overall weight of 
evidence is that nivalenol is unlikely to be genotoxic. 
•  The available studies do not allow conclusions to be drawn on carcinogenicity of nivalenol in 
experimental animals. 
•  Since the SCF evaluation, there is no evidence that other toxic effects occur at doses lower 
than those inducing immunotoxicity and haematotoxicity.  
•  There is a recent 90-day study in rats which confirmed haematotoxicity, myelotoxicity and 
immunotoxicity of nivalenol in the same dose range as in previous mouse studies, and in 
addition provided data most appropriate for dose-response modelling. Nivalenol in food and feed
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•  A reduction in white blood cell (WBC) counts in this 90-day rat study was identified as the 
critical effect for human risk assessment with the 95 % lower confidence limit for the 
benchmark dose response of 5 % extra risk (BMDL05) amounting to 0.35 mg nivalenol/kg b.w. 
per day based on the combined data for males and females. 
•  Since nivalenol is unlikely to be genotoxic the CONTAM Panel considered it appropriate to 
establish a tolerable daily intake (TDI). 
•  To establish a TDI an uncertainty factor of 3 was applied for gaps in the database in addition 
to the default uncertainty factor of 100 for inter- and intra-species differences to the BMDL05 
resulting in a TDI of 1.2 µg/kg b.w. per day.  
•  The database describing possible effects of combined exposure to nivalenol and other 
mycotoxins is weak and not sufficient for establishing the nature of combined effects. 
 Adverse effects in livestock, fish and companion animals 
•  A time-dependent increase of the plasma concentration of immunoglobulin A and pathological 
changes in the gastrointestinal tract, the kidneys and spleen were observed in young pigs. A 
lowest-observed-adverse-effect level (LOAEL) of 100 µg nivalenol/kg b.w. per day could be 
identified for young pigs.  
•  For poultry, the available studies showed some adverse effects such as gizzard reduced 
weights and erosions in chickens, and pale and fragile livers and pale kidneys in laying hens. 
Based on these data, a LOAEL of 360 µg nivalenol/kg b.w. per day for broiler chickens and 
53 µg nivalenol/kg b.w. per day for laying hens could be identified. 
•  No studies were identified which examined adverse effects in ruminants, rabbits, fish, horses, 
cats or dogs. 
Human health risk characterisation 
•  All chronic dietary exposures to nivalenol estimated, based on the available occurrence data in 
food, are below the TDI of 1.2 µg/kg b.w. per day, and are therefore not of health concern.  
Animal health risk characterisation 
•  The estimates of exposure based on the available occurrence data on nivalenol in feed indicate 
that the risk of adverse health effects of feed containing nivalenol is low for pigs and poultry. 
•  Due to the lack of data the health risk from the exposure to nivalenol in feed could not be 
assessed for ruminants, rabbits, fish, horses, dogs and cats. The susceptibility of ruminants to 
nivalenol is likely to be low, as there is evidence that nivalenol is detoxified by de-epoxidation 
by rumen microorganisms. 
Other 
•  The available information does not preclude that the approach used for protecting humans 
against deoxynivalenol exposure may be regarded as sufficient for protection against exposure 
to nivalenol. The usefulness of this combined approach can only be fully validated when more 
extensive dietary exposure assessments of deoxynivalenol and nivalenol become available. 
The CONTAM Panel was not able to conclude the same for animals due to the lack of data. Nivalenol in food and feed
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RECOMMENDATIONS 
•  Methods which have proved suitable for the determination of nivalenol in the low  µg/kg 
range should be validated in interlaboratory validation studies, and performance criteria 
should be developed. Certified reference materials should be developed to suport the 
determination of nivalenol in food and feed. 
•  More information is needed on occurrence of nivalenol, including masked nivalenol, and co-
occurrence with deoxynivalenol and structurally related mycotoxins in food and feed. 
•  To further reduce the uncertainties in the risk assessment more data on genotoxicity and 
developmental toxicity are required. 
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APPENDICES 
Appendix A.   Occurrence of nivalenol in cereal grains and cereal based food poducts reported in the literature 
Table A1:  Occurrence of nivalenol in cereal grains
(a). 
Country Year  Cereal  Type  of 
sampling
(b) 
No of 
samples 
LOQ 
µg/kg
 
Samples 
greater 
than 
LOQ 
Mean of 
positive 
samples 
µg/kg 
Mean of all 
samples 
µg/kg 
Median 
µg/kg 
Min of 
positive 
samples 
µg/kg
Max 
µg/kg 
Reference 
Austria  2000 Wheat  Targeted  36  100  33 183.1 38.1
(c) < LOQ  nr
(d) 270  Gareis et al. (2003) 
 2001  Oats  Targeted  40  100  8  235.5  197.2
(c) 135  nr  980  Gareis et al. (2003) 
Czech 
Republic 
2005 Wheat
(e)  Targeted  41  10  32  nr  < LOQ  <LOQ  15.4  25.9  Hajšlová et al. (2007) 
  Barley  Targeted  24  10  5  nr  < LOQ  nr  9.4  15.4  Hajšlová et al. (2007) 
 2005  Barley
(e)  Random  36  10  7  4  nr  nr  nr  nr  Malachova et al. (2010) 
 2006  Barley
(e)  Random  40  10  4  2  nr  nr  nr  nr  Malachova et al. (2010) 
 2007  Barley
(e)  Random  36  10  33  45  nr  nr  nr  nr  Malachova et al. (2010) 
 2008  Barley
(e)  Random  36  10  7  4  nr  nr  nr  nr  Malachova et al. (2010) 
Finland 2001  Wheat  Random  35  25/40  nr  30.3  4.9
(c) < LOQ  nr  30.3  Gareis et al. (2003) 
   Barley Random  20  25/40  nr  59.2  9.7
(c)  < LOQ  nr  87.4  Gareis et al. (2003) 
   Barley  malt  Random  25  25/40  nr  74.3  43.4
(c)  27  nr  225  Gareis et al. (2003) 
   Oats  Random  30  25/40  nr  70.2  24
(c)  < LOQ  nr  131  Gareis et al. (2003) 
   Rye 
(conventional) 
Random  10  25/40  nr  nr  < LOQ  < LOQ  nr  nr  Gareis et al. (2003) 
France 2001  Wheat  Random  30  20  nr  83.3  19.3
(c)  < LOQ  nr  285  Gareis et al. (2003) 
   Maize  Random  25  nr  nr  148  41
(c)  nr  nr  170  Gareis et al. (2003) 
   Barley Random  9  20  nr  40  7.0
(c)  < LOQ  nr  40  Gareis et al. (2003) 
   Soft  wheat  Random  31  20  nr  nr  3.3
(c)  < LOQ  nr  nr  Gareis et al. (2003) 
 2002  Durum  wheat  Targeted  52  60  nr  95  52
(c)  < LOQ  nr  230  Gareis et al. (2003) 
   Malting  barley  Random  68    nr  nr  15
(c)  15  nr  nr  Gareis et al. (2003) 
 2004  Maize  Targeted  nr  5-10  nr  nr  54  nr  nr  nr  Scudamore and Patel (2009) 
 2005  Maize  Targeted  nr  5-10  nr  nr  17  nr  nr  nr  Scudamore and Patel (2009) 
 2006  Maize  Targeted  nr  5-10  nr  nr  46  nr  nr  nr  Scudamore and Patel (2009) 
 2007  Maize  Targeted  nr  5-10  nr  nr  34  nr  nr  nr  Scudamore and Patel (2009) 
Germany  2000  Wheat  Random  41  nr  nr  33  nr  nr  nr  nr  Schollenberger et al (2006) 
  2001  Oats  Random  17  nr  nr  155  nr  nr  nr  nr  Schollenberger et al (2006) 
    Maize  Random  41  nr  nr  291  nr  nr  nr  nr  Schollenberger et al (2006) 
    Maize  Random  24  nr  nr  406  nr  219  21  1388  Schollenberger et al (2005a) 
    Maize  Random  44  20  10  160  nr  nr  nr  4410  Goertz et al. (2010) 
    Maize  Random  40  20  19  210  nr  nr  nr  2120  Goertz et al. (2010) Nivalenol in food and feed
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Table A1:  Continued.
 
Country Year  Cereal  Type  of 
sampling
(b) 
No of 
samples 
LOQ 
µg/kg
 
Samples 
greater 
than 
LOQ 
Mean of 
positive 
samples 
µg/kg 
Mean of all 
samples 
µg/kg 
Median 
µg/kg 
Min of 
positive 
samples 
µg/kg
Max 
µg/kg
Reference 
Italy 2002  Maize
(e)  Random  46  nr  7  549  nr  nr  12  2440  Cavaliere et al. (2005) 
Luxembourg 2007-2008 Winter  wheat
(e)  Random  nr  70 nr  nr nr nr  nr  293  Giraud  et  al.  (2010) 
Norway 2001  Wheat  Random  45  60  1  33  10.5
(c)  < LOQ  33  33  Gareis et al. (2003) 
 2001  Oats  Random  24  60  0  nr  10
(c)  < LOQ  nr  < LOQ  Gareis et al. (2003) 
 2001  Maize  Random  19  60  nr  23.8  14.3
(c)  < LOQ  nr  26  Gareis et al. (2003) 
 2004  Barley
(e) Random  nr  nr  nr  nr  <30
(f) <30  nr  nr  Bernhoft et al. (2010) 
  O a t s
(e) Random  nr  nr  nr  nr  <30
(f)  <30  nr  nr  Bernhoft et al. (2010) 
Poland 2002  Rye  grain
(e)  Targeted  5  nr  nr  nr  nr  0  nr  nr  Krysinska-Traczyk et al. (2007) 
 2006  Maiz  grain
(e)  Targeted  2  nr  nr  nr  nr  85  nr  nr  Krysinska-Traczyk et al. (2007) 
   Barley  grain
(e)  Targeted  5  nr  nr  nr  nr  30  nr  nr  Krysinska-Traczyk et al. (2007) 
   Oats  grain
(e)  Targeted  6  nr  nr  nr  nr  36  nr  nr  Krysinska-Traczyk et al. (2007) 
Romania 2009  Wheat  Random  42  nr 1  30 nr  30  nr  30  Macri et al. (2009) 
Spain 2007-2008  Barley  Targeted  123  10-20  25  21  5
(g) 0.7  nr  143  Ibanez-Vea et al (2012) 
Sweden  2001  Wheat  Targeted  17 10  17  159 159 143 nr  275  Gareis  et  al.  (2003) 
United 
Kingdom 
2002-2004 Oats
(e) Targeted  458  10  330  nr  49
(h) 24 nr  847  Edwards  (2009a) 
2001-2005 Wheat  Targeted  1624  10  1088  nr  27
(h) 16 nr  430  Edwards  (2009a) 
 2002-2005  Barley  Targeted  446  10  112  nr  <  LOQ
(h) nr  nr  15  Edwards  (2009a) 
  2005  Malting barley  Targeted  18  nr  nr  nr  3.4  nr  nr  12  Baxter et al. (2009) 
 2006  Milling  wheat
(e)  Targeted  40  nr  nr  nr  7.7  nr  nr  38  Baxter et al. (2009) 
    Malting barley  Targeted  20  nr  nr  nr  1.8  nr  nr  10  Baxter et al. (2009) 
   Malting  barley
 (e) Targeted  20  nr  nr  nr  4.2  nr  nr  22  Baxter et al. (2009) 
 2007  Milling  wheat
(e)  Targeted  50  nr  nr  nr  13  nr  nr  164  Baxter et al. (2009) 
    Malting barley  Targeted  20  nr  nr  nr  8.5  nr  nr  39  Baxter et al. (2009) 
   Malting  barley
 (e) Targeted  40  nr  nr  nr  9.8  nr  nr  39  Baxter et al. (2009) 
 2008  Milling  wheat
(e)  Targeted  50  nr  nr  nr  8.6  nr  nr  46  Baxter et al. (2009) 
    Malting barley  Targeted  19  nr  nr  nr  9.6  nr  nr  45  Baxter et al. (2009) 
   Malting  barley
 (e) Targeted  36  nr  nr  nr  15  nr  nr  137  Baxter et al. (2009) 
LOQ: limit of quantification; LOD: limit of detection; Min: Minimum; Max: Maximum; nr: data not reported 
(a):  Several studies reported limited data; calculation of mean and median values was not always clear (e.g. based on positive data only, mathematical handling of non-detected not always clear); 
(b):  Sampling was carried out either randomly or it was targeted i.e. samples were taken from certain area or specific location. 
(c):  For results lower than LOD, value of LOD/2 used for calculation. For results lower than LOQ, numerical value used; if not available, value of LOQ/6 used; 
(d):  25/40 indicates that the LOQ is not specified but is either 25 µg/kg or 40 µg/kg; 5-10 indicates that the LOQ ranges from 5 µg/kg to 10 µg/kg; 10-20 indicates that the LOQ ranges from 10 
µg/kg to 20 µg/kg; 
(e):  Field sample; 
(f):   Half of the LOD was used for results below LOD (30 µg/kg); 
(g):  Half of the LOQ (range of 0.3-3.9 µg/kg) was used for results below the LOQ (10-20 µg/kg); (h): Based on a value of 1.667 for samples below LOQ. Nivalenol in food and feed
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Table A2:  Occurrence of nivalenol in food products
(a) 
Country Year  Food  product  Number 
of 
samples 
LOQ 
µg/kg 
Samples 
greater 
than 
LOQ 
Mean of 
positive 
samples 
µg/kg 
Mean of all 
samples 
µg/kg 
Median 
µg/kg 
Min of 
positive 
samples 
µg/kg
Max 
µg/kg 
Reference 
Denmark 2001  Wheat  flour  29  20  14 26  nr  13  nr 189  Rasmussen et al. (2003) 
  Rye flour  20  20  1  < LOQ  nr
  10  nr  10  Rasmussen et al. (2003) 
Germany 2000-2001  Semolina  (Maize)  14  nr  1  36  nr  nr nr  36  Schollenberger et al. (2005a) 
 Maize  flour  15  nr  Nr  39  nr 39
(d)  22  56  Schollenberger et al. (2005a) 
  Wheat germ  5  nr  2  26  nr  26  21  30  Schollenberger et al. (2005b) 
  Gluten free food  23  nr  1  21  nr  nr  nr  21  Schollenberger et al. (2005b) 
  Wheat bran  5  nr  5  37  nr  32  21  65  Schollenberger et al. (2005b) 
Not 
specified 
Soy food  45  nr  nr  nr  < LOQ  < LOQ  nr  < LOQ  Schollenberger et al. (2007) 
  2005-2006  Wheat flour  39  2.2  22  nr  4.3  1.8  nr  77  Gottschalk et al. (2009) 
  Whole wheat flour  11  2.2  10  nr  13  9.5  nr  62  Gottschalk et al. (2009) 
  Wheat kernels  52  2.2  40  nr  5.7  1.8  nr  31  Gottschalk et al. (2009) 
  Semolina  13  2.2  4  nr  3.4  < LOQ  nr  35  Gottschalk et al. (2009) 
  Wheat bran  10  2.2  9  nr  23  14  nr  96  Gottschalk et al. (2009) 
    Wheat-based infant food  5  2.2  2  nr  2.1  < LOQ  nr  8.8  Gottschalk et al. (2009) 
    Rye flour  15  2.2  nr  nr  < LOQ  < LOQ  nr  < LOQ  Gottschalk et al. (2009) 
    Whole rye flour  9  2.2  nr  nr  < LOQ  < LOQ  nr  < LOQ  Gottschalk et al. (2009) 
    Rye kernels  37  2.2  2  nr  0.1  < LOQ  nr  1.8  Gottschalk et al. (2009) 
    Fine oat flakes  31  2.2  12  nr  2  < LOQ  nr  17  Gottschalk et al. (2009) 
    Oat flakes  23  2.2  4  nr  0.3  < LOQ  nr  1.8  Gottschalk et al. (2009) 
    Oat kernels  19  2.2  5  nr  1.1  < LOQ  nr  8.7  Gottschalk et al. (2009) 
    Oat bran  12  2.2  2  nr  0.3  < LOQ  nr  1.8  Gottschalk et al. (2009) 
   Oat-based  infant  food  13  2.2  1  nr  0.1  < LOQ  nr  1.8  Gottschalk et al. (2009) 
  2004-2005  Refined edible oil  61  24  0  < LOQ  <LOQ  < LOQ  < LOQ  < LOQ  Schollenberger et al. (2008) 
    Non-refined oil  49  24  0  < LOQ  <LOQ  < LOQ  < LOQ  < LOQ  Schollenberger et al. (2008) 
  2005  Soy food  45  28  0  < LOQ  <LOQ  < LOQ  < LOQ  < LOQ  Schollenberger et al. (2007) 
Italy 1002  Grain-based 
product
(a)(organic) 
4  30  1  nr nr nr  nr  79  Jestoi  et  al.  (2004) 
   Grain-based  product 
(conventional) 
8  30  1  nr nr nr  nr  <30  Jestoi  et  al.  (2004) 
 Nivalenol in food and feed
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Table A2:  Continued.
 
Country Year  Food  product  Number 
of 
samples 
LOQ 
µg/kg 
Samples 
greater 
than 
LOQ 
Mean of 
positive 
samples 
µg/kg 
Mean of all 
samples 
µg/kg 
Median 
µg/kg 
Min of 
positive 
samples 
µg/kg
Max 
µg/kg 
Reference 
Spain 2005  Maize-based  breakfast 
cereal 
55 16 6  nr  nr  67.8
(b)  51.1  106.5  Castillo et al. (2008) 
   Maize-based  baked 
snacks 
57 16 1  55.7  nr  55.7
(b)  nr  nr  Castillo et al. (2008) 
Sweden  2001  Durum wheat flour  10  nr  10  47  nr  52  nr  83  Rasmussen et al. (2003) 
United 
Kingdom 
2001  Maize products  24  10  nr  19  nr  <10  nr  58  Gareis et al. (2003) 
  Wheat products  13  10  nr  15.5  nr  <10  nr  17  Gareis et al. (2003) 
LOQ: limit of quantification; LOD: limit of detection; Min: Minimum; Max: Maximum; nr: data not reported 
(a):  Several studies reported limited data; calculation of mean and median values was not always clear (e.g. based on all data or based on positive data only, mathematical handling of non-
detects not always clear); 
(b):  Median of positive samples. 
 
 
 
 
 
 
 
 
 
 Nivalenol in food and feed
 
EFSA Journal 2013;11(6):3262  108
Appendix B.   Intakes and composition  of diets used in estimating animal exposure to 
nivalenol  
This Appendix gives feed intakes for different livestock, fish and companion animals used in this 
Scientific Opinion. The composition of diets for each of the major farm livestock species are based on 
published guidelines on nutrition and feeding (e.g. AFRC, 1993; Carabano and Piquer, 1998; NRC 
2007a,b; Leeson and Summers, 2008; EFSA, 2009a; OECD, 2009; McDonald et al., 2011) and data on 
EU manufacture of compound feeds (FEFAC, 2009). They are therefore estimates of the Panel on 
Contaminants in the Food Chain (CONTAM Panel), but are in agreement with common practice. 
Based on these estimates of intake, the lower-bound (LB) and upper-bound (UB) mean concentrations 
of nivalenol in the estimated diets for the farm livestock species and companion animals have been 
calculated and are given in this Appendix. 
B1. Feed intake 
B1.1. Cattle, sheep and goats 
The diets of cattle, sheep and goats consist of predominantly of forages supplemented mainly with 
cereal grains and vegetable proteins and other by-products of food production as necessary (see 
Section 5.2). In the absence of any occurrence data of nivalenol in grass and legume-based forages 
(Table 7), it is assumed that they make no significant contribution to exposure. Therefore, exposure 
has been estimated for the non-forage feeds only
30. Live weights, feed intakes and growth 
rates/productivity are from AFRC (1993) and NRC (2007a). The live weights, feed intakes, the 
proportion of the daily ration that is non-forage feed and growth rates/productivity for cattle, sheep 
and goats used in this Scientific Opinion are given in Table B1. 
Table B1:  Live weights, growth rate/productivity, dry matter intake for cattle, sheep and goats, and 
the proportions of the diet as non-forage. 
 Live  weight 
(kg) 
Growth rate or 
productivity 
Dry matter 
intake 
(kg/day) 
% of diet as 
non-forage 
feed  
Reference 
Dairy cows, lactating  650  40 kg milk/day  20.7  40  AFRC (1993) 
Fattening cattle: beef
(a) 400  1  kg/day  9.6  15  AFRC  (1993) 
Fattening cattle: maize 
beef 
400  1.4 kg/day  10.5  10  Browne et al. 
(2004) 
Fattening cattle: cereal 
beef 
400 1.4  kg/day  8.4  85 AFRC  (1993) 
Sheep: lactating  80  Feeding twin 
lambs 
2.8 50  AFRC  (1993) 
Goats: milking
(b)  60  6 kg milk/day  3.4  65  NRC (2007a) 
Goats: fattening   40  0.2 kg/day  1.5  40  NRC (2007a) 
(a):  housed castrate cattle, medium maturing breed;  
(b):  months 2-3 of lactation. 
 
Forage maize, fed as maize silage, is widely used as a feed for ruminants in Europe.  As noted in 
Section 4.2.14, nivalenol has been reported in maize silage (Table 7). AFSSA (2009) have provided 
example intakes of dairy cows fed maize silage, maize grain and soybean meal, and these are given in 
Table B5. 
B1.2. Pigs, poultry and fish 
Data for feed intake and live weight of pigs, poultry and fish are from EFSA (2009a) and of ducks 
from Leeson and Summers (2008) are used in this Scientific Opinion (Table B2). 
                                                      
30 Forages may include whole-crop cereals. While nivalenol may be present, there are no data available. Nivalenol in food and feed
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Data for feed intake and live weight of pigs, poultry and fish are from EFSA (2009a) and of ducks 
from Leeson and Summers (2008) are used in this Scientific Opinion (Table B2). 
Table B2:  Live weights and feed intake for pigs, poultry and fish (EFSA, 2009a) and ducks (Leeson 
and Summers, 2008). 
  Live weight (kg)  Feed intake (kg dry matter/day) 
Pigs: piglets  20  1.0 
Pigs: fattening pigs  100  3.0 
Pigs: lactating sows  200  6.0 
Poultry: broilers
(a) 2  0.12 
Poultry: laying hens  2  0.12 
Turkeys: fattening turkeys  12  0.40 
Ducks: fattening ducks  3  0.14 
Salmonids 2  0.04 
(a):  chickens for fattening. 
 
B1.3. Rabbits 
A daily intake of 75 g/kg b.w. for a 2 kg rabbit is used in this Scientific Opinion to estimate exposure 
(derived from Carabano and Piquer, 1998). 
B1.4. Horses 
In this Scientific Opinion, exposure to nivalenol has been estimated for a  mature horse (450 kg live 
weight) with a moderate level of activity and a dry matter intake of 9 kg/day, of which half is non-
forage feeds (NRC, 2007b). 
B1.5. Companion animals (dogs and cats) 
The amount of food consumed is largely a function of the mature weight of the animal, level of 
activity, physiological status (e.g. pregnancy or lactation) and the energy content of the diet. In this 
Scientific Opinion the CONTAM Panel estimated daily intake of dogs and cats based on NRC (2006). 
Intakes for a 25 kg dog and a 4 kg cat given below in Table B3 have been used in this Scientific 
Opinion to estimate exposure. 
Table B3:  Estimates of total food and intake, derived from NRC (2006) and the proportion that 
might consist of cereals and cereal by-products for adult dogs and cats (J.M. Fremy, 2011, personal 
communication). 
  Dogs Cats 
Body weight (kg)  25  4 
Feed intake (g/day)  360  60 
% cereals and cereal by-products  65  55 
 
B2. Diet composition and concentration estimates 
Many livestock in the European countries are fed proprietary commercial compound feeds. However, 
in the absence of any reliable data on levels of nivalenol in compound feeds provided by the European 
countries (Section 4.2.14), it has not been possible to estimate exposure based on compound feed 
intakes. As discussed in Section 5.2, a wide range of cereals and cereal by-products are used, in 
varying proportions, in livestock diets in Europe. However, in the absence of suitable data on levels of 
nivalenol in individual feed materials, the CONTAM Panel decided to use the LB and UB values for Nivalenol in food and feed
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the feed group ‘cereal grains, their products and by-products’ of 11 and 43 µg/kg (Table 7), 
respectively. Inclusion rates of cereal grains, their products and by-products in the non-forage 
component of the diet for different livestock and companion animals are given below, and these have 
been used to calculate the nivalenol concentrations in the diets.  
As noted above, levels of nivalenol in forage crops are low and it has been assumed that with the 
exception of maize silage they make no contribution to the exposure. Therefore, for cattle, sheep, 
goats and horses exposure has only been estimated for non-forage component of the ration. An 
exception to this is maize silage mean LB and UB values of 80 and 173 µg/kg, respectively have been 
reported (Table 7, Section 4.2.14), and these values have been used in estimating the exposure for 
livestock fed maize silage-based diets. 
B2.1. Cattle, sheep and goats 
Assumed inclusion rates of cereal grains, their products and by-products in the non-forage component 
of diets for cattle, sheep and goats are given in Table B4, together with the calculated mean LB and 
UB concentrations of nivalenol assuming LB and UB concentrations above. 
Table B4:  Assumed inclusion rates (%) of cereal grains, their products and by-products in the non-
forage component of diets for cattle, sheep and goats, and the calculated mean lower-bound and upper-
bound concentrations of nivalenol in these diets. 
 Dairy  cow: 
High 
yielding 
Beef 
cattle: 
Cereal 
beef  
Beef 
cattle: 
Fattening 
Beef 
cattle: 
Maize 
beef 
Sheep: 
Lactating 
Goats: 
Dairy  
Goats: 
Fattening 
Cereal grains and 
cereal by-products
(a) 
55 %  75 %  60 %  75 %  55 %  60 %  70 % 
  Nivalenol concentration (µg/kg dry matter) 
Lower-bound 2.4  7.0  1.3  72  3.0  4.3  3.1 
Upper-bound 9.5  27.4  5.2  157  11.8  16.8  12.0 
(a): The percentage of the non-forage component of the diet as reported in Table B1. 
 
Levels of nivalenol in ruminant diets reported above assume that forages do not contain any nivalenol. 
However, maize silage is an important forage in ruminant diets, and as reported in Table 7 in Section 
4.2.14 nivalenol has been reported in samples of maize silage. A report from France described typical 
rations for dairy cows fed diets based on different forages with non-forage feeds and milk yields 
(AFSSA, 2009) (Table B5). For the cereal grains, their products and by-products, the LB and UB 
concentrations of 11 and 43 µg/kg, respectively were calculated. 
Table B5:  Feed intakes of dairy cows fed diets based on maize silage with non-forage feeds adjusted 
for milk yield (From AFSSA, 2009, modified), and the calculated mean lower-bound and upper-bound 
concentrations of nivalenol in these diets. 
Milk 
production 
(kg/day) 
Quantities of feed consumed   
(kg dry matter/day) 
Nivalenol concentration  
(µg/kg dry matter) 
Maize silage  Maize grain  Soybean meal  Lower bound  Upper bound 
30 15.3  4.4  2.3  58  130 
40 15.0  9.5  2.8  48  111 
50 14.7  8.8  4.4  46  105 
 Nivalenol in food and feed
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B2.2. Pigs and poultry 
Pig and poultry diets consist predominantly of cereals and vegetable proteins. Pig diets may also 
include more fibrous feeds, particularly for older animals. The assumed inclusion rates of cereal 
grains, their products and by-products in the non-forage component of diets for pigs and poultry are 
presented in Table B6 together with the calculated mean LB and UB concentrations of nivalenol 
assuming LB and UB concentrations above.  
Table B6:  Assumed inclusion rates (%) of cereal grains, their products and by-products in the non-
forage component of diets for pigs and poultry, and the calculated mean lower-bound and upper-bound 
concentrations of the nivalenol in these diets. 
  Piglets Pigs  for 
fattening 
Lactating 
sow 
Broilers Laying 
hens 
Turkeys 
for 
fattening 
Ducks for 
fattening 
Cereal grains, their 
products and by-
products  
74 %  72 %  75 %  74 %  65 %  65 %  72 % 
Nivalenol concentration (µg/kg dry matter) 
Lower-bound 8.1  7.9  8.3  8.1  7.2  7.2  7.9 
Upper-bound 31.8  31.0  32.3  31.8  28.0  28.0  31.0 
 
B2.3. Rabbits 
Although there are no published standard rations for rabbits, in a typical French commercial rabbit 
compound feed cereal grains, their products and by-products account for 36 % of the total diet 
(T. Gidenne, 2011, personal communication). Assuming LB and UB concentrations above, estimated 
dietary LB and UB nivalenol concentrations are 3.9 and 15.4 µg/kg, respectively.  
B2.4. Farmed fish 
A wide range of diets is used for commercially farmed fish in Europe. However, fish meal and fish 
oils are usually the main ingredients. The salmon feed composition described by Berntssen et al. 
(2010) has been used as being representative of commercial feed producers, and in this formulation 
cereal grains and cereal by-products accounted for 25 % by weight of all ingredients. On this basis 
when cereal grains, their products and by-products contain 11 (LB) and 43 (UB) µg nivalenol/kg, the 
calculated mean LB and UB nivalenol concentrations in this diet are 2.7 and 10.6 µg/kg, respectively.  
B2.5. Horses 
Oats and oat by-products are widely used as feeds for horses. In this Scientific Opinion, it is assumed 
that cereal grains, their products and by-products represent 75 % of the non-forages component of the 
diet. Assuming that forages account for half of the total feed dry matter intake, and the above LB and 
UB concentrations, then the calculated LB and UB nivalenol concentrations in this diet are 4.5 and 
17.6 µg/kg, respectively. 
B2.6. Companion animals (dogs and cats) 
In typical French commercial pet foods, the cereals used are wheat, maize, barley, rice, maize gluten 
based on data compiled from six and seven different food brands for dogs and cats, respectively, 
collected from pet food stores and veterinary clinics (J.M. Fremy, 2011, personal communication). 
The amounts of cereals in the premium quality and the standard quality dog food are 45 % and 65 %, Nivalenol in food and feed
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respectively; in cat foods cereals and cereal by-products represented 40 % in premium quality food 
and 55 % in the standard quality food (B.M. Paragon, 2011, personal communication)
31.  
Assuming 65 and 55 % cereal grains, their products and by-products in standard dog and cat foods, 
respectively, and the above LB and UB concentrations, the mean LB and UB concentrations of 
nivalenol are estimated as 7.2 and 28.0 µg/kg in dog food, and 6.1 and 23.7 µg/kg in cat food, 
respectively. 
 
 
                                                      
31   Based on statistics of 2010 of the French association of pet food manufacturers (FACCO), http://www.facco.fr/ Nivalenol in food and feed
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Appendix C.   A summary of the median contribution of the different food groups across the dietary surveys 
 
Table C1:  Contribution (%) of the different food groups to chronic dietary exposure to nivalenol in lower-bound scenario. Median values across dietary 
surveys and ranges from the lowest to the highest average contribution are presented. 
Food group  Median contribution across dietary surveys  (Lowest average contribution – Highest average contribution) 
Infants Toddlers  Other  children  Adolescents  Adults Elderly  Very  elderly 
  % 
Grains for human consumption  -
(a) (0-0.06)  0.90 (0-8.5)  0.76 (0-4.8)  0.93 (0-6.7)  0.71 (0-30)  2.4 (0-7.6)  1.1 (0-3.7) 
Grain milling products  -
(a) (49-50)  17 (0-57)  15 (0-90)  11 (1.6-73)  38 (2.5-77)  45 (2.1-77)  43 (3.0-77) 
Bread and rolls
(b)  -
(a) (0.70-28)  50 (6.0-86)  34 (9.0-85)  36 (8.0-76)  27 (10-74)  35 (15-78)  34 (14-81) 
Pasta
(b) -
(a) (1.6-27)  9.1 (2.0-23)  7.3 (1.9-41)  12 (1.5-22)  6.8 (0.50-26)  8.8 (1.2-18)  8.3 (1.0-20) 
Breakfast cereals
(b) -
(a) (0-0.050)  0.8 (0-6.0)  5.8 (0-37)  6.7 (0-22)  2.8 (0.45-16)  1.7 (0.11-5.9)  1.0 (0.32-4.3) 
Fine bakery wares
(b) -
(a) (0-17)  11 (2.4-15)  10 (0.80-39)  11 (0.70-35)  12 (0.37-34)  5.4 (0.48-15)  5.2 (0.70-18) 
Food for infants and small children
(b) -
(a) (4.0-23)  7.5 (1.1-24)  0.16 (0-5.1)  0 (0-0.17)  0 (0-0.11)  0 (0-0.020)  0 (0-0.060) 
Beer and beer-like beverage
(c) -
(a) (0-0)  0 (0-0)  0 (0-0)  0 (0-0)  0 (0-0)  0 (0-0)  0 (0-0) 
(a):  Median value not calculated as only two dietary surveys were available for infants;  
(b):  Calculation based on occurrence data with more than 90 % of left-censored data: for bread and rolls only 13 positive results available, for pasta only five positive results available, for 
breakfast cereals only 30 positive results available, for fine bakery wares only 16 positive results available, for food for infants and small children only four positive results available;  
(c):  Calculation based on occurrence data with 100 % of left-censored data. 
 Nivalenol in food and feed
 
EFSA Journal 2013;11(6):3262  114
Appendix D.   Dose-response modelling  
The details of the benchmark dose (BMD) analysis of the white blood cell (WBC) count data of the 
90-day rat study of Takahashi et al. (2008) on nivalenol identified as the critical data for the risk 
characterisation of nivalenol in this Scientific Opinion in Sections 7.7 and 7.8 are presented in this 
Appendix B. Since the observed dose response curves for males and females exhibited a high degree 
of similarity, the dose ranges were by design identical and the range of the observed WBC count was 
comparable in both sexes, a combined BMD modelling of the male and female dose-response data 
using sex as covariate was performed using the PROAST software
32. For the benchmark response 
(BMR) the default value for continuous data recommended by EFSA (2009b) of 5 % extra risk was 
used in the absence of statistical or toxicological considerations supporting a deviation from that 
default value. The BMR was defined as a percent change of the magnitude of the response when 
compared to that predicted at background, i.e. a relative deviation from background. The BMD 
analysis was based on means and standard deviations available from the 90-day study for the two 
sexes using the PROAST software following advice given in EFSA (2011), with technical support 
from W. Slob and B.G.H. Bokkers, personal communication (2012). 
Two sets of nested families, the Exponential (E) and the Hill (H) models were fitted to the data, 
respectively. The Exponential Model E1 denotes the reduced model for both families.  
The models of the two nested families were fitted to the combined two data sets analysed using a 
covariate adjusted BMD analysis as implemented in the PROAST software to derive a common 
BMDL for both sexes for the critical endpoint of decrease in the WBC counts. The best fitting models 
were identified using the implemented algorithms of the software for calculating the BMD05 and the 
95 % benchmark dose lower confidence limit (BMDL05) for each model family. In both, the 
Exponential family and the Hill family the models E2 and H2 fitted best. 
Table D1 presents the results of this analysis. In addition to the BMD05, BMDL05 and the 95 % upper 
confidence limit for the benchmark dose response of 5 % extra risk (BMDU05) values, also the log-
likelihood values, the number of model parameters and the results of testing for goodness of fit at the 
default significance level of 5 % are reported. 
The interval from the BMDL05 to the BMDU05 represents the 90 % confidence interval of the BMD 
and provides such a descriptive measure for the accuracy of the BMD, which for an acceptable 
BMD/L value should not be larger than one order of magnitude, i.e. the BMD/BMDL or the 
BMDU/BMDL ratio should not be considerably larger than about 5 or 10, respectively (EFSA, 2009).  
Of the two best fitting models E2 and H2, the smallest BMDL05 value of 0.35 mg/kg b.w. per day was 
chosen as the BMDL05 to be used for risk characterization.  
                                                      
32   http://www.rivm.nl/en/Library/Scientific/Models/PROAST. See the application of both the Exponential and the Hill nested 
model families for continuous data. Nivalenol in food and feed
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Table D1:  The benchmark dose (BMD), its 95 % lower confidence limit (BMDL) and 95 % upper 
confidence limit (BMDU) values for white blood cell (WBC) count values calculated for benchmark 
response (BMR) of 5 % extra risk in units of mg/kg b.w. per day. Two data sets, one on males and one 
on females of the 90-day sub-chronic study, were combined and the BMD analysis for the combined 
data was performed by using sex as a covariate. E2 denotes the best fitting model of the Exponential 
nested family and H2 the best fitting model of the Hill nested family. 
        90 % CI, two-sided 
Model 
Log-likelihood 
(number of 
parameters) 
Model fit
(a) 
(acceptance 
probability) 
BMD05
(b) 
BMDL05
(c) 
mg/kg b.w. per 
day 
BMDU05
(c) 
mg/kg b.w. per 
day 
Exponential 
nested family 
        
E2   -0.94 (4)  selected (p > 0.05)  0.60  0.50  0.76 
Hill nested 
family 
 
 
      
H2   -1.19 (4)  selected (p > 0.05)  0.46   0.35  0.62 
E: Exponential model; H: Hill model; CI: confidence interval; BMD: benchmark dose; b.w.: body weight; p: p-value.  
(a):  p-value of the comparison with the full model;  
(b):  BMD05: benchmark dose estimate for the BMR = 5% extra risk: 
(c):  BMDL05: the 95 % benchmark dose lower confidence limit and BMDU05: 95% benchmark dose upper confidence limit 
for the BMR = 5% extra risk.  
 
Figures D1 and D2 show the fit of the Exponential and the Hill models E2 and H2 for the covariate 
adjusted BMD analysis, respectively. For interpreting the graphs it should be noted that the data of 
each dose group are assumed to be log-normally distributed as the PROAST software has been 
designed. Therefore, the software reconstructs from the reported summary data of arithmetic means 
and standard deviations a lognormal distribution by calculating the corresponding geometric means 
and geometric standard deviations, fits each nested model family to these data and back-calculates 
them to the original scale. It should be also noted that PROAST software presents the 95 % confidence 
interval of the means using the lognormal distribution such that the whiskers in the graphic do not 
indicate the range of the data or the range between plus/minus the standard deviation or standard errors 
of the mean.  
 For comparison reasons, the CONTAM Panel also calculated the BMD, BMDL and BMDU values 
for a BMR of 10 % extra risk and 20 % extra risk. Roughly, the BMDL values doubled 
(BMDL10 = 0.75 mg/kg b.w. per day and BMDL20 = 1.67 mg/kg b.w. per day) when increasing the 
BMR from 5 % to 10 % or from 10 % to 20 %, respectively. Furthermore, the sensitivity of the 
combined BMD analysis of the data of the two sexes of rats was investigated by fitting the two nested 
families separately to the male and the female data. For the Hill model chosen for the calculation of 
the BMDL the BMD05 values for males and females were 0.49 and 0.41 mg/kg b.w. per day, 
respectively, with BMDL05/BMDU05 values of 0.35/0.77 mg/kg b.w. per day for males and 
0.30/0.62 mg/kg b.w. per day for females. Therefore, the BMD analysis of the combined data with sex 
as covariate resulted in a BMD approximately equal to the mean of the two sex specific values and 
was supported by the results obtained from separate analyses of the male and female data. The 
BMDL05 value of the combined analysis was higher than the lowest BMDL05 value calculated for the 
two sexes separately which reflects the higher precision of the BMDL05 when combining data and 
such increasing the power of statistical modeling.   Nivalenol in food and feed
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Figure D1:   Fitted Exponential family model E2 to the combined white blood cell (WBC) count data 
on the males and females of the 90-day sub-chronic study and analysed using a covariate adjusted 
BMD. The dotted vertical line indicates the BMDL05. The upper dose-response curve is for males and 
the lower one for females. The circles represent the geometric means of the lognormal distribution 
reconstructed from the reported data used in the BMD analysis and they are plotted on the original 
scale. The range of the whiskers at each mean represents the 95 % confidence interval of that mean for 
the respective dose group. 
 
Figure D2:   Fitted Hill family model H2 to the combined white blood cell (WBC) count data on the 
males and females of the 90-day sub-chronic study and analysed using a covariate adjusted BMD. The 
dotted vertical line indicates the BMDL05. The upper dose-response curve is for males and the lower 
one for females. The circles represent the geometric means of the lognormal distribution reconstructed 
from the reported summary data used in the BMD analysis and they are plotted on the original scale. 
The range of the whiskers at each mean represents the 95 % confidence interval of that mean for the 
respective dose group. Nivalenol in food and feed
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ABBREVIATIONS 
 
ACE    Accelerated  solvent  extraction 
ACN    Acetonitrile 
AcOH    Acetic  acid 
AFSSA   French Food Safety Authority/Agence Française de Sécurité des Aliments 
ALP    Alkaline  phosphatase 
ANSES  French National Agency for Sanitary Safety of Food, Environment and 
Labour/Agence Nationale de Sécurité Sanitaire de l'Alimentation, de 
l'Environnement et du Travail  
APCI    Atmospheric  pressure  chemical  ionisation 
APPI    Atmospheric  pressure  photoionisation 
Bax      Bcl-2 associated X protein 
BE    Belgium 
BG    Bulgaria 
BMD    Benchmark  dose 
BMDL05  95 % lower confidence limit for the benchmark dose response of 5 % extra 
risk 
BMDU05  95 % upper confidence limit for the benchmark dose response of 5 % extra 
risk 
BMR    Benchmark  response 
b.w.    Body  weight 
CAS    Chemical  Abstracts  Service 
CONTAM Panel  Panel on Contaminants in the Food Chain 
CPK    Creatinine  phosphokinase 
CRM    Certified  reference  materials 
CY    Cyprus 
CZ    Czech  Republic 
DART      Direct analysis in real time 
DCs    Dendritic  cells 
DCM Unit    Dietary and Chemical Monitoring Unit 
DCNB    1,2-dichloro-4-nitrobenzene   
DE    Germany 
DK    Denmark 
DNA    Deoxyribonucleic  acid 
DON    Deoxynivalenol 
EC    European  Commision 
ECD    Electron  capture  detection 
EFSA      European Food Safety Authority 
ELISA    Enzyme-linked  immunosorbent  assay 
ERK      Extracellular signal regulated kinase 
EROD      Ethoxyresorufin  O-deealkylase   
ES    Spain 
ESI    Electrospray  ionization 
EtOAc    Ethyl  acetate 
EU    European  Union 
EVIRA    The  Finnish  Food  Safety  Authority 
EXPOCHI   Article 36 project ’Individual food consumption data and exposure assessment 
studies for children‘ 
FAO/WHO    Food and Agriculture Organization of the United Nations/World Health 
Organization 
FEFAC     European Feed Manufacturers Federation  
FI    Finland 
FID    Flame  ionisation  detection Nivalenol in food and feed
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FLD    Fluorescence  detector 
FR    France 
GC    Gas  chromatography 
GOT    Glutamic-oxaloacetic  transaminase 
GPT      Glutamic-pyruvic  transaminase 
GR    Greece 
GST-P      Glutathione S-transferase placental form 
HCOOH   Formic  acid 
HIGA      High IgA strain of mice 
HPLC      High performance liquid chromatography 
HRMS    High-resolution  mass  spectrometry 
HT-2    HT-2  toxin 
HU    Hungary 
H2O    Water 
IgA    Immunoglobulin  A 
IgE    Immunoglobulin  E 
IgG    Immunoglobulin  G 
IgM    Immunoglobulin  M 
IARC      International Agency for Research on Cancer 
IC10       10 % inhibitory concentration 
IE    Ireland 
IFN-beta   Interferon-beta 
IFN-γ    Interferon-γ 
IL-2    Interleukin-2 
IL-8    Interleukin-8 
IL-1β    Interleukin-1beta 
iNOS    inducible  NO  synthase 
INRA  French National Institute for Agricultural Research/Institut national de la 
recherche agronomique, France 
i.p.    Intraperitoneal 
IT    Italy 
JECFA     Joint FAO/WHO Expert Committee on Food Additives 
LB    Lower-bound 
LC    Liquid  chromatography 
LC  data    Left-censored  data 
LCL    Lowest  calibration  levels 
LC-MS/MS    Liquid chromatography-tandem mass spectrometry 
LFDs    Lateral  flow  devices 
LOAEL  Lowest-observed-adverse-effect  level 
LOD    Limit  of  detection 
LOEL    Lowest-observed-effect  level 
LOQ    Limit  of  quantification 
LPS    Lipopolysaccharide 
LV    Latvia 
MCP1      Monocyte chemoattractant protein 1 
MHC    Major  histocompatibility  complex 
MeOH    Methanol 
MRP2      Multi drug resistance associated protein 2 
MS    Mass  spectrometry 
MS/MS    Tandem  mass  spectrometer 
MTT    Agrifood  Research  Finland 
N    Number  of  samples 
NEFA    Non-esterified  fatty  acids 
NDEA    Nitroso-diethylamine 
NIV    Nivalenol Nivalenol in food and feed
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NK cells    Natural killers cells 
NL    The  Netherlands 
NO    Nitric  oxide 
NOAEL  No-observed-adverse-effect  level 
NOEL    No-observed-effect  level 
NRC    National  Research  Council    
nr    Data  not  reported 
P25    25
th percentile 
P50    50
th percentile 
P75    75
th percentile 
P95    95
th percentile 
PARP      Poly-adenosine diphosphate (ADP)-ribose polymerase 
PCBs    Polychlorinated  biphenyls 
PMA    Paramethoxyamphetamine 
PMTDI     Provisional maximum tolerable daily intake 
RIVM      National Institute for Public Health and the Environment, Netherlands 
PROD    Pentoxyresorufin  O-depenthylase 
PSA    Primary-secondary  amine 
QuEChERS     Quick, easy, cheap, effective, rugged and safe 
RM    Reference  material 
RNA    Ribonucleic  acid 
SCF      Scientific Committee on Food 
SCOOP    Scientific  Co-operation     
SE    Sweden 
SRM    Selected  reaction  monitoring 
SPE    Solid  phase  extraction 
SPR    Surface  plasmon  resonance 
T-2    T-2  toxin 
TDI    Tolerable  daily  intake 
TDS1      First total diet study 
TDS2    Second  total  diet  study 
TMS    Trimethylsilyl 
TOF-MS   Time-of-flight  mass  spectrometry 
TPA    12-O-tetradecanoylphorbol-13-acetate 
t-TDI      Temporary tolerable daily intake 
TNF-alpha    tumor necrosis factor-alpha 
UB    Upper-bound 
UHPLC    Ultra high performance-liquid chromatograph 
UK    United  Kingdom 
UV    Ultraviolet 
v/v    volume/volume 
WBC    White  blood  cells 
WHO    World  Health  Organization 
 